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Chapter 1
In t r o d u c t i o n
1.1 Background
History of the ff-lactam antibiotics.*
The ff-lactam antibiotics account for approximately 50% of the total world 
sales of all currently available antibiotics. The development of this class of antibiotics 
started with the serendipitous discovery of penicillin G by Alexander Fleming in 
1928.2 When Fleming returned from a vacation to his laboratory at St. Mary's 
Hospital in London, he noticed that one of the Petri-dishes containing colonies of 
Staphylococcus bacteria was contaminated with a mold that had inhibited the growth 
of the bacteria.1 He named the contaminating substance penicillin after the mold 
Pénicillium notatum.
O
CO2H
penicillin G
During the decade after this discovery, Fleming and others searched for 
methods for the purification and stabilization of penicillin. The breakthrough in the 
preparation of penicillin was made in 1939 by the research team supervised by 
Florey and Chain.3 Florey showed in 1940 that penicillin protected mice against 
infection from Streptococci bacteria. In the year thereafter, penicillin was used for the 
first time on a patient who had an infection from a scratch, which had spread 
through his body. The patient's condition improved significantly after penicillin was 
administered. Unfortunately, the supplies of penicillin ran out, and the patient 
eventually died from this infection. The clinical trials of penicillin started in 1942.
* Inform ation concerning the historical background of ff-lactam antibiotics w as derived from ref. 1.
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Many academic and industrial groups were involved in the further development of 
the chemistry and fermentation of penicillin G.4 In order to have sufficient supplies 
of penicillin available for the D-day invasion of Europe, 21 companies were selected 
for the wartime penicillin production program. At the end of the Second World War, 
an estimated 95% of soldiers with an infected wound were surviving, thanks to 
medication with penicillin. When after the war all restrictions on the availability of 
penicillin were removed, the antibiotic became available for the consumer in 
pharmacies.1 For their discovery Fleming, Chain and Florey were jointly awarded 
the Nobel Prize in physiology and medicine in 1945.
A clearly negative feature of penicillin G is that it is only active when 
administered by intravenous injection. In addition, there were a few cases of 
hypersensitivity and shock reaction to such injections. Several orally active salts of 
penicillin G were introduced, followed by the discovery of the unnatural penicillin V 
in 1953. After the discovery of penicillin V, the extensive search for new penicillins 
started. The isolation of 6-amino-penicillanic acid (6-APA) by scientists from 
Beecham in 1957 was a major breakthrough that opened avenues for the 
development of semi-synthetic penicillins.5 The first semi-synthetic penicillin 
pheneticillin was launched by Bristol in 1959. After some other semi-synthetic 
penicillins, Ampicillin was introduced by Beecham in 1961 as the first orally active 
broad-spectrum penicillin. Ampicillin was followed up by the superior Amoxicillin, 
also a Beecham product that was introduced in 1972. The Amoxicillin market was 
threatened by the emerging resistance of bacteria against this antibiotic. However, 
this problem was substantially countered by combining Amoxicillin with the orally 
active ff-lactamase inhibitor clavulanic acid, a combination drug that was marketed 
as Augmentin.
O O
CO2H CO2H
penicillin V 6-APA
O
CO2KCO2H
R = H Ampicillin 
R = OH Amoxicillin
clavulanic acid potassium salt
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The cephalosporins are a younger class of ff-lactam antibiotics of which the 
first discovered naturally occurring example is cephalosporin C.6 The first semi­
synthetic derivative of cephalosporin C was cephaloglycine. From this compound 
Cephalexin (desacetoxycephaloglycine) was derived, which appeared to be 
encouragingly active.7 The ff-lactam nucleus of Cephalexin, i.e. 7-amino-desacetoxy- 
cephalosporanic acid (7-ADCA), became an important intermediate from which the 
biggest selling semi-synthetic cephalosporins Cephalexin, Cephradine and 
Cefadroxil were derived. Of today's 7-ADCA production 99% is used for the 
manufacture of these three antibiotics. The advantages of cephalosporins, in 
comparison with penicillins, are their lesser degree of sensitivity to ff-lactamases and 
the less frequent occurrence of allergies.
Only a few years after the second world war, strains of Staphylococcus aureus 
had emerged that were immune to penicillin.8 Since then, resistance to antibiotics 
has spread and has become a serious threat to humanity. Especially the 
abovementioned microbe has evolved immunity to almost all antibiotics except 
Vancomycine. Bacteria have developed several ingenious mechanisms to protect 
themselves against antibiotics.8'9 The genetic information for their resistance usually 
resides on plasmids. This provides microbes with the possibility to copy and pass on 
their resistance genes to other bacteria. A defense mechanism active against ff-lactam 
antibiotics makes use of ff-lactamases, which are enzymes that open the ff-lactam 
ring of the antibiotic molecule.10 The ff-lactam ring is the bioactiphore of the 
penicillins and cephalosporins, which acts by inhibition of the biosynthesis of cell 
wall peptides. Several factors enhance the problem of resistance dramatically. 
Inappropriate prescription by doctors, incorrect usage of the drugs by patients, and
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excessive use of penicillins in animal feeding form an important contribution to the 
cause of the problem. Combination of ff-lactam antibiotics with ff-lactamase 
inhibitors, such as clavulanic acid, form only a temporary solution to the problem as 
bacteria will develop defense mechanisms to these compounds as well. Due to their 
extra genetic luggage, resistant bacteria are in competitive disadvantage to non- 
resistant bacteria. Hence, bacteria will loose their resistance to an antibiotic when 
they are no longer exposed to it, through the same evolutionary process that made 
them resistant. Responsible prescription and use of antibiotics are therefore 
important remedies to solve the resistance problem so that many antibiotics will 
continue to serve as life-saving drugs during the 21th century.
Despite the threat of resistance, the markets for Ampicillin, Amoxicillin and 
the cephalosporins are forecasted to be substantial for the next two decades. The 
economy of the manufacture of the bulk final products is such that buying penicillin
G, 6-APA or 7-ADCA as intermediates for the production of the semi-synthetic 
penicillins and cephalosporins is not profitable.11 Hence, manufacturers mainly are 
fully backwards integrated and produce both the intermediates and the bulk final 
products. Companies in south-east Asia force western producers to develop superior 
technology in order to remain competitive. The estimated world markets of the most 
important semi-synthetic penicillins and cephalosporins for the year 2000 are shown 
in Table 1.
Table 1 Forecasted demand for semi-synthetic penicillins and cephalosporins for the 
year 2000.11
antibiotic world market (tonnes)
Ampicillin 5500
Amoxicillin 10000
Cephalexin 2500
Cephradine 400
Cefaclor 300
Cefadroxil 300
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Process development for the production of semi-synthetic antibiotics.
This section only deals with the semi-synthetic antibiotics listed in Table 1. 
The production of semi-synthetic penicillins and cephalosporins mainly involves 
coupling of the ff-lactam nuclei to the desired D-amino acid side chains. As most 
manufacturers of these products are fully backwards integrated, also the production 
of the intermediates can contribute to an improved economy of the overall 
production process. It is important to emphasize that the ff-lactam nuclei are the 
most expensive of the intermediates and, thus, determine 50% and 70% of the 
variable cost in the production of the penicillins and cephalosporins, respectively. 
Hence, a high yield on the ff-lactam nuclei is crucial for an economically feasible 
route towards the penicillins and the cephalosporins.
The ff-lactam nucleus of the penicillins, abbreviated as 6-APA, can be 
obtained either by chemical cleavage12 or by enzymatic hydrolysis13 of the 
phenylacetic acid side chain of penicillin G. The production of the ff-lactam nucleus 
of the cephalosporins Cephalexin, Cephradine and Cefadroxil, abbreviated as 7- 
ADCA, also starts with penicillin G. Via penicillin G sulfoxide the 5-membered ring 
of the ff-lactam nucleus is expanded to a 6-membered ring.14 Subsequent cleavage of 
the phenylacetic acid side chain then furnishes 7-ADCA. Recently, it became possible 
to obtain 7-ADCA by direct fermentation.15 Of all cephalosporins, Cefaclor is the 
most difficult semi-synthetic antibiotic to produce on a large scale in a profitable 
manner. This is mainly due to the difficult accessibility of its ff-lactam nucleus.15 The 
side chains of the six aforementioned antibiotics are D-phenylglycine, D- 
cyclohexadienylglycine and D-p-hydroxyphenylglycine. Phenylglycine, the side 
chain of Ampicillin, Cephalexin and Cefaclor, can be obtained by a Strecker 
synthesis using benzaldehyde as starting material.17 The Cephradine side chain D- 
cyclohexadienylglycine can be obtained via a Birch reduction of phenylglycine.18 The 
side chain of Amoxicillin and Cefadroxil, i.e. D-p-hydroxy-phenylglycine, is most 
efficiently obtained via a Mannich reaction employing glyoxilic acid, urea and 
phenol,19 and a subsequent enantioselective hydrolysis of the resulting p- 
hydroxyphenylhydantoin.20
Over the past 30 years, several changes have been introduced in the processes 
used for the coupling of the ff-lactam nuclei and the side chains. This is outlined in 
Scheme 1. The first route towards semi-synthetic antibiotics uses the Dane salt as the 
side chain precursor, which is activated by conversion into a mixed anhydride with 
ethyl chloroformate and subsequent coupling to the ff-lactam nucleus, i.e. 6-APA or 
7-ADCA.21 Over the years, several manufacturers replaced this route by the
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chloride/hydrochloride route (Scheme 1), which requires fewer reactors and 
processing vessels and does not require the low temperatures of the Dane salt 
route.22 The Dane salt route, however, revived by employing pivaloyl chloride as the 
activating agent for the side chain and tetramethylguanidine as the base. At present 
the chloride/hydrochloride route has superseded and the majority of the 
manufacturers prefers the Dane salt route. The chemical yields for the coupling 
process have increased over the years from 75% to above 90%. New developments in 
the preparation of semi-synthetic antibiotics make use of an enzymatic coupling of 
side chain amides or esters to the ff-lactam nuclei.23 Although several drawbacks, 
such as low coupling efficiency and difficult down-stream processing, have to be 
eliminated, this technology may prove its value in the years to come.
Dane route
,C O 2Me
HN
CO2K
ethyl chloroformate 
or pivaloyl chloride
H2N
Cl/HCl route
S
O
CO2H
7-ADCA
(Me3)3SiCl
base
H2N
O
K
CO2Si(Me)3
NH2.HCl
COCl
Cephalexin
Scheme 1 The Dane route versus the Cl/HCl route in the preparation of Cephalexin.
6
Introduction
1.2 Biocatalysis in the manufacture of semi-synthetic antibiotics
Integration of biocatalysis in the manufacture of the intermediates of semi­
synthetic penicillins and cephalosporins has enormous consequences for both the 
economy of the processes and for their environmental impact.24 The achievement in 
reducing the number of steps required to obtain the intermediates from the basic 
raw materials has strongly reduced the production cost. In addition, the number of 
kilograms of waste per kilogram of product has been decreased by a factor of four to 
five.25 The conventional routes to achieve the coupling of the ff-lactam nucleus to the 
amino acid side chain are, however, still examples of stoichiometric chemistry. As is 
outlined in scheme 1, these routes require protective groups, activating agents, low 
temperatures and the reactions are usually conducted in halogenated solvents, such 
as dichloromethane. As a consequence, the conventional coupling reaction has a 
considerable environmental impact. Furthermore, the final products obtained via the 
chemical coupling contain up to 40 ppm of dichloromethane. Despite the high 
toxicity of dichloromethane, the products are consumed for several decades already. 
Another clearly negative feature of the chemical coupling is the economy of the 
process. The yields obtained for the chemical coupling are fully optimized and in 
some cases exceed 90%. This implies that further cost reduction by process 
optimization is hardly possible. Improvement of the economical benefit and 
competitive strength, therefore, require new methodologies.
A novel way to accomplish coupling of the ff-lactam nucleus to the amino acid 
side chain makes use of biocatalysis. Although the enzymatic coupling of nucleus 
and side chain is present in the literature for about twenty years, only recently the 
industrial realization became possible.23,24 The enzymatic coupling, which is 
illustrated in scheme 2, does not require protective groups, activating agents, or low 
temperatures and can be conducted in water. Hence, this process can have an 
enormous benefit for the environment. Although immediate economical benefit is 
difficult to obtain, this process leaves more opportunities for future cost reduction 
than the conventional chemical coupling.
7
Chapter 1
NH2
j j ^ j ^ C O N ^
phenylglycine amide immobilized 
penicillin acylase
H2N jSK
O
c o 2h
7-ADCA
NH2
c o 2h
NH
2 H 
N
immobilized 
S penicillin acylase
phenylglycine
(unwanted
side reaction) h  n  s
CO 2H ‘  K - f
Cephalexin 
Yield < 60%
O
c o 2h
7-ADCA
Scheme 2 The enzymatic synthesis of Cephalexin.
++
The enzymatic process has several drawbacks of which two are explained below.
i. Low coupling efficiency due to secondary hydrolysis of the product.
Because of the unfavorable equilibrium constant of the thermodynamic 
coupling,26 the enzymatic reaction has to be carried out in a kinetic fashion. This 
means that the amino acid side chain must be offered to the enzyme as an ester 
or amide derivative. In that form the enzyme can couple the side chain to the 
nucleus via an intermediate enzyme-acyl complex.27 The thus formed product, 
however, also serves as a substrate for the enzyme and as a consequence the 
product is hydrolyzed to nucleus and amino acid side chain. The side chain 
resulting from this secondary hydrolysis is no longer present in the form of an 
ester or amide but is obtained as the amino acid which cannot be coupled again. 
As a result the coupling efficiency and thus the yield of the enzymatic reaction 
are very low.
ii. Difficult down-stream processing.
The reaction mixture resulting from the enzymatic coupling is an aqueous 
solution containing starting materials, product and side products, which are all 
amino acid derivatives. From this complicated reaction mixture the desired 
antibiotic must be isolated in a pure form. Conventional methods for the 
isolation of the cephalosporins from aqueous solutions cannot be applied, as 
they require higher concentrations and, in the case of the enzymatic reaction 
mixtures, these methods are also hampered by the presence of impurities.
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By eliminating these drawbacks important cost reductions can be achieved. A 
solution to the problem encountered in the down-stream processing was given in a 
patent of NOVO Nordisk.28 This patent claims that after the addition of ff-naphthol 
to a solution of Cephalexin, a precipitate is formed that contains Cephalexin and ff- 
naphthol in a 2:1 ratio. The applicability of this concept of complexation was 
investigated both for the isolation of Cephalexin from solutions and by direct 
incorporation during the enzymatic synthesis.29 Complexation with ff-naphthol 
during the enzymatic synthesis, which is depicted in scheme 3, appeared to work 
surprisingly well. After Cephalexin is assembled enzymatically, it immediately 
precipitates as a complex with ff-naphthol. As in this way the product is withdrawn 
from solution it is not susceptible to secondary hydrolysis anymore, which results in 
a substantially higher yield of Cephalexin. In addition, after completion of the 
reaction the product can readily be separated from the reaction mixture by filtration 
of the complex. Subsequent hydrolysis of the complex yields pure Cephalexin, while 
ff-naphthol can be reused.
Scheme 3 Complexation with ff-naphthol during the enzymatic synthesis.
Besides the application in the enzymatic synthesis, complexation of 
Cephalexin with ff-naphthol can also be used for the isolation of a second crop
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product from aqueous waste streams resulting from the chemical coupling. In this 
way a considerable increase of the yield can be realized.
The enzymatic coupling procedure in the production of cephalosporin type 
antibiotics is a typical example of greening of chemical processes, i.e. the use of 
environmentally benign operations employing biocatalysis. Currently, green 
chemistry receives worldwide much attention, as its principles will considerably 
reduce the amounts of waste, which are inherent to the conventional chemical 
processes.30 Moreover, the public image of chemistry will be improved enormously 
by including the concepts of green chemistry in the chemical process industry, 
especially in the production of fine-chemicals.
1.3 Aim of research
The research described in this thesis is focused on the problem of down­
stream processing in the production of the semi-synthetic cephalosporin type 
antibiotics Cephalexin, Cephradine, Cefaclor and Cefadroxil. Despite its industrial 
relevance, the complexation process has received little attention thus far. Data on the 
structure of the cephalosporin/ ff-naphthol complexes have not been reported thus 
far. The research described in this thesis, therefore, has three main objectives, which 
are outlined below.
i. To gain fundamental insight in the complexation of cephalosporin antibiotics. 
Detailed investigation of the structure of the complexes may reveal important 
information regarding the process of molecular recognition between the 
cephalosporins and ff-naphthol.
ii. Improvement of the complexation process for the four cephalosporins.
Based on the structural information, clues for improving the complexation 
process may be found.
iii. Design of new complexing agents.
Fundamental insight in the structures of the cephalosporin complexes may, in 
combination with computational techniques, make rational design of new 
complexing agents possible.
10
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Although complexation with ff-naphthol is highly selective for all four 
cephalosporins, it is desirable to improve the efficiency of the process for each 
specific cephalosporin. Most importantly, ff-naphthol is a rather toxic compound and 
for that reason not suitable for incorporation in a "green" enzymatic process. In spite 
of the fact that ff-naphthol can be reused and the quality of the products obtained via 
complexation being much better than that of the product obtained via the 
conventional chemical process, the use of ff-naphthol may cause marketing problems 
because of the suspect image of this complexing agent. Therefore, it would be 
desirable to replace ff-naphthol as a complexing agent by more acceptable 
compounds. An important objective of this study is an unbiased design of new 
effective complexing agents, which are environmentally benign.
1.4 Outline of this thesis
In chapter 1 the background of the research is described and the objectives are 
defined. Chapters 2 and 3 deal with structural features of the cephalosporin 
complexes with ff-naphthol and other naphthalene derivatives. In chapter 4, the 
possibilities revealed in chapter 3 are further explored by investigating the 
applicability of benzene derivatives in the complexation with Cephradine. In chapter
5, the improvement of the complexation process for the four cephalosporins by 
replacing ff-naphthol by other molecules is described. This chapter also deals with 
some relevant thermodynamic aspects of the complexation process. In chapter 6, the 
effect of complexation during the enzymatic synthesis of Cephalexin is described in 
a quantitative manner. Furthermore, a series of non-toxic complexing agents are 
scrutinized with regard to the requirements that have to be fulfilled for application 
during the enzymatic synthesis. The research described in chapter 7 was aimed at 
the development of a model that predicts the complexing behavior of a molecule 
based on the molecular similarity principle. Two clearly distinct approaches have 
been followed, viz. docking and QSAR. Chapter 8 deals with the use of 
cephalosporin complexation to achieve an asymmetric transformation of 
cephalosporins. The asymmetric transformation has been applied in a new synthesis 
of cephalosporins, starting from racemic amino acid side chains. Chapter 9 
elaborates the separation of ortho- and para-disubstituted benzene derivatives. This 
chapter also elucidates the cooperative effect of complexants in the clathration with 
Cephradine. This thesis is concluded with summaries in English and Dutch.
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C l a t h r a t e  T y p e  C o m p l e x a t i o n  o f  C e p h a l o s p o r i n  
A n t i b i o t i c s  w i t h  ^ -N a p h t h o l
Abstract: The cephalosporin derivatives Cephradine, Cephalexin, Cefaclor and Cefadroxil 
form complexes with ff-naphthol, provided water is present. The crystal structures of these 
complexes have been determined by single-crystal X-ray diffraction. The complexes appear 
to be inclusion compounds of the clathrate type. In all cases, the cephalosporin molecules 
play the role of the host while ff-naphthol is the guest molecule. Water molecules, which are 
accommodated in the crystal, play an essential role in the interaction between the host and 
guest molecules. Cephradine, Cephalexin and Cefaclor form isomorphous complexes with 
ff-naphthol, whereas Cefadroxil crystallizes in a different morphology. The crystal 
structures are described in detail and discussed in terms of hydrogen bonding, van der 
Waals and electrostatic interactions.
2.1 Introduction
The cephalosporin derivatives Cephalexin 1, Cephradine 2, Cefaclor 3 and 
Cefadroxil 4 are important life saving antibiotics, which are already in medical use 
for many years all over the world. Large scale isolation and purification of the 
aforementioned cephalosporins from an aqueous solution is hampered by a number 
of problems. Due to the ff-lactam structure, the molecules are very labile, especially 
under basic conditions. As a consequence the pH of the cephalosporin solution has 
to be monitored continuously during a reaction or purification procedure. It would, 
therefore, be highly convenient to isolate the cephalosporins by crystallization or co-
This chapter has been published; G.J. Kemperman, R. de Gelder, F.J. Dommerholt, P.C. Raemakers­
Franken, A.J.H. Klunder, and B. Zwanenburg, Chemistry, A European Journal, 1999, 5, 2163-2168.
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crystallization with some additive, preferably immediately after their formation. It is 
known that selective co-crystallization can be achieved by adding ff-naphthol to 
aqueous solutions of the cephalosporin derivatives 1, 2, 3 and 4.1 The cephalosporins
1, 2, 3 and 4 selectively form complexes with ff-naphthol, which precipitate from an 
aqueous solution. In the crystalline state, the cephalosporins are less susceptible to 
degradation. Moreover, complexation provides a method for the isolation of the 
product, since the precipitated complex can be separated from the reaction mixture 
by simple filtration. This facilitates down stream processing in the large scale 
production of these cephalosporins, which indicates the industrial relevance of this 
method. After decomplexation, which can be achieved by acidification of an aqueous 
suspension followed by extraction with an organic solvent, the cephalosporins can 
be obtained in pure state from the aqueous phase, by neutralization and 
crystallization.
NH,
c o 2h
NH2 H 
,NO V N
c o 2h
1 R1 = H , R2 = CH3
3 R1 = H , R2 = Cl
4 R1 = OH , R2 = CH3
R
2
Despite the industrial relevance of efficient down stream processing of the 
aforementioned cephalosporin derivatives, the molecular structures of their ff- 
naphthol complexes have not been elucidated so far. Only the ratio of the 
cephalosporin and ff-naphthol has been reported, as well as the water content.1 
Crystal structure analysis of complexes of ff-naphthol with ff-cyclodextrin2 and with 
androsta-1, 4-diene-3, 17-dione3 revealed that in the former case ff-naphthol is the 
guest molecule, whereas in the latter case no clear distinction can be made between 
host and guest molecules. Crystal structure data of cephalosporins in either the pure 
or the complexed state are scarce. So far only the crystal structures of Cefadroxil 
mono-hydrate and Cefaclor dihydrate have been recorded.4'5
The aim of the present study is to elucidate the crystal structures of 
cephalosporin complexes with ff-naphthol, in order to shed light on the nature of the 
interactions responsible for molecular recognition of the constituents in the solid 
state. An intriguing question is whether ff-naphthol serves as the host or acts as a 
guest molecule. Single-crystal X-ray diffraction was used for this purpose.
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2.2 Results and Discussion
Complexes of cephalosporins with ff-naphthol are usually obtained as 
precipitates upon treatment of an aqueous solution of these antibiotics with ff- 
naphthol. For the preparation of single crystals for the X-ray analyses however, 
methanol was used as a co-solvent. The presence of methanol enhances the solubility 
of ff-naphthol, and moreover, allows cooling below 0°C. From a 1% solution of 
cephalosporin in water or water/m ethanol no crystallization results, even not after 
cooling to 4°C for 24 hours. However, after the addition of ff-naphthol, 
crystallization starts instantaneously. ff-Naphthol, which is only poorly soluble in 
water/methanol, undergoes a solid to solid transition from the pure state into the 
complexed state with cephalosporin. The crystal data of the respective 
cephalosporin/ ff-naphthol complexes are summarized in Table 1.
Table 1 Crystal data of the complexes of Cephalexin 1, Cephradine 2, Cefaclor 3 and
Cefadroxil 4 with ff-naphthol.
1 /  ff-naphthol 2 /ff-naphthol 3/ ff-naphthol 4/ ff-naphthol
Crystal system Monoclinic Monoclinic Monoclinic Orthorhombic
space group C2 C2 C2 P2221
a [A] 23.398 23.421 23.447 7.112
b [A] 7.062 6.971 7.026 21.717
c [A] 14.918 15.004 14.841 30.959
« [°] 90 90 90 90
ff [°] 109.80 110.41 110.55 90
y[°] 90 90 90 90
The complexes of Cephalexin, Cephradine and Cefaclor with ff-naphthol.
Remarkably, the crystal structures of the complexes of Cephalexin, 
Cephradine and Cefaclor with ff-naphthol are isomorphous, as can be deduced from 
the powder diffraction patterns shown in Figure 1. Although the van der Waals 
radius of chlorine is comparable with that of a methyl group and partial saturation 
of a phenyl ring hardly results in structural changes, in general, such subtle 
molecular alterations may cause drastic structural deviations. The ff-naphthol 
complexes of cephalosporins 1, 2 and 3 are of the clathrate type in which the 
cephalosporin serves as the host and ff-naphthol as the guest molecule. In these 
clathrates, the host molecules form 2-dimensional layers, in which they are held 
together by hydrogen bonding and electrostatic interactions. The 2-dimensional
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layers are packed in such a manner that a 3-dimensional structure is formed. The 
remaining cavities are filled with ff-naphthol and water molecules. In contrast, 
Cefadroxil complexes with ff-naphthol as a clathrate with an entirely different 3­
dimensional structure, lacking the two-fold symmetry that is present in the 
complexes of 1, 2 and 3. The large difference between the structure of the complex of 
Cefadroxil and the complexes of Cephalosporins 1, 2 and 3 is demonstrated in the 
powder diffraction patterns shown in Figure 1.
---- Cefadroxil
Cefaclor
Cephradine
---- Cephalexin
20
Figure 1 The powder diffraction patterns of the ff-naphthol complexes of Cephalexin, 
Cephradine, Cefaclor and Cefadroxil.
Figure 2 shows the crystal structure of the Cephalexin/ ff-naphthol complex 
viewed in the direction of the b-axis. The cephalosporin molecules are in the zwitter- 
ionic form bearing a negative charge at the carboxylate group and a positive charge 
at the ammonium group. Within the 2-dimensional layers, the host molecules are 
assembled in a head to tail fashion. One carboxylate group has both hydrogen 
bonding and electrostatic interactions with two ammonium groups and vice-versa. 
This results in 4-point junctions at which the host molecules have strong non- 
covalent interactions with each other. In the crystal structures of the Cephalexin, 
Cephradine and Cefaclor complexes, the antibiotic molecules adopt an arrangement 
in which from a 4-point junction, two molecules go up and two go down resulting in 
2-fold symmetry along the b-axis, as is visualized in Figure 3a. Building up these 4- 
point junctions leads to the formation of 2-dimensional layers of cephalosporin 
molecules. In addition, this arrangement has the consequence that the 2-dimensional
18
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layers contain holes as is shown in Figure 3b. Basically, this is the cause of the 
formation of channels when 3-dimensional cephalosporin framework is built-up 
from these 2-dimensional layers.
Figure 2 PLUTON6 drawing of the structure of the Cephalexin/ff-naphthol complex 
viewed along the b-axis.
The channels shown in Figure 3b, are filled with water and ff-naphthol. The 
water molecules are positioned at the polar regions inside the channels, whereas ff- 
naphthol is sandwiched between apolar parts of the antibiotic molecules. The water 
molecules are involved in multiple hydrogen bonding with both cephalosporin and 
other water molecules. The amino- and amide- hydrogen atoms are pointing 
towards the oxygen atoms of the water molecules. In addition, the hydrogen-oxygen
o
distance is about 2 A, which is the appropriate distance for effective hydrogen 
bonding (Figure 3c). Although the positions of the hydrogen atoms of the water 
molecules could not be determined by X-ray analysis, it is assumed that they also 
participate in the formation of the hydrogen bonding network. This assumption is 
justified as follows. The distance of the water molecules towards the carbonyl- and 
carboxylate groups is about 3 A. Taking into account the length of the oxygen-
o
hydrogen bond in water of 0.95 A , it is reasonable to assume that indeed a hydrogen 
bond is present. Except for the hydrogen bonding and electrostatic interactions at the
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4-point junctions, all other hydrogen bonding interactions between host molecules 
involve water molecules. These interactions give the 2-dimensional layers a 
substantial additional strength. This suggests that the water molecules play the role 
of cement in the crystal. Recently it was shown, that water incorporated in crystal 
structures often serves as a gluing agent.7 The water molecules surround ff-naphthol 
at two sides, allowing a hydrogen bond to be formed between the hydroxyl group of 
ff-naphthol and a water molecule. This implies that the ff-naphthol molecules are 
indirectly bound to the cephalosporin molecules via water.
Figure 3a A PLUTON6 drawing of the 4-point junction formed by four Cephradine 
molecules, each donating an ammonium- or a carboxylate group.
Figure 3b The 2-dimensional layer viewed in the direction of the c-axis. The holes which 
are present, are a consequence of the arrangement of the cephalosporin 
molecules at a 4-point junction.
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Figure 3c The water molecules (black balls) are positioned within the 2-dimensional layers 
and form hydrogen bonds with the cephalosporin molecules. The hydrogen 
bonds between the hydrogens of water and acceptor atoms of the 
cephalosporins are not shown because the positions of the hydrogens could not 
be exactly determined. The dotted arrows are pointing at an amino and a 
carboxylate function which are interacting at a 4-point junction.
The isomorphism found for the ff-naphthol complexes of Cephalexin, 
Cephradine and Cefaclor, which was initially deduced from powder diffraction 
experiments, was confirmed by single-crystal X-ray diffraction, as is evident from 
the data in Table 1. The structures of the complexes of Cephradine and Cefaclor are 
shown in Figure 4a-b.
Figure 4a The clathrate of Cephradine with ff-naphthol.
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Figure 4b The clathrate of Cefaclor with ff-naphthol.
The complex of Cefadroxil and ff-naphthol.
Both the data in Table 1 and the powder diffraction patterns in Figure 1, 
clearly reveal that the crystal structure of the Cefadroxil/ ff-naphthol complex, differs 
considerably from that of the other cephalosporin complexes. This difference must 
be attributed to the replacement of a hydrogen on the phenyl ring for a hydroxyl 
group. This replacement influences the molecular structure both sterically and 
electronically, and has dramatic consequences for the recognition properties of the 
molecule.8 This orthorhombic crystal structure, contains Cefadroxil, ff-naphthol and 
water in a ratio of 2:1:8. Thus, it contains three molecules of water per unit cell more 
than the cephalosporin complexes described above. The overall molecular geometry 
of the Cefadroxil molecule in the ff-naphthol complex is practically the same as its 
conformation in its uncomplexed mono-hydrate form4 and as the conformation of 
the other cephalosporin molecules in their complexes with ff-naphthol. Also the 
Cefadroxil/ ff-naphthol complex forms a crystal structure of the clathrate type. 
Similar to the complexes of Cephalexin, Cephradine and Cefaclor with ff-naphthol, 
Cefadroxil is the host and ff-naphthol is the guest. The ff-naphthol molecule in this 
crystal structure is disordered but could be refined in terms of two possible 
orientations. For sake of clarity, the two orientations for ff-naphthol are shown 
separately in Figure 5a-b.
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a
b
Figure 5 The crystal structure of the Cefadroxil complex with ff-naphthol. For sake of 
clarity the two orientations for ff-naphthol are shown separately in a and b.
In the Cefadroxil clathrate structure, 4-point junctions similar to those 
observed for cephalosporins 1, 2, and 3, are present. However, the 2-fold symmetry 
is lacking in the case of Cefadroxil. This deviating arrangement results in an essential 
difference between the Cefadroxil complex and the complexes derived from the 
cephalosporins 1, 2 and 3, namely the dimensionality of the hydrogen bonding 
network formed by the host molecules. While the cephalosporins 1, 2 and 3 form 2-
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dimensional nets of hydrogen bonds, Cefadroxil forms a 3-dimensional network. 
Although the phenolic hydroxyl-group is involved in hydrogen bonding 
interactions, its function is not essential for the formation of the 3-dimensional 
network. The 3-dimensional network is constructed by interactions of only the 
ammonium and carboxylate groups of the Cefadroxil molecules.
2.3 Concluding Remarks
Cephalexin, Cephradine, Cefaclor and Cefadroxil form clathrates with ff- 
naphthol in the presence of water. The essential feature of these clathrates is that in 
these clathrates the cephalosporins are the hosts and ff-naphthol is the guest. The 
third constituent of the clathrates is water, which fulfils the role of cement in the 
crystal. The clathrates of Cephalexin, Cephradine and Cefaclor are isomorphous. 
Although these three cephalosporins have subtle structural differences, their 
complexation behavior with ff-naphthol is essentially the same. The introduction of a 
hydroxyl group, as in Cefadroxil, has a profound effect on the polarity and 
hydrophilicity of the molecule. In addition, it has a notable steric influence at that 
position of the molecule. As a consequence, the Cefadroxil/ ff-naphthol complex is a 
clathrate with a different crystal structure. Remarkably, although the host 
framework formed by Cefadroxil is very different, the remaining cavities are quite 
similar, because the same guest molecule can be accommodated. In both types of 
structures, ff-naphthol is hydrogen bonded to a water molecule. Apart from this 
hydrogen bond, ff-naphthol has only van der Waals interactions with both 
cephalosporin and water molecules. The clathrate formation of cephalosporins with 
ff-naphthol allows an effective withdrawal of cephalosporins from a diluted aqueous 
solution, which is industrially highly relevant.
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2.4 Experimental section
The cephalosporins were obtained from DSM Life Sciences Group (geleen, 
The Netherlands). ff-Naphthol was purchased from ACROS.
Crystallization procedure
Cephalosporin mono hydrate (500 mg) was dissolved in 20% aqueous methanol 
(approximately 50 ml). ff-Naphthol (110 mg, 0.75 mmole) was dissolved in acetone (3 
ml) and subsequently added to the cephalosporin solution. The solution was cooled 
at 4 °C overnight.
Crystal structure solution of the ff-naphthol complexes of 1, 2, 3 and 4
The crystals were measured on an ENRAF-Nonius CAD4 diffractometer. The
o
radiation used was CuKa (graphite mon.) with A=1.54184 A. Intensity data were 
corrected for Lorentz and polarization effects. Semi-empirical absorption corrections 
(^-scan) were applied.9 The structure was solved by the program system DIRDIF10 
using the program ORIENT and TRACOR11 to orient and position a ff-lactam 
fragment in the Patterson map and was refined anisotropically, by full-matrix least 
squares on F2 (program SHELXL12). Crystal data and data collection parameters are 
given in Table 2.
Structure refinement for (Cephalexin/ff-naphthol), (Cephradine/ff-naphthol) and (Cefaclor/ff- 
naphthol)
A crystallographic twofold axis is passing through the center of the cavity in which 
the ff-naphthol molecule is situated. As a consequence the ff-naphthol molecule is 
disordered along this twofold axis. The two possible orientations of the ff-naphthol 
molecule, which are related by twofold symmetry, could be refined using a disorder 
model. The naphthalene skeletons belonging to the two possible orientations of the ff 
-naphthol molecule do not overlap but are shifted away from the twofold axis. The ff 
-naphthol is (locally) surrounded by five water molecules: two at the side of the 
hydroxyl group, three at the other side of the cavity. The shift of the molecule with 
respect to the twofold axis may be the result of the replacement of a water molecule 
in the polar part of the cavity by the hydroxyl group of ff-naphthol. The hydrogens 
of the primary amino function at the side chain could be found in a difference 
Fourier map but proved unstable during refinement. Therefore, these hydrogens and 
also the hydrogen atoms of the methyl group were refined as rigid rotors with
o
idealized sp3 hybridization and a C-H bond length of 0.97 A to match maximum 
electron density in a difference fourier map. The hydrogens of the water molecules
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could not be localized and are therefore not included in the model. All other 
hydrogen atoms were placed at calculated positions and were refined riding on the 
parent atoms. The SQUEEZE procedure of the PLATON program13 was used to 
correct for disordered solvent. For Cephalexin/ ff-naphthol two voids at 0.500, 0.251, 
0.000 and 0.000, 0.751, 0.000, having a volume of respectively 33 and 34 A3 showed 
an electron count of 5 electrons indicating that in each void half a water molecule is 
present. For Cefaclor/ff-naphthol two voids at 0.500, 0.240, 0.000 and 0.000, 0.740,
0.000, having a volume of respectively 29 and 29 A3 showed an electron count of 6 
electrons indicating that in each void half a water molecule is present.
Structure refinement of Cefadroxil/ff-naphthol.
The ff-naphthol molecule showed severe disorder. Careful analysis showed that 
there are two possible ways in which the ff-naphthol molecule can be positioned in 
the cavity. In both cases the hydroxyl-group is bonded via a hydrogen bond to the 
same water molecule. The two possible orientations of the ff-naphthol molecule are 
related by a 180° rotation of the naphthalene skeleton along the long axis of the 
molecule. The naphthalene skeletons belonging to the two possible orientations of 
the ff-naphthol molecule do not overlap but are slightly shifted with respect to each 
other, clearly, to optimize the fit in the cavity. The two possible orientations could be 
refined using a disorder model. The hydrogens of the primary amino function at the 
side chain could be found in a difference Fourier map but proved unstable during 
refinement. Therefore, these hydrogens and also the hydrogen atoms of the methyl 
group were refined as rigid rotors with idealized sp3 hybridization and a C-H bond
o
length of 0.97 A to match maximum electron density in a difference fourier map. 
The hydrogens of the water molecules could not be localized and are therefore not 
included in the model. All other hydrogen atoms were placed at calculated positions 
and were refined riding on the parent atoms.
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Table 2 Crystal data and data collection parameters for the ff-naphthol complexes of 
Cephalexin, Cephradine, Cefaclor and Cefadroxil.
Cephalexin/ff-
naphthol
Cephradine/ ff- 
naphthol
Cefaclor/ff-naphthol Cefadroxil/ff-
naphthol
Crystal color transp. orange colorless transparent light yellow-brown pale yellow-brown
Crystal shape regular fragment rather regular needle regular rod needle
Crystal size [mm] 0.38 x 0.28 x 0.20 0.60 x 0.19 x 0.05 0.28 x 0.09 x 0.06 0.31 x 0.14 x 0.13
Empirical formula C42 H55 N6 O14.50 S2 C42H 56N 6O14S2 C4öH47Cl2N6O14.5S2 C42H 58N 6O 19S2
Mw 940.04 933.05 978.86 1015.06
T  [K] 293(2) 208(2) 293(2) 293(2)
Crystal system Monoclinic Monoclinic Monoclinic Orthorhombic
space group C2 C2 C2 P2i2i2i
a [A] 23.398(4) 23.4212(6) 23.447(3) 7.1117(2)
b [A] 7.0623(18) 6.9715(2) 7.0262(8) 21.7170(8)
c [A] 14.918(4) 15.0047(4) 14.8413(15) 30.9586(14)
a  [°] 90 90 90 90
ff [°] 109.80(3) 110.405(2) 110.550(10) 90
Y [°] 90 90 90 90
reflections 6 25 15 25
8-range [°] 22.329 - 40.260 40.234 - 46.787 17.322 - 22.038 19.907 - 26.398
V [A3] 2319.3(10) 2296.24(11) 2289.4(4) 4781.4(3)
Z 2 2 2 2
Dc [M g/m 3] 1.346 1.349 1.420 1.346
Abs. coef. [mm-1] 1.655 1.659 2.751 1.721
F(000) 994 988 1022 2144
8 range data col. [ °] 4.02 - 69.91 3.14 -70.00 3.18 - 70.01 2.85 - 69.30
Index ranges h -28 to 26 -26 to 28 -26 to 8 0 to 8
k -8 to 0 0 to 8 -8 to 0 0 to 26
l 0 to 18 -18 to 0 -18 to 0 0 to 37
Refl. col./unique 2486 /  2391 2475/ 2381 2452/ 2357 4870/ 4870
R(int) 0.0270 0.0322 0.0168
Refl.obs.[Io>2o(Io)] 2130 2130 2130 3488
Range of relative 
transm. factors
1.131 /  0.923 1.123 /  0.941 1.179 /  0.906 1.033 /  0.971
D ata/ restraints/ par. 2391 /  249 /  346 2381 /  56 /  346 2391 /  222 /  345 4870 /  72 /  617
g.o.f. on F2 1.068 1.098 1.070 1.059
SHELXL-97 0.100400 0.072000 0.096200 0.103300
weight par. 0.573100 1.253000 0.088500 7.821700
Final R indices R1 = 0.0488 R1 = 0.0413 R1 = 0.0568 R1 = 0.0740
[I>2o(I)] wR2 = 0.1372 wR2 = 0.1135 wR2 = 0.1507 wR2 = 0.1861
R indices R1 = 0.0537 R1 = 0.0442 R1 = 0.0808 R1 = 0.1076
(all data) wR2 = 0.1424 wR2 = 0.1162 wR2 = 0.1649 wR2 = 0.2112
Largest diff. peak and 
hole [e.A-3]
0.291 /  -0.255 0.330 /  -0.457 0.368 /  -0.232 0.642 /  -0.639
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In d u c e d  Fit  P h e n o m e n a  i n  C l a t h r a t e  S t r u c t u r e s  
o f  C e p h a l o s p o r i n s
Abstract: For the hosting frameworks of Cephalexin, Cephradine, Cefaclor and Cefadroxil, a 
list of potential guest molecules was designed using the concept of molecular similarity. 
This list was extended by a series of compounds, which are not supposed to fit. It was 
shown that a large variety of naphthalene derivatives can be hosted in clathrates with 
Cephalexin, Cephradine and Cefaclor. Cefadroxil, however, is much more selective in 
accommodating guest molecules. Although Cephalexin, Cephradine and Cefaclor form the 
principal hosting lattice and govern the overall crystal structure of the clathrates, the guest 
molecules are capable of inducing deviations in the framework of the host molecules, i.e. 
induced fit. Cefadroxil, however, lacks this adaptability due to the rigid three-dimensional 
hydrogen bonded structure of its hosting framework, and an exact fit of a guest molecule in 
the hosting framework of Cefadroxil is thus required, i.e. lock and key concept. All four 
antibiotics have a limited adaptability by varying the number of water molecules in the 
clathrates. Certain guest molecules replace water in order to obtain the required space for 
inclusion, whereas other guest molecules cause incorporation of extra water, which is 
apparently beneficial for the crystal packing. However, the adaptability due to varying the 
water content cannot account the remarkable flexibility in accommodating guest molecules 
exhibited by Cephalexin, Cephradine and Cefaclor. The concept of induced fit is relevant for 
the understanding and design of clathrate type structures.
3.1 Introduction
An interesting feature of the cephalosporin antibiotics Cephalexin 1, 
Cephradine 2, Cefaclor 3 and Cefadroxil 4, is their ability to form inclusion
This chapter has been published: G.J. Kemperman, R. de Gelder, F.J. Dommerholt, P.C. Raemakers­
Franken, A.J.H. Klunder, B. Zwanenburg, J. Chem. Soc. Perkin Trans. 2, 2000, 1425-1429
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compounds with ff-naphthol in the presence of water.1 These complexes are 
industrially of great importance as they can be used in the selective isolation of these 
cephalosporins from aqueous solutions.2 Although this phenomenon is known for 
several years, the structural features of these clathrates received almost no attention. 
Recently, we reported the crystal structures of complexes of ff-naphthol with the four 
aforementioned cephalosporins.3 In all four cases the antibiotic molecules appeared 
to be the host, while ff-naphthol functions as the guest, whereby water fulfils the role 
of "cement". The crystal structures of the complexes of 1, 2 and 3 with ff-naphthol 
are isomorphous, all having channel-type frameworks based on a two-dimensional 
network of hydrogen bonds. The crystal structure of the clathrate derived from 
Cefadroxil 4 and ff-naphthol on the other hand has a quite different morphology, viz. 
a three-dimensional network in which ff-naphthol is hosted with a higher water 
content than found in the clathrates derived from 1-3.
NH
2 H 
N
O
W - . 2
c o 2h
NH2 H 
,Ncrry
c o 2h
1 R1 = H , R2 = CH3
3 R1 = H , R2 = Cl
4 R1 = OH , R2 = CH3
R
2
Having elucidated the crystal structures of the four clathrates of 
cephalosporins with ff-naphthol, the interesting question arises whether other guest 
molecules than ff-naphthol can be accommodated in these hosting antibiotic 
frameworks. An attractive prospect of identifying other guest molecules, is that such 
guests may open avenues for a more effective removal of cephalosporin from 
aqueous solutions. For such a study, a series of compounds was selected, which on a 
molecular level show structural similarity with ff-naphthol. This approach, based on 
the concept of molecular similarity, resembles that often used for the design of 
substrates for biological targets, such as receptors and enzymes. In this paper, the 
scope of clathrate formation of cephalosporins 1-4 with various selected guest 
molecules is described, whereby the role of these guests on the crystallization and 
crystal morphology is analyzed. During this investigation some highly remarkable 
induced-fit phenomena were encountered in the clathrates.
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3.2 Results and Discussion
For the selection of a series of potential guest molecules for the clathrates 
derived from cephalosporins 1-4, the concept of molecular similarity was applied. In 
this way, a set of new molecules having similar structural features as ff-naphthol 
were selected. These molecules were subjected to a molecular modeling study using 
docking, implying that the ff-naphthol molecule was taken out of the lattice and the 
new molecules were fit into the remaining cavity. The crystal structure of the 
clathrates formed by 1-3 with ff-naphthol is referred to as type A, whereas that of 4 
with ff-naphthol as type B. The procedure of selecting potential guests as outlined 
above, leads to a series of substituted naphthalenes and other two ring aromatics, 
listed in Table 1 (entries 1-16). This list was extended by a series of potential guests 
on more intuitive grounds, viz. entries 17-22 in Table 1. The compounds listed in 
Table 1 were all tested in clathrate formation experiments. Cephradine, Cephalexin 
and Cefadroxil were examined with all potential guests, while for Cefaclor a limited 
number of experiments was performed because of the scarcity of this material. The 
Cephalosporins 1-3 gave complexes with all compounds tested, whereas with 
Cefadroxil 4 only clathrate formation was observed in a limited number of cases. 
These results are compiled in Table 1. The X-ray powder patterns of the clathrates 
derived from Cephalexin 1, Cephradine 2 and Cefaclor 3 reveal that they are all 
isomorphous with type A, while the few complexes obtained from Cefadroxil 4 are 
all isomorphous with type B. These observations indicate that the cephalosporin host 
molecules, strongly dictate the basic lattice in which the guest molecules are being 
accommodated. It is highly relevant to notice that for several potential guests, which 
were selected on intuitive grounds and for which docking experiments suggested 
that fitting into the ff-naphthol cavity cannot be achieved, the crystallization 
experiments show the opposite. Especially the type A complexes show a remarkable 
tolerance for guest molecules, much more so than the type B complex. This 
observation for the type A clathrates clearly suggests that there must be a 
considerable flexibility in the accommodation of guests, much more than can be 
envisaged by a straightforward replacement of ff-naphthol.
Several crystal structures of both type A and type B clathrates have been 
solved by single-crystal X-ray diffraction. These structures revealed an interesting 
unpredicted role of the water molecules in these clathrates. Initially, it was thought 
that the water molecules in the ff-naphthol clathrates are essential for the stability of 
the basic host framework and were therefore regarded as fixed parts in these 
complexes. The X-ray structures clearly showed that some guest molecules are able
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to remove water molecules from the cavity, whereas in other cases extra water 
molecules are incorporated. Such a possibility of having a variable amount of 
structural water was not taken into account during the docking studies, thus 
explaining the disagreements between prediction and experiments. The phenomena 
just mentioned are nicely illustrated in Figure 1a-c for three type A clathrates 
derived from Cephradine. Similar observations involving a varying number of water 
molecules were made for type B complexes as can be deduced from Figure 2a-c. This 
phenomenon of varying amounts of structural water in the clathrates has some 
analogy with biological systems, in which often the scope of suitable substrates for a 
given receptor can be enlarged by removal of water molecules from the binding site.
Table 1 The isolated complexes of Cephradine, Cephalexin, Cefaclor and Cefadroxil 
with varying complexing agents.
Complexing agent Cephradine Cephalexin Cefaclor Cefadroxil
1. ff-naphthol A A A B
2. a-naphthol A A A B
3. quinoline A A A *
4. naphthalene A A — *
5. 1,2-dihydroxynaphthalene A A — *
6. 1,3-dihydroxynaphthalene A A — *
7. 1,4-dihydroxynaphthalene A A — *
8. 1,5-dihydroxynaphthalene A A — *
9. 1,6-dihydroxynaphthalene A A A B
10. 2,3-dihydroxynaphthalene A A A *
11. 2,6-dihydroxynaphthalene A A — B
12. 2,7-dihydroxynaphthalene A A — B
13. coumarin A A — *
14. 8-hydroxyquinolin A A A *
15. indole A A — *
16. indene A A — *
17. 1-acetonaphtone A — — *
18. 2-acetonaphtone A A — *
19. 1-chloronaphthalene A — — *
20. 1,2,3,4-tetrahydro-1-naphthol A — — *
21. 1,5-dihydroxy-1,2,3,4- 
tetrahydro naphthalene
22. 2,2'-bipyridyl
A
A A A
*
*
* no complex formation, — not tried, A means the complex formed has the type A structure and B 
means the complex formed has the type B structure.
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a. Cephradine/2-acetonaphthone, host/guest/water is 2:1:4.
b. Cephradine/ a-naphthol, host/guest/water is 2:1:6.
c. Cephradine/2,2'-bipyridyl, host/guest/water is 2:1:7.
Figure 1 Three Cephradine complexes with a varying number of water molecules.
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a. Cefadroxil/2,7-dihydroxynaphthalene, host/guest/water is 2:1:7.
c. Cefadroxil/2,6-dihydroxynaphthalene, host/guest/water is 2:1:9.
Figure 2 Three complexes of Cefadroxil with a varying number of water molecules.
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The role of water as a cementing agent in these clathrates derived from 
cephalosporins, allows a certain flexibility in accepting guest molecules in these 
complexes. However, the higher guest tolerance in type A clathrates cannot be 
reconciled by solely varying the amount of water. More information became 
available by a detailed analysis of the structures of a series of type A clathrates, as 
determined by single-crystal X-ray diffraction. The dimensions and shapes of the 
hosting cavities in these complexes were compared. The distances between three 
sulfur atoms, which form three corners of a parallelogram (see Figure 3) are 
measured. The S1-S2 distance is a measure for the length of the type A cavity as can 
be deduced from Figure 1a-c and 3, because the line between S1 and S2 parallels the 
longest dimension of the guest molecule. For the type A structure, the distance (d) 
between two two-dimensional hydrogen bonded layers of Cephalosporin molecules 
can be defined. In addition, the relative slip of two layers with respect to each other 
can be determined, as is indicated in Figure 3. The sulfur-sulfur distances, the slip 
and the distance d are collected in Table 2. These data reveal that the dimensions of 
the cavity vary with the guest accommodated in the complex. The S1-S2 distance, 
which is in first approximation proportional with the size of the cavity, decreases 
from the large guest 2,2'-bipyridyl to the smaller guests naphthalene, quinoline and 
ff-naphthol. Apparently, the hosting framework is able to adjust the dimensions of 
the cavity to match the size of the guest, in order to achieve the most favorable 
crystal packing. The slip and the distance d are measures for the extent that the 
hosting framework is using its flexibility to adjust the size and shape of the cavity. 
For the Cephradine complexes the distance d between the two-dimensional layers
o
varies only marginally, viz. 0.20 A. On the other hand, the slip shows a considerable
o
decrease (1.07 A) going from the largest to the smallest guest. These observations 
lead to the conclusion that the adjustment of the size and shape of the hosting cavity 
mainly takes place by varying the slip rather than the interlayer distance. The 
consequence of this adjustment of the cavity to the nature of the guest molecule is 
that a wider range of guest molecules than predicted can be accommodated in the 
Cephradine framework, including those guest molecules which would not fit in the 
cavity arising from the removal of ff-naphthol from the clathrate structures. The 
adaptability of the type A clathrate framework towards different guest molecules, 
finds its origin in the rather weak interactions based on non-directional van der 
Waals forces between the two-dimensional layers of Cephradine, allowing the 
slipping process to occur. This fitting of the guest into the hosting cavity has some 
analogy with the induced fit of substrates in enzyme cavities.
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Figure 3 A Pluton4 drawing of the hosting-framework formed by Cephradine viewed
along the b-axis. Three sulfur-atoms have been numbered to define the distances 
listed in Table 2.
Table 2 The dimensions of the cavities for different Cephradine complexes.
Complex (A)3S-2S(A)3S-1
cn(A)2S-1S Slip (A) d (A)
Cephradine /  2,2'-bipyridyl 8.69 11.51 6.62 7.13 4.97
Cephradine /  2-acetonaphthone 8.18 11.69 7.22 6.48 5.00
Cephradine /  a-naphthol 8.12 11.74 7.33 6.39 5.01
Cephradine /  naphthalene 8.06 11.73 7.33 6.34 4.97
Cephradine /  quinoline 8.04 11.71 7.30 6.34 4.94
Cephradine /  ff-naphthol 7.73 11.71 7.54 5.98 4.90
The situation with clathrates derived from Cefadroxil is entirely different. 
This cephalosporin only forms complexes with a few guest molecules (Table 1), 
which is in strong contrast with the other three antibiotics. The four Cefadroxil 
clathrates are isomorphous with the type B structure of its ff-naphthol complex, as 
was established by powder diffraction analysis. This type B structure is three­
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dimensional in nature and is therefore lacking the adaptability by means of a 
slipping process as was observed for the type A clathrates. The type B framework is 
very rigid due to highly directional and strong hydrogen bonds, and as a 
consequence the flexibility in accommodating guest molecules is rather limited. 
Precise fitting is actually a prerequisite. In fact, only the adjustment of the number of 
water molecules accounts for the minimal adaptability. In other words Cefadroxil 
conforms more to the lock and key model.
3.3 Concluding Remarks
In conclusion, clathrate formation of Cephalexin, Cephradine and Cefaclor 
can be achieved with a variety of complexing agents, designed by the concept of 
molecular similarity using the clathrate with ff-naphthol as a basic model. The list of 
effective clathrate forming agents can be extended to a series of molecules that on 
basis of molecular similarity and docking would not fit. This is due to the highly 
remarkable adaptability of the cephalosporine framework through an induced fit 
process. However, the clathrates derived from Cefadroxil, containing an extra 
phenolic hydroxyl function in comparison with the abovementioned cephalosporins, 
are very rigid and only a limited number of precisely fitting guest molecules can be 
accommodated in this antibiotic framework. For all four antibiotics a limited 
flexibility in accommodating guest molecules exists, due to variation of the number 
of cementing water molecules, but this effect is small compared with the induced fit 
process mentioned above. The research described in this paper is an example of 
crystal engineering, which is of great practical importance for identifying novel 
effective complexing agents for an efficient isolation of this important class of 
antibiotics.
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3.4 Experimental section
Cephalexin, Cephradine, Cefaclor and Cefadroxil were obtained from DSM (Geleen). 
a-Naphthol, ff-naphthol, 1,4-dihydroxynaphthalene, 2,7-dihydroxynaphthalene,
1,2,3,4-tetrahydro-1-naphthol and 1,5-dihydroxy-1,2,3,4-tetrahydronaphthalene were 
purchased from ACROS. 1,2-Dihydroxynaphthalene, 1,3-dihydroxynaphthalene, 1,5- 
dihydroxynaphthalene, 1,6-dihydroxynaphthalene, 2,3-dihydroxynaphthalene and
2,6-dihydroxynaphthalene were purchased from Aldrich.
Crystallization experiments
To a solution of cephalosporin (1.5 mmole) in 20% methanol (50 ml), complexing 
agent (0.75 mmole) dissolved in acetone (2 ml) was added. After one night at 4°C the 
crystals were collected. The crystals were dried under a nitrogen flow and subjected 
to powder diffraction or, if appropriate, to single-crystal X-ray diffraction.
X-ray structure determinations
Crystals were mounted on glass fibers and intensity data were collected on a Nonius 
CAD4 diffractometer. Intensity data were corrected for Lorentz and polarization 
effects. Semi-empirical absorption corrections (^-scan) were applied.5 Details of all 
structure determinations are collected in Table 3. The structures of 2a, 2c, 4a and 4b 
were solved using the ORIENT option of the DIRDIF program system.6 The 
structures of 2b, 2d and 2e were solved using the PATTY option of the DIRDIF 
program system.7 Refinements were carried out with the SHELXL program.8 All 
non-hydrogen atoms were refined with anisotropic temperature factors. The 
hydrogens were placed at calculated positions and refined isotropically in riding 
mode. Hydrogens attached to methyl groups and to the amine nitrogens were 
refined as rigid rotors with idealized sp3 hybridization to match maximum electron 
density in a difference fourier map. For 2a and 2e the hydrogens attached to the 
Cephradine molecule were freely refined subsequently. For 2c all hydrogens, except 
the hydrogens attached to the amine group, were freely refined subsequently. All 
refinements were full-matrix least-squares on F2. In the case of 2a, 2b, 2c, 2d and 2e a 
crystallographic twofold axis is passing through the centers of the cavities in which 
the guest molecules are situated. As a consequence, in the case of 2a, 2b and 2e the 
guest molecules are disordered along this twofold axis. In all cases the two possible 
orientations of the guest molecules, which are related by twofold symmetry, could 
be refined using a disorder model. The naphtalene skeletons belonging to the two 
possible orientations of the 2-acetonaphton molecule do not overlap but are shifted 
away from the twofold axis.
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Table 3 The crystal data of the complexes described in this paper.
2a[a] 2 b 2c 2 d 2 e 4 a 4 b
Crystal color colorless Transparent transparent colorless transparent transparent transparent
light yellow colorless colorless colorless colorless
Crystal shape irregular regular regular regular platelet regular thick regular thin regular
chunk platelet platelet needle needle
Size [mm] 0.36x0.25x0.23 0.17x0.12x0.06 0.31x0.17x0.09 0.27x0.15x0.09 0.49x0.17 x0.12 0.46x0.09x0.06 0.28x0.08x0.06
Formula C41H 59N 7O 15S2 C42H 58N 6O15S2 C42H 60N 8O 15S2 C42H58N 6O14.5S2 C44H57N 6O 13.5S2 C42 H 56N 6O 19S2 C42H 60N 6O21S2
Mw 954.07 951.06 981.10 943.06 950.08 1013.05 1049.08
T [K] 293(2) 293(2) 173(2) 293(2) 293(2) 208(2) 293(2)
Crystal syst. Monoclinic Monoclinic Monoclinic Monoclinic Monoclinic Orthorhombic Orthorhombic
Space group C2 C2 C2 C2 C2 P212121 P212121
a [A] 23.4127(9) 23.471(2) 23.0227(8) 23.4584(6) 23.3855(5) 7.0902(7) 7.1079(18)
b [A] 7.1091(2) 7.1215(10) 7.1467(4) 7.1179(2) 7.1965(3) 21.273(3) 21.863(5)
c [A] 14.8060(6) 14.9304(19) 14.5544(4) 14.8922(5) 14.7588(4) 31.004(4) 32.306(4)
a  [°] 90 90 90 90 90 90 90
ß [°] 108.146(3) 108.268(14) 104.644(3) 108.571(2) 108.580(3) 90 90
Y [°] 90 90 90 90 90 90 90
Reflections 25 21 25 25 25 15 15
0-range [°] 23.029 - 52.473 13.125 - 20.888 40.106 - 45.680 40.492 - 46.469 39.960 - 46.191 20.890 -23.058 18.122 - 22.543
V [A3] 2341.79(15) 2369.8(5) 2316.94(16) 2357.12(12) 2354.36(11) 4676.4(9) 5020.4(18)
Z 2 2 2 2 2 4 4
Dc [M g/m 3] 1.353 1.333 1.406 1.329 1.340 1.439 1.388
Abs.coef. 1.660 1.633 1.700 1.629 1.620 1.759 1.687
[mm-1]
F(000) 1012 1008 1040 1000 1006 2136 2216
0-range 3.14 - 69.88 3.97 -  69.90 3.14 - 69.95 3.13 - 69.91 3.16 - 69.88 2.85 -  70.05 2.74 - 70.05
collected[°]
Ind.rang. h 0 to 28 -28 to 26 -28 to 0 -26 to 28 -26 to 28 0 to 8 -8 to 0
k -8 to 0 -8 to 8 -8 to 0 -8 to 0 0 to 8 0 to 25 -26 to 0
l -18 to 17 0 to 18 -17 to 17 -18 to 0 -17 to 0 0 to 37 0 to 39
Reflections 2468 /  2402 4988 /  4411 2453 /  2387 2522 /  2425 2507 /  2410 5017 /  5017 5384 /  5384
col./uniq.
R(int) 0.0096 0.0347 0.0102 0.0149 0.0167
Refl.obs. 2369 2413 2263 2236 2329 3705 2881
[Io>2 g (Io)]
Range of rel.. 1.070 /  0.968 1.024 /  0.976 1.115 /  0.950 1.072 /  0.932 1.030 /  0.970 1.033 /  0.979 1.012 /  0.987
Transm. fact.
D ata/restr./ 2402 /  1 /  395 4411 /  1 /  299 2387 /  1 /  384 2425 /  1 /  297 2410 /  71 /  445 5017 /  0 /  630 5384 /  0 /  648
par.
g.o.f. on F2 1.061 1.034 1.095 1.149 1.029 1.092 1.046
SHELXL-97 0.067200 0.094700 0.069400 0.081400 0.069700 0.186600 0.120700
Weight par. 0.651900 2.032900 1.427200 1.515400 0.469600 10.970497 0.000000
Final R ind. R1 = 0.0329 R1 = 0.0756 R1 = 0.0370 R1 = 0.0435 R1 = 0.0329 R1 = 0.1085 R1 = 0.0771
[I>2o (I)] wR2 = 0.0915 wR2 = 0.1792 wR2 = 0.1005 wR2 = 0.1229 wR2 = 0.0899 wR2 = 0.2737 wR2 = 0.1898
R indices R1 = 0.0332 R1 = 0.1431 R1 = 0.0398 R1 = 0.0493 R1 = 0.0339 R1 = 0.1394 R1 = 0.1557
(all data) wR2 = 0.0920 wR2 = 0.2188 wR2 = 0.1036 wR2 = 0.1389 wR2 = 0.0914 wR2 = 0.3064 wR2 = 0.2369
Apmax/min 0.288 /-0.190 0.353 /  -0.250 0.322 /  -0.245 0.355 /-0.238 0.240 /  -0.243 0.977 /  -0.839 0.452 /-0.372
[e.A-3]
Ial 2a Cephradine/quinoline, 2b Cephradine/ a-naphthol, 2c Cephradine/2,2'-bipyridyl, 2d
Cephradine/naphthalene, 2e Cephradine/2-acetonaphthone, 4a Cefadroxil/2,7- 
dihydroxynaphthalene, 4b Cefadroxil/2,6-dihydroxynaphthalene
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C a v i t i e s ,  La y e r s  a n d  C h a n n e l s  
IN THE HOSTING FRAMEWORK OF COMPLEXES 
D e r iv e d  Fr o m  C e p h r a d i n e
Abstract: The cephalosporin-type antibiotics Cephradine, Cephalexin and Cefaclor form 
clathrate-type complexes with a variety of naphthalene derivatives. The crystal structures of 
these complexes are isomorphous. Interestingly, the hosting framework formed by these 
cephalosporins can adapt to the guest molecule. This phenomenon of induced-fit appears to 
have a much larger potential, with the consequence that also a series of smaller compounds, 
e.g. benzene derivatives, as well as more bulky compounds can be hosted by Cephradine. 
Using benzene derivatives as guests, pronounced deviations are observed in the antibiotic 
framework. It is possible to induce deviations which are strikingly different from those 
found for the complexes with the naphthalene derivatives. Evidently, the hosting structure 
formed by Cephradine is highly flexible. Hosting frameworks containing layers, channels 
and various other types of cavities can be obtained by selecting an appropriate guest 
molecule. Remarkably, in all these antibiotic frameworks, a number of structural features 
and interactions remain unaffected. These persistent features seem to form the boundaries of 
framework formation for these antibiotics, thus defining their scope of complex formation.
4.1 Introduction
Crystal engineering is receiving fast growing attention from chemists and 
physicists. Not only solid state chemists and material scientists are active within this 
field but also supramolecular chemists and synthetic chemists are often inspired and
This Chapter is submitted for publication: G.J. Kemperman, R. de Gelder, F.J. Dommerholt, P.C. 
Raemakers-Franken, A.J.H. Klunder, B. Zwanenburg, Cavities, layers and channels in the hosting 
framework of complexes derived from Cephradine.
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challenged by phenomena exhibited by molecules in the solid state. Clathrates 
receive special attention from synthetic chemists, since they can be used to isolate 
organic compounds in a chemoselective or enantioselective manner.1'2'3 There is, 
however, no general theory available by which clathrates can be systematically 
designed. Supramolecular synthons have been postulated as a tool to understand 
and to predict crystal structures of organic molecules and complexes thereof.4 An 
approach to the design of clathrates is to construct a framework from 
supramolecular synthons built up from host molecules, in which cavities are present 
that can be occupied by guest molecules. This approach is often hampered by the 
lack of robust supramolecular synthons, which are not distorted by the guest 
molecules. Hence, this approach requires that the host molecules form a 
supramolecular synthon that is composed of strong intermolecular interactions. An 
example of an extremely robust supramolecular synthon is the basis of the molecular 
framework present in clathrates formed by the cephalosporin antibiotics 1-3 and a 
variety of guest molecules.5
In these clathrates the cephalosporin molecules form bilayers held together by 
strong hydrogen bonding and electrostatic interactions. When these bilayers are 
packed to form a three-dimensional structure, channels remain which are filled by 
water and guest molecules. Effectively, the guest molecules are present in discrete 
cavities. Some remarkable induced-fit phenomena were observed in the clathrates of 
cephalosporins 1-3 with a series of naphthalene derivatives.5 The cephalosporins are 
able to adapt their hosting framework to the size and the shape of the guest 
included. This adaptability arises from a slipping mechanism in which the bilayers 
move with respect to each other. As a result of this slipping mechanism, the scope of 
suitable guest molecules is significantly enlarged. In contrast, the cephalosporin 
Cefadroxil, which forms clathrates of a different structure type, lacks this 
adaptability.5 The principle of induced fit has been reported previously for inclusion 
compounds consisting of layered hosting frameworks formed by the dipeptide (R)- 
phenylglycyl-(R)-phenylglycine6 and by guanidinium and disulfonate ions.7 In these
CO2H c o 2h
1 Cephradine 2 Cephalexin (R = CH3)
3 Cefaclor (R = Cl)
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molecular frameworks the interlayer distance can be altered by pillaring with guest 
molecules.
Selective complexation of cephalosporins is a valuable methodology for the 
isolation of these important antibiotics from aqueous solutions.8'9 A drawback of the 
currently known guest molecules, which are all naphthalene derivatives, is their 
toxicity and the inherent environmental image problem associated with these 
compounds. Hence, assuming an extended adaptability of cephalosporins 1-3, the 
search for novel complexing agents was directed towards benzene derivatives. In 
contrast to naphthalenes, many benzene derivatives have more acceptable 
characteristics with regard to toxicity and environmental image. Examples are 
biphenyl 4 (preservative E230), 2-hydroxybiphenyl 5 (preservative E231), 
acetylsalicylic acid 6 (Aspirin), and methyl 4-hydroxybenzoate 7 (preservative E218). 
From a fundamental point of view, it is also interesting to study cephalosporin 
complexation with tricyclic guest molecules that are larger than naphthalene, such as 
fluorene 8. In this way the boundaries of the adaptability of the hosting framework 
formed by the cephalosporins 1-3 can be explored. The results of this exploration 
with Cephradine are described in this chapter.
OH
5 74 6
4.2 Results and discussion
Preparation and characterization of the complexes.
A series of benzene derivatives and several molecules larger than 
naphthalene, e.g. fluorene and benzilic acid, were subjected to complexation 
experiments with Cephradine. Crystalline complexes were analyzed by X-ray
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powder diffraction in order to establish whether the structure has the C2 cavity 
structure observed for the complexes of cephalosporins 1-3 with naphthalenes.10 The 
powder diffraction technique proved to be highly valuable for this study, as non- 
isomorphous structure types could be readily recognized. This is illustrated in 
Figure 1 for two different structure types formed by Cephradine by varying the 
complexing agents. In a number of cases the deviations caused by the induced-fit 
processes are so large that the resulting structure no longer shows the typical X-ray 
powder pattern of the C2 cavity structure observed for the complexes of 1-3 with 
naphthalenes. In these cases, the crystal structure of the complex was elucidated by 
single-crystal X-ray diffraction, in order to establish the nature of the hosting 
framework.
20
Figure 1 Powder diffraction patterns of complexes of Cephradine with 2- 
hydroxyacetophenone (a) and methyl benzoate (b) (type A, C2 cavity) and with 
2,2'-biphenol (c) and 2-phenylphenol (d) (C2 layers).
a
A large series of new guest molecules that form complexes with Cephradine 
could be identified. Most of these complexes were shown to have the C2 cavity type 
structure, however, several other structure types were discovered as well. The 
adaptability of the hosting framework of this structure-type appeared to be high as 
benzene derivatives, e.g. benzoic acid, as well as much larger molecules, e.g. fluorene
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and carbazole, can be hosted therein. Some of the new structure types are clathrates, 
like the naphthalene complexes, containing discrete cavities. In addition, also 
layered and channel type structures can be created for certain guest molecules. The 
various types of complexes that have been prepared and characterized are 
summarized in scheme 1, classified by their space group and their structure type, i.e. 
cavity, layer or channel type. The complexing behavior of the guest molecules is 
rather capricious, as subtle structural changes in the guest molecule can result in 
substantial changes of the overall structure of the Cephradine complexes, which is 
evident from scheme 1. A complete list of newly discovered guest molecules and the 
structure of their corresponding Cephradine complexes is given in the experimental 
section.
pseudo-channels, 
P21, 1 compound cavities, P1,13 compounds
layers,
C2 or P1,
3 compounds
Scheme 1 Complexants studied in the complexation with Cephradine and the type of 
complexes derived thereof. For each structure-type the number of compounds 
that form that type of complex with Cephradine is shown.
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Structural features of the complexes.
In order to quantify the conformational changes of the Cephradine molecule 
in the new structures compared with the known C2 cavity structure, five torsion 
angles were analyzed. These torsion angles are compiled in Table 1. The Cephradine 
complexes with 3-hydroxybenzoic acid, ff-naphthol, 2,2'-bipyridyl and fluorenone 
were taken as references for the C2 cavity structure, which is obtained with the 
majority of guest molecules.
Table 1 Five torsion angles of Cephradine measured in the corresponding complexes for 
all the structure types observed.
complexing agent
structure
type
N a T1 ° T2 ° T3 ° T4 ° T5 °
3-hydroxybenzoic acid C2 cavity 1 41 115 -177 -167 45
ff-naphthol C2  cavity 1 44 115 179 -169 50
2 ,2 '-bipyridyl C2 cavity 1 45 106 178 -169 46
fluorenone C2 cavity 1 40 106 177 -161 44
4 -hydroxybenzoic acid P21 cavity 2 74 104 179 -159 37
94.3 87 -179 -136 100
hydroquinone P1 cavity 2 85 124 177 -176 42.0
80.3 125 -180 -175 41
2-hydroxybiphenyl C2 layers 1 38.0 110 -175 -163 49
benzilic acid P1 layers 4 56 106 -172 -158 68.1
49 104 -169 -159 50
39 106 -170 -139 77
55 112 -167 -152 56
4-methylacetophenone P21 pseud. 2 50 94 -176 -147 27
channels 31 101 -178 -157 40
methyl 3-hydroxybenzoate P21
channels
1 60 -73 -179 -139 52
dimethylformamide P21
channels
1 70 -71 -177 -155 50
a The number of independent Cephradine molecules per unit cell. 
The torsion angles in the table are specified in the figure below.
T1 = 1-2-3-4, T2 = 5-6-7-8, T3 = 6-7-8-9, T4 = 7-8-9-10, T5 = 8-9-10-11
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The information compiled in Scheme 1 and Table 2 (Experimental section) 
reveals that the majority of guest molecules form complexes with Cephradine having 
the C2 cavity structure. Remarkably, the complexants show a considerable variation 
in structure as benzene, naphthalene and fluorene derivatives belong to this 
category, implying a substantial adaptability of this structure type. This adaptability 
can be accounted for by the bilayer slipping mechanism that was observed 
previously for naphthalene derivatives as the guest molecules. It is of interest, 
however, to compare the details of the variations in the cavities exhibited by the 
various complexants, in order to shed light on the extent of the flexibility and 
accordingly on the limitations of the adaptability of the abovementioned slipping 
mechanism.
The hosting framework of Cephradine with the C2 cavity structure, which 
consists of bilayers of cephalosporin molecules, is depicted in Figure 2. Assemblage 
of this structure is conceivable from a supramolecular synthon as encircled in Figure
2, containing two carboxylate and two ammonium groups provided by four 
individual Cephradine molecules. The adaptability of the C2-cavity structure can be 
mainly attributed to the slipping mechanism along the crystallographic a-axis. 
However, two other modes of induced-fit can be envisaged for the bilayer structure 
shown in Figure 2. These other modes of induced-fit are slipping along the b-axis 
and variation of the interlayer distance. Although these induced-fit mechanisms 
were not observed for the C2 cavity structures,11 they may well be important for 
understanding the formation of the new types of structures. In addition to the extra 
induced fit modes, the new structures may also go accompanied by conformational 
changes of the cephalosporin molecules and may show a completely different motif 
of interactions in the repetitive unit of the hosting framework.
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layer 1
interlayer
distance
layer 2
a
Figure 2 Three modes of induced-fit can be envisaged, viz. slipping of the bilayers along 
the a-axis and the b-axis and variation of the interlayer distance.
For 4-hydroxybenzoic acid the complex with Cephradine has a P21 cavity type 
structure as can be deduced from scheme 1 and Table 2. This structure can be readily 
distinguished from the C2  cavity structure by X-ray powder diffraction. Remarkably, 
benzoic acid as well 2- and 3-hydroxybenzoic acid (scheme 1, Table 2) form C2 cavity 
structures with Cephradine, whereas 4-hydroxybenzoic acid leads to a very different 
structure as is shown in Figure 3. The following differences can be noted. The 
Cephradine molecules adapt two different conformations, which are present in a 1:1 
ratio. The main difference between the two conformations resides in the torsion 
CH2,ring-C-C-NH3 (T5 in Table 1). The pattern of intermolecular interactions between 
the Cephradine molecules, which is the basis for the formation of bilayers, is 
virtually identical to that in Figure 2.
c
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Figure 3 The complex formed by Cephradine and 4-hydroxybenzoic acid viewed along 
the b-axis. The host/guest/water ratio is 2:1:4.
Cephradine forms layer type complexes with 2-hydroxybiphenyl, 2,2'- 
dihydroxybiphenyl and benzilic acid. These three complexing agents have non­
planar molecular structures, implying that these molecules would not easily fit into 
the cavities available in the C2 cavity type structures which only tolerate practically 
flat substrates. The accommodation of planar guest molecules in the C2 cavity 
structure was already demonstrated previously.5 This phenomenon is further 
exemplified by the observation that 2-decanol forms no complex with Cephradine, 
while ff-naphthol and 5,6,7,8-tetrahydro-2-naphthol do so. Apparently, sufficient 
space for the inclusion of the hydroxybiphenyls as the guest molecules can be 
achieved by an induced-fit process of the bilayers. The structure of the complex of 
Cephradine with 2-hydroxybiphenyl, which is depicted in Figure 4a, reveals that the 
layered structure formed by Cephradine molecules are identical to those in the C2 
cavity type complex. Also the conformation of the Cephradine molecule is very 
similar as can be deduced from the torsional data shown in Table 1. The dissimilarity 
between the C2 cavity structure and the structure shown in Figure 4a,b is the
enormous difference in the interlayer distance, amounting to an elongation of the c­
o
axis with 3.7 A. Hence, this complex is not a clathrate with discrete cavities but an 
intercalate formed by layers of cephalosporin molecules and layers of guest
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molecules as is evident from Figure 4b. Accordingly, the accommodation of the 
guest molecule is not restricted by the shape of the cavity in the hosting framework 
of this type.
4-point junction
Figure 4a The complex of Cephradine and 2-hydroxybiphenyl viewed along the b-axis.
Figure 4b The complex of Cephradine and 2-hydroxybiphenyl viewed along the a-axis. For 
the sake of visualizing the intercalate structure the guest molecules are omitted.
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The structure of the complex of Cephradine and benzilic acid shown in Figure
5, reveals that also the benzilic acid molecules form two-dimensional layers. In this 
complex the guest molecules exert a pillaring effect on the layers formed by the 
Cephradine molecules.
HO c o 2h 
benzilic acid
/
Figure 5a The complex of Cephradine (sticks) and benzilic acid (space filling) viewed 
along the a-axis.
Figure 5b The complex of Cephradine (space filling) and benzilic acid (sticks) viewed 
along the a-axis.
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Next to the C2 cavity type structure, the P1 cavity structure is most abundant 
as it is observed for 13 guest molecules (Table 2). The P1 cavity structure was solved 
by X-ray diffraction for the complex of Cephradine and hydroquinone and is 
depicted in Figure 6. The same motif of intermolecular interactions can be 
recognized in this structure but it is, however, highly distorted in comparison with 
that in the C2 cavity structure. The cavities present in the P1 cavity structure are 
smaller than those present in the C2 cavity structure. In addition, the cavities are 
tilted due to slipping of the bilayers in the direction of the b-axis (Figure 6b). This 
induced-fit mode, which is a combination of slips in two independent directions, 
was not encountered previously. Moreover, the cephalosporin molecules have 
undergone conformational changes in comparison with the C2 cavity structure, as 
can be deduced from the torsional angles in Table 1.
4-point junction
Figure 6a The structure of the complex of Cephradine and hydroquinone viewed along the 
a-axis. The host/guest/water ratio is 2:1:4.
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2-dimensional layers
cavity
Figure 6b The complex of Cephradine and hydroquinone viewed along the b-axis.
Many of the P1 cavity complexes are initially isolated as needles that undergo 
a spontaneous transformation into powders during drying. In case of 2- 
aminophenol, aniline and methyl 3-aminobenzoate stable complexes of both the C2 
cavity structure and the P1 cavity structure have been isolated and characterized. So 
far these are the only examples in which pseudo-polymorphs of cephalosporin 
complexes were isolated. Interestingly, the C2 type complex could be converted into 
the P1 cavity structure by placing the crystals at low pressure. This transition is 
accompanied by powdering of the crystals, and presumably by the loss of one water 
molecule per antibiotic molecule. The crystal structure of the resulting powders 
could be established by X-ray powder diffraction. Probably, a number of complexes 
that initially give needles but subsequently turn into powders have undergone a 
similar but spontaneous transformation of the C2 cavity structure into the P1 cavity 
structure.
The complex of Cephradine and 4-methylacetophenone is depicted in Figure
7. Here, the bilayers are somewhat waved, but the pattern of the intermolecular 
interactions between the Cephradine molecules is very much the same as that shown 
in Figure 2. In addition to conformational changes of the Cephradine molecule, the 
major difference between the C2 cavity structure and the structure shown in Figure 7 
is the enormous slip of the bilayers along the a-axis, which is much more
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pronounced than in the case of naphthalenes as the complexants. This arrangement 
of Cephradine molecules gives rise to the inclusion of two guest molecules per cavity 
instead of one as is common for the C2 cavity structure. Accordingly, the host:guest 
ratio amounts to 1:1. Moreover, two neighboring cavities have merged, which results 
in the formation of pseudo-channels winding through the hosting framework. In 
these pseudo-channels the complexant molecules adopt two different orientations.
4-point junction
Figure 7 The complex of Cephradine and 4-methylacetophenone viewed along the b-axis.
The structure most strongly deviating from the most abundant C2 cavity type 
structure was found for the complexes of Cephradine with methyl 3- 
hydroxybenzoate, methyl 4-hydroxybenzoate and dimethylformamide, respectively. 
It is highly remarkable that subtle changes in the guest molecule (scheme 1) have 
such enormous consequences for the structure of their complexes with Cephradine. 
The structure of these complexes with the just mentioned complexants have a 
hosting framework containing genuine non-interrupted channels, which are directed 
along the b-axis and do not contain any water molecules. Although the Cephradine 
network has similar features as in the C2 cavity structure, the complex as a whole 
has an entirely different structure. This goes accompanied by the enormous change 
in the conformation of the Cephradine molecules, as is evident from the torsional 
angles compiled in Table 1. In Figure 8a the conformation of Cephradine in the 
abundant C2 cavity structure and in the P21 channel type structure are presented, 
clearly demonstrating the enormous difference. As the result of this alternative
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conformation, one of the four intermolecular bonds of the 4-point junction, which is 
present in all other structure types, is disrupted. An amide NH of Cephradine serves 
as a substitute for this disrupted bond, resulting in a cyclic array of hydrogen 
bonding and electrostatic interactions consisting of five interaction points, as is 
pictured in Figure 8b. When the resulting bilayers are packed, a hosting framework 
with channels along the b-axis is formed. In contrast to all other structure types, in 
these channel type complexes the guest molecules are not surrounded by water. 
Figure 8c and 8d show the complexes of Cephradine with methyl 3- 
hydroxybenzoate and dimethylformamide, respectively, which clearly reveal the 
channels.
C2 Cavity-type complex P2 1 Channel-type complex
Figure 8a A Pluton drawing of the conformation of Cephradine in the C2 cavity type and 
the P21 channel type complex, respectively.
Figure 8b The intermolecular interactions within the hosting framework of the P21channel 
type structure viewed along the c-axis.
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channel with 
guest molecules
2-dimensional 
layer
Figure 8c The complex of Cephradine and methyl 3-hydroxybenzoate viewed along the b- 
axis.
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4.3 Concluding remarks
The molecular complexes of the cephalosporin antibiotics Cephradine, 
Cephalexin and Cefaclor with a variety of complexants all show bilayers of the 
antibiotic molecule with weak van der Waals interactions between the layers thereby 
allowing them to move with respect to each other with a relative ease. This layer 
arrangement provides the hosting skeleton an adaptability in accommodating guest 
molecules of different sizes by three modes of induced-fit to adjust the size of the 
cavities for the complexing compound. This adaptability expands the range of guest 
molecules considerably, which is clearly not restricted to naphthalene derivatives, 
the initially discovered group of suitable complexants. It was found that a series of 
benzene derivatives can serve as effective complexing agents for Cephradine, which 
in this study was taken as the representative antibiotic. These complexants are 
potential candidates for the isolation of Cephradine from aqueous solutions, e.g. in 
an industrial production of this antibiotic whereby an enzymatic coupling of the 
Cephradine nucleus with an appropriate side chain is performed in aqueous media. 
Among the benzene derivatives there are several compounds that have an 
environmentally and toxicologically fully acceptable profile, much better than that of 
naphthalene derivatives, which were reported previously.
This study also revealed that subtle variations of the structure of the guest molecules 
can have an enormous impact on the structure of the molecular complex with 
Cephradine. In all the variants of the Cephradine complexes the head to tail 
interactions of the zwitterionic Cephradine molecules, which in the majority of cases 
are present as 4-point junctions, remained unaffected. The adaptability of the 
inclusion of guest molecules is fully governed by shifting of antibiotic layers and by 
varying the interlayer distance. Evidently, the head to tail interactions are 
determining the boundaries of the adaptability of the hosting framework for the 
accommodation of guest molecules.
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4.4 Experimental Section
Cephradine monohydrate was a generous gift of DSM Life Sciences Group 
(Geleen, The Netherlands). All complexing agents used are commercially available 
and were purchased from either Acros or Aldrich. X-ray powder patterns were 
recorded on a Philips PW1820 Automatic Powder Diffractometer equipped with a 
Philips PW1830 High Voltage Generator.
Complexation experiments
Cephradine monohydrate (525 mg, 1.5 mmole) was dissolved in water (50-100 ml). 
The complexing agent was dissolved in methanol (2 ml) and subsequently added to 
the Cephradine solution. Crystalline complexes were filtered off and dried using a 
flow of nitrogen. The complexes were analyzed by X-ray powder diffraction and in 
some cases also by single crystal X-ray diffraction. When the complexing agent was 
only poorly soluble in water, the complexes were crystallized from water/methanol 
mixtures. The results of the complexation experiments are compiled in Table 2.
Crystal structure determination
Crystals were mounted on glass fibers and intensity data were collected on a Nonius 
CAD4 diffractometer. The radiation used was CuKa (graphite monochromated) with
o
a=1.54184A. Intensity data were corrected for Lorentz and polarization effects. Semi- 
empirical absorption corrections (y-scan) were applied.12 The structures were solved 
using the program system DIRDIF.13 Structure refinement was performed by full- 
matrix least squares on F2 (program SHELXL).14 Details of all structure 
determinations are given in Table 3.
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Table 2 The Cephradine complexes that were prepared and characterized classified by 
their structure type.
structure type guest molecules
benzoic acid, salicylic acid, 3-hydroxybenzoic acid, methyl benzoate, 
methyl salicylate, o-methoxybenzoic acid, o-toluic acid, m-toluic acid, 
methyl p-toluylate, benzamide, 2-aminobenzoic acid, methyl 2-amino- 
benzoate, 2-aminobenzamide, 4-aminosalicylic acid , methyl N-methyl-2- 
aminobenzoate, methyl 3-aminobenzoate* , 2,4-dihydroxybenzoic acid,
3,4-dihydroxybenzoic acid, 3,5-dihydroxybenzoic acid, gallic acid, methyl 
gallate , methyl 2,4-dihydroxybenzoate, methyl 3,5-dihydroxybenzoate, 
2-methoxybenzaldehyde, vanillin, 2-hydroxyacetophenone, 2-methoxy- 
acetophenone, 2-methylacetophenone, catechol, pyrogallol, 
phlorogucinol, anisole, m-anisidine, aniline*, 2-aminophenol*, toluene, 
benzene,
4-hydroxybiphenyl, phluorene, phluorenone, carbazole, 
methyl 4-aminobenzoate
C2
Cavities
(Type A)
P21
Cavities
C2
Layers
P1
Layers
P1
Cavities
P21
Pseudo­
Channels
P21
Channels
p-hydroxybenzoic acid 
2-hydroxybiphenyl, 2,2'-dihydroxybiphenyl 
benzilic acid
acetophenone, 3-hydroxyacetophenone, 4-aminoacetophenone, 1- 
indanone, phenol, resorcinol, hydroquinone, 4-methoxyphenol, p-cresol, 
2-aminophenol*, 3-aminophenol, aniline*, methyl 3-aminobenzoate*
4-methylacetophenone
methyl 3-hydroxybenzoate, methyl 4-hydroxybenzoate, 
dimethylformamide
Two pseudo-polymorphs have been isolated and characterized.
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Table 3 The crystal data of the complexes described in this chapter.
1aM 1b 1c 1d 1e 1f 1g
Crystal color colorless colorless colorless colorless colorless colorless colorless
Crystal shape regular thick regular flat regular rod large regular regular rod regular regular
needle needle platelet platelet platelet
Size [mm] 0.46x0.20x0.11 0.53x0.20x0.09 0.23x0.10x0.09 1.20x0.50x0.20 0.44x0.16x0.06 0.34x0.18x0.08 0.33x0.25x0.07
Formula C39H52N6O15S2 C56H70N6O16S2 C46H50N6O11S2 C38H52N6O14S2 C25H34N3O7.5S C24H27N3O7S C22H33N5O6S
Mw 908.99 1147.30 927.04 880.98 528.61 501.55 495.59
T [K] 293(2) 293(2) 293(2) 208(2) K 208(2) 208(2) 208(2)
Crystal syst. Monoclinic Monoclinic Triclinic Triclinic Monoclinic Monoclinic Monoclinic
Space group P21 C2 P1 P1 P21 P21 P21
a [A] 14.917(5) 23.5642(6) 11.7069(13) 7.07185(19) 15.4038(6) 10.9073(3) 10.8747(4)
b [A] 7.382(3) 7.1320(2) 11.8689(10) 10.7031(2) 7.2983(4) 9.40654(19) 9.5114(3)
c [A] 20.503(9) 18.6893(9) 19.0047(17) 14.2342(5) 23.5735(12) 12.1992(3) 12.3904(3)
a [°] 90 90 75.064(9) 87.154(3) 90 90 90
ß [°] 105.77(6) 109.380(3) 74.695(14) 78.999(3) 99.354(4) 98.533(2) 98.705(3)
Y [°] 90 90 85.408(16) 89.743(2) 90 90 90
Reflections 15 25 24 25 25 25 25
0-range [°] 21.927-22.942 40.229-46.835 15.383-23.563 39.912-45.180 22.865-46.103 40.666-45.763 40.203-45.994
V [A 3] 2172.7(15) 2962.96(19) 2460.8(4) 1056.28(5) 2614.9(2) 1237.79(5) 1266.82(7)
Z 2 2 2 1 4 2 2
Dc [Mg/m3] 1.389 1.286 1.251 1.385 1.343 1.346 1.299
Abs.coef. 1.756 1.412 1.503 1.769 1.536 1.582 1.525
[mm-1]
F(000) 960 1216 976 466 1124 528 528
0-rang.col.[°] 3.08 - 69.96 3.94 - 69.98 3.85 - 70.30 3.17 - 69.86 2.91 - 69.97 3.66 - 69.89 3.61 - 69.99
Ind. range h -17 to 18 -28 to 26 -14 to 14 -8 to 8 0 to 8 -13 to 0 -13 to 13
k 0 to 8 0 to 8 -14 to 0 -13 to 13 -8 to 0 -11 to 0 0 to 11
l -24 to 0 0 to 22 -23 to 22 -17 to 0 -28 to 28 -14 to 14 0 to 15
Refl. 4570 / 4441 3143 / 3046 9805 / 9805 4162 / 4162 5570 / 5365 2639 / 2504 2687 / 2566
col./uniq
R(int) 0.0195 0.0605 0.0000 0.0577 0.0896 0.0181
Refl.obs. 4235 2788 4073 3897 4871 2349 2474
[Io>2g (Io)]
Range of rel. - 1.152/0.939 1.017 /0.986 1.175/ 0.907 1.317/ 0.864 1.583/ 0.766 1.176/ 0.917
Transm. fact.
Data/restr./ 4441/1/567 3046/1/363 9805/375/ 4162/3/545 5365/1/666 2504/1/110 2566/1/377
par. 1272
g.o.f. on F2 1.049 1.098 1.073 1.725 4.010 5.308 1.055
SHELXL-97 0.087800 0.132100 0.064500 0.200000 0.100000 0.100000 0.087500
Weight par. 0.392400 1.880800 5.013600 0.000000 0.000000 0.000000 0.169400
Final R ind. R1 = 0.0423 R1 = 0.0555 R1 = 0.0883 R1 = 0.1218 R1 = 0.2095 R1 = 0.2492 R1 = 0.0373
[I>2a(I)] wR2 = 0.1187 wR2 = 0.1755 wR2 = 0.1727 wR2 = 0.3341 wR2 = 0.4176 wR2 = 0.5187 wR2 = 0.1060
R indices R1 = 0.0442, R1 = 0.0616 R1 = 0.2256 R1 = 0.1218 R1 = 0.2183 R1 = 0.2580 R1 = 0.0387
(all data) wR2 = 0.1213 wR2 = 0.1888 wR2 = 0.2285 wR2 = 0.3341 wR2 = 0.4329 wR2 = 0.5318 wR2 = 0.1078
Apmax/mta 0.347/ -0.279 0.428/ -0.389 0.412/ -0.390 1.086/ -1.110 3.651/ -2.717 4.361/ -2.739 0.427/ -0.206
[e.A -3]
[a] 1a Cephradine/4-hydroxybenzoic acid, 1b Cephradine/2-hydroxybiphenyl 
1c Cephradine/ benzilic acid, 1d Cephradine/hydroquinone 
1e Cephradine/4-methylacetophenone, 1f Cephradine/methyl 3-hydroxy- 
benzoate, 1g Cephradine/dimethylformamide
60
Cavities, layers and channels in the hosting framework of complexes derived from Cephradine
4.5 References
1. D. Worsch, F. Vögtle, Top. Curr. Chem., 1987, 140, 22-42
2. F. Toda, Top. Curr. Chem., 1987, 140, 43-69
3. F. Toda, Adv. in Supramolecular Chemistry, 1992, 2, 141-191
4. G.R. Desiraju, Angew. Chem., Int Ed Engl., 1995, 107, 2541-2558
5. G.J. Kemperman, R. de Gelder, F.J. Dommerholt, P.C. Raemakers-Franken, A.J.H. 
Klunder, B. Zwanenburg, J. Chem Soc. Perkin Trans. 2, 2000, 1425-1429
6. M. Akazome, Y. Yanagita, R. Sonobe and K. Ogura, Bull. Chem. Soc. Jpn. 1997, 70, 
2823-2827
7. V.A.Russell, C.C. Evans, W. Li, M.D. Ward, Science, 1997, 276, 575-579
8. US 4003896, [Chem. Abstr. 1977, 86, 171490m]
9. WO 93/12250, EP 618979, US 5470717, [Chem. Abstr. 1993, 119, 137533w]; A. 
Bruggink, E.C. Roos, E. de Vroom, Org. Proc. Res. Dev., 1998, 2, 128-133; A. 
Bruggink, Chimia, 1996, 50, 431-432
10. The C2 cavity structure corresponds to the type A structure, which is referred to 
in Chapter 3.
11. Slipping along the b-axis would lift the C2 symmetry present in the hosting 
framework shown in Figure 2.
12. A.C.T. North, D.C. Philips, F.S. Mathews, Acta Crystallogr., Sect. A, 1968, 24, 351.
13. P.T. Beurskens, G. Beurskens, W.P. Bosman, R. de Gelder, S. Garcia-Granda, R.O. 
Gould, R. Israel, J.M.M. Smits, DIRDIF-96. A computer program system for 
crystal structure determination by Patterson methods and direct methods 
applied to difference structure factors; Crystallography Laboratory, University of 
Nijmegen: The Netherlands, 1996.
14. G.M. Sheldrick, SHELXL-97. Program for the refinement of crystal structures; 
University of Gottingen: Germany, 1997.
61
62
Chapter 5
E f f ic ie n c y  o f  C e p h a l o s p o r i n  C l a t h r a t i o n  w it h  
A r o m a t i c  C o m p o u n d s
Abstract: Complexation with ff-naphthol analogues can be employed to withdraw the 
cephalosporins Cephalexin, Cephradine, Cefaclor and Cefadroxil selectively from an 
aqueous solution. In this process, the most important parameter is the complexation 
efficiency, that expresses to which extent the cephalosporins can be withdrawn from a 
solution. The complexation efficiencies for a series of guest molecules are explained in terms 
of both the thermodynamics of the complexation reaction and the structural features of the 
cephalosporin complexes. In this manner, insight is gained in the subtle relationship 
between the molecular structure of naphthalene derivatives, and the stability of their 
complexes with the antibiotics. It is shown which molecular properties of the guest 
molecules are the most important ones for an optimal complexation efficiency of 
cephalosporins.
5.1 Introduction
The introduction of biocatalysis in the manufacture of the semi-synthetic 
cephalosporins is an outstanding example of greening of the chemistry employed by 
the fine-chemical industry. By introducing biocatalysis in the production of the 
constituents of the semi-synthetic cephalosporins, i.e. a ff-lactam nucleus and a D­
amino acid side chain, the environmental impact of these processes has been 
reduced considerably.1,2 For the coupling of nucleus and side chain, however, most 
manufacturers still use processes based on stoichiometric chemistry. These 
conventional chemical processes require protecting groups and activating agents 
and are conducted in halogenated solvents.3'4 Hence, the preparation of the semi-
This chapter has been published: G.J. Kemperman, R. de Gelder, F.J. Dommerholt, P.C. Raemakers­
Franken, A.J.H. Klunder, B. Zwanenburg, J. Chem. Soc., Perkin Trans. 2, in press.
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synthetic cephalosporins via these processes inherently leads to the formation of a 
large amount of chemical waste. Utilization of biocatalysis for the coupling of 
nucleus and side chain makes this process much more environmentally benign since 
the enzymatic synthesis takes place in water and demands neither protecting groups 
nor activating agents. The penicillin G acylase catalyzed synthesis of Cephalexin has 
been investigated extensively in the past years.5 The thermodynamical coupling of 
nucleus and side chain yields only very low product concentrations.6 Therefore, the 
enzymatic synthesis has to be conducted in a kinetic fashion using the ester or amide 
derivative as an activated precursor of the side chain, as is depicted for Cephalexin 
in scheme 1. A drawback of the enzymatic synthesis is that Cephalexin is also 
hydrolyzed by the enzyme giving back the nucleus (7-ADCA) and inactivated side 
chain (phenylglycine). As a result of this unwanted secondary hydrolysis the kinetic 
enzymatic synthesis provides Cephalexin in only moderate yield.7 The success of the 
enzymatic process is, therefore, strongly dependent on how well secondary 
hydrolysis of the product can be effectively prevented or suppressed. In this respect, 
selective clathration is a powerful method to tackle this problem. Selective 
complexation with ff-naphthol8 can be employed for the in situ removal of 
Cephalexin during the enzymatic synthesis, which results in a considerable increase 
of the yield of Cephalexin.9 In addition, complexation provides a method for efficient 
down-stream processing of Cephalexin.
NH'2
CONH
H2N
O
CO2H
7-ADCA 7-ADCA
scheme 1 The kinetic enzymatic synthesis of Cephalexin from phenylglycine amide and 7- 
aminodesacetoxycephalosporanic acid (7-ADCA).
+
Although ff-naphthol is a reasonable complexing agent for all four 
cephalosporins 1-4, the aim of the research described in this chapter is to find the
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optimal complexant for each individual cephalosporin. The present study is a 
systematic investigation of a series of naphthalene derivatives as potential 
complexing agents for cephalosporins. The thermodynamics of the complexation 
reaction have been studied to reveal which parameters of a guest molecule influence 
the complexation efficiency. In addition, the correlation of the complexation 
efficiency of a complexing agent with its molecular structure, has been investigated 
using structural information of the respective complexes.
N H
C O 2H
R
NH.
R
C O 2H
2  R 1 = H, R 2 = C H 3
3 R 1 = H, R 2 = Cl
4  R 1 = O H , R 2 = C H 3
1
5.2 Results
A series of complexing agents has been identified for all four cephalosporins. 
A relatively large number of these agents form isomorphous clathrates with the 
cephalosporins 1-3.10 Cefadroxil 4 forms clathrates with only a small set of agents, 
which are not isomorphous with the clathrates formed from 1-3.10 The influence of a 
guest molecule on the complexation efficiency can be investigated by comparing ff- 
naphthol and a newly identified complexing agent. The cavities present in the 
hosting framework of 1-3 differ from those in the framework of Cefadroxil 4. Thus it 
may be concluded that the most efficient complexing agent for 1-3, is not per se the 
optimal one for 4. On the other hand, cephalosporins 1-3 may have the same optimal 
complexing agent. As cephalosporins 1-3 form isomorphous clathrates, one of them 
can in principle serve as a model for the other two. In this paper the main focus is on 
Cephradine, Cephalexin and Cefadroxil, while Cefaclor receives less attention due to 
the limited availability of this antibiotic.
The complexes derived from ff-naphthol have been used as a reference for a 
systematic investigation of the influence of the molecular structure of the guest 
molecule on the complexation efficiency. The influence of the hydroxyl function in ff- 
naphthol was studied by comparing its efficiency with that of naphthalene. 
Conceivably, a hydroxyl function can serve as a hydrogen bond donor and acceptor
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to the surrounding water molecules11 and hence it can contribute to the overall 
stability of the crystal, which may result in a more efficient crystallization. The 
behavior of ff-naphthol has been compared with that of a-naphthol to investigate the 
influence of the position of the hydroxyl function at the naphthalene skeleton on the 
complexation. The influence of an additional hydroxyl function and its relative 
position has been studied using a series of dihydroxynaphthalenes as complexing 
agents. The study was restricted to commercially available dihydroxynaphthalenes. 
Quinoline and 8-hydroxyquinoline have been examined as guest molecules in order 
to shed light on the effect of a strong hydrogen bond acceptor in the aromatic 
system.
Complexation experiments were performed on a 1.5 mmole scale and a twofold 
excess of complexant, i.e. using equimolar amounts of cephalosporin and 
complexant.12 The complexation was studied by measuring the decrease of the 
concentration of cephalosporin with time after addition of the complexing agent. The 
complexing agent was added as such to the cephalosporin solution as this procedure 
most closely resembles the use of the complexation methodology in a production 
process. Except for quinoline, all complexing agents are solids. The concentration 
data which reflect the kinetics of the complexation process are collected in Table 1. 
These data reveal that some complexing agents form complexes very rapidly, in fact 
the remaining concentration of antibiotic does not change anymore after 90 minutes. 
Clearly, the solubility of the complexant in water and its rate of dissolution are of 
importance.13 If the rate of dissolution of the complexant is too slow, it may not reach 
its maximum complexation efficiency within 24 h, which was the cut off time for the 
monitoring of the antibiotic concentration. Examples are naphthalene and 1,5- 
dihydroxynaphthalene for Cephradine. To facilitate the dissolution of the 
complexant in water it was added as a solution in a small amount of methanol, viz. 2 
ml. In this manner a supersaturated solution of complexant in water was obtained 
which results in an almost instantaneous clathration with the antibiotic. Moreover, 
the excess of complexing agent is present as a saturated solution in water and in part 
as a precipitated solid, implying that the concentration of complexant in this 
complexation procedure remains constant. The residual concentration of Cephradine 
was measured after 90 minutes of incubation. These data are also included in Table
1, viz. bottom row for Cephradine 1. Except for ff-naphthol, naphthalene and 1,5- 
dihydroxynaphthalene the residual concentrations are the same as observed for the 
addition of complexant as such after 24 h, implying that in these cases an 
equilibrium between the antibiotic, the complexant and their complex has been 
reached. Thus, when the complexing agent is sufficiently soluble in water the 
efficiency of the complexant is the same as achieved when methanol is used as a
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mediating solvent for the complexing agent. It is important to emphasize that the use 
of methanol to prior dissolution of the complexing agent considerably enhances the 
rate of complexation in most cases.
Table 1 The residual concentrations of Cephradine 1, Cephalexin 2, Cefaclor 3 and 
Cefadroxil 4 after complexation with naphthalene derivatives.
residual concentration of cephalosporins 1-4 (mM)
t a b c d e f g h i j k l m
1 0 28 29 27 16 3.2 9.8 29 1.4 4.5 5.4 3.6 3.2 29
30 23 29 19 8.0 2.9 5.3 26 1.1 1.8 3.6 4.5 2.9 26
90 19 27 1.3 8.0 2.6 6.3 25 1.1 1.8 3.6 4.2 2.9 23
24h 17 17 1.3 8.0 2.6 9.8 16 1.1 1.8 3.0 3.9 2.9 3.6
a09 2.7 3.7 1.3 8.0 2.6 9.8 1.7 1.1 1.8 3.0 3.9 2.9 3.6
2 0 19 29 13 b 11 5.5 13 8.7 29
30 10 21 2.3 5.5 5.5 4.6 6.6 6.1
90 10 17 2.3 5.2 4.0 4.6 6.4 5.8
24h 9.2 7.8 2.0 3.2 4.0 3.8 4.3 5.2
3 0 29 29 6.0 25
30 13 21 4.9 20
90 12 5.9 4.9 18
24h 7.8 3.3 4.9 8.5
4 0 26 _c 31 _ _ _ _ 13 _ 5.8 3.6 _ _
30 13 27 11 5.5 3.0
90 13 22 11 5.2 2.8
24h 12 20 11 5.2 2.8
a The complexing agent was added as a solution in methanol. Concentration measured after 
90 min. b Not measured. c No complex formation.
a ff-naphthol, b naphthalene, c a-naphthol, d 1,2-dihydroxynaphthalene, 
e 1,3-dihydroxynaphthalene, f 1,4-dihydroxynaphthalene, g 1,5-dihydroxynaphthalene, 
h 1,6-dihydroxynaphthalene, i 2,3-dihydroxynaphthalene, j 2,6-dihydroxynaphthalene, 
k 2,7-dihydroxynaphthalene, l quinoline, m 8-hydroxyquinoline
The residual concentration of Cephradine obtained by using methanol to 
dissolve the complexant are representing the antibiotic concentrations during the 
complexation process at equilibrium, whereby in most cases the complexant is 
present as a saturated aqueous solution (vide supra). Hence, these data can be utilized 
to calculate some relevant thermodynamic parameters of the complexation process
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(scheme 2), which are helpful in understanding the efficiency of the clathrate 
formation. Under the complexation conditions whereby the complexant 
concentration is constant, the equilibrium constant can be simply derived from 
equation I. When, however, the conditions of saturation are not fulfilled then the K 
value can be derived by inserting the actual concentration of complexant and 
antibiotic in equation II. This situation is encountered for three cases, viz. quinoline,
2,3-dihydroxynaphthalene and 2,7-dihydroxynaphthalene. The thus obtained K 
values and the Gibbs free energies of complexation derived therefrom using 
equation III are collected in Table 2.
K = 1 / [Cephradine] (eq. I)
K = 1/[Cephradine][complexant]05 (eq. II)
AGcomplexation = -RT ln K (eq. III)
K
Cephradine +  0.5 complexant +  n H20  “  Cephradine(com plexant)05.nH2O(s)
Scheme 2 The complexation reaction equation.
Table 2 The equilibrium concentrations of Cephradine and complexing agent (CA) and 
the equilibrium constant (K) and Gibbs free energy of complexation (AG )derived 
therefrom.
Complexing agent [1] mMa [CA] mM K AG (kJ/mole)
ff-naphthol 2.7 5.1 370 -14.7
naphthalene 3.7 0.2 270 -13.9
a-naphthol 1.3 7.7 769 -16.5
1,2-dihydroxynaphthalene 8.0 c
1,3-dihydroxynaphthalene 2.6 11.4 385 -14.7
1,4-dihydroxynaphthalene 9.8 5.4 102 -11.5
1,5-dihydroxynaphthalene 1.7 1.0 588 -15.8
1,6-dihydroxynaphthalene 1.1 c
2,3-dihydroxynaphthalene 1.8 15.9 b 4406 -20.8
2,6-dihydroxynaphthalene 3.0 6.9 333 -14.4
2,7-dihydroxynaphthalene 3.9 17.0 b 1967 -18.8
quinoline 2.9 16.5 b 2684 -19.6
8-hydroxyquinoline 3.6 2.7 278 -14.1
a The complexant was dissolved in methanol prior to addition to the Cephradine solution. 
b The equilibrium constant is calculated according to equation II. 
c The solubility was not reported in the literature.
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By comparing the efficiencies of the complexing agents for Cephradine shown 
in Table 2, the intriguing question arises whether the overall stability of the 
complexes can be correlated with the structure of the complexant. It is important to 
note that the complexation efficiency, which is directly related to the AG of the 
complexation reaction, depends on the stability of the clathrate formed and on the 
energy of solvation of both the complexing agent and the cephalosporin in water. 
The data in Table 2 refer to complexation experiments with the same cephalosporin, 
viz. Cephradine, thus only the differences in solvation energy between the individual 
complexing agents have to be accounted for. Prior to stabilization by complexation 
with Cephradine, the complexant has to be desolvated from water, which costs 
energy. Thus the intermediary stage of the complexing agent can be represented by 
the molecule in the gas phase deprived of all intermolecular interactions. The Gibbs 
energy of complexation (AGcomplexation), which is related to the efficiency of the 
complexation reaction (Table 2), is the difference between the Gibbs energy of 
stabilization (AGstabnization) and the Gibbs energy of solvation (AGsolvation). 
Consequently, the complexation efficiency is determined both by stabilizing 
interactions within the complex (AGstabilization) and the Gibbs energy of solvation of 
the complexing agent (AGsolvation), which is sacrificed upon complexation. Therefore, 
it is only justified to directly attribute variations in the complexation efficiency to 
structural features of the complexes, when the difference between the energy of 
solvation of the complexing agents is relatively small compared with the differences 
between their energy of complexation. The energy diagram of the complexation 
reaction is depicted in Scheme 3.
CA,(g)
A G solvation
A G stabilization
CTCC
<
C
A G complexation
L.............................................. J
compleX(s)
Scheme 3 The energy diagram for the complexation reaction. CA stands for complexant.
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The AGsolvation can be deduced from the energy of sublimation (AGsublimation) 
and the energy of solution (AGsolution) according to Scheme 4. The AGsolution can be 
derived from the solubility of a complexing agent which in most cases is reported in 
the literature.17 For the five of complexants shown in Table 2 the AGsublimation is 
reported.27 Hence, only for these five complexing agents the thermodynamical 
quantities of complex formation with Cephradine can be discussed in more detail. 
The respective numbers are compiled in Table 3.
CA,(g)
AG,sublimation
CA,(aq)
CA,(s)
AG solvation
AG solution
Scheme 4 The energy diagram correlating the Gibbs energy of solvation, the Gibbs energy 
of solution and the Gibbs energy of sublimation of a complexing agent (CA).
Table 3 Comparison of the Gibbs energy of complexation (AGcompl), solvation (AGsolv) and 
stabilization (AGstab) for the complexation of Cephradine with five different 
complexing agents ( in kJ/mole).
complexing agent 0.5xAGsolv AGcompl AGstaba
naphthalene -1.4 -13.9 -15.3
a-naphthol -11.6 -16.5 -28.1
ff-naphthol -12.7 -14.7 -27.4
quinolineb 3.5 -19.6 -16.1
8-hydroxyquinoline -11.4 -14.1 -25.5
a AGstab is calculated by AGstab = 0.5 xAGsolv + AGcompl (the ratio complexant:Cephradine is 
2:1).
b For quinoline AGsolv is calculated from AGvaporization27 and AGsolution.
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5.3 Discussion
The data in Table 1 reveal that the residual concentration of the antibiotic in 
solution is strongly dependent on the complexing agent used. Evidently, the 
efficiency of the complexation process can be controlled by choosing the most 
suitable complexing agent. It should be noted that considerable improvement in 
efficiencies can be achieved with respect to our reference compound ff-naphthol. For 
an efficient isolation of the antibiotics from an aqueous reaction mixture, the residual 
concentration of antibiotic should be as low as possible. For cephalosporins 1-3, the 
highest efficiency is obtained for a-naphthol as the complexant. In the case of 
Cephradine only 1,6-dihydroxynaphthalene is slightly better than a-naphthol, 
however, this complexant performs much worse in case of Cephalexin and Cefaclor. 
The difference of 0.2 mM between the residual concentrations of Cephradine 
obtained with a-naphthol and 1,6-dihydroxynaphthalene, respectively, is within the 
limits of accuracy of approximately 0.3 mM. In practice, the performance of these 
two complexing agents may be regarded as the same. The finding that 
cephalosporins 1-3 are most efficiently complexed with a-naphthol, can be explained 
by the isomorphism of their complexes.
The complexation data of Cefadroxil shown in Table 1 reveal that ff-naphthol is 
neither the best complexing agent for this cephalosporin. However, a-naphthol 
behaves the worst in this series, in strong contrast to the results obtained with the 
cephalosporins 1-3. The best performing complexing agent for Cefadroxil in this 
study is 2,7-dihydroxynaphthalene. The difference in behavior between the 
cephalosporins 1-3 on one hand and Cefadroxil 4 on the other as far as the best 
complexant is concerned, can be attributed to differences in the hosting cavities of 
the respective antibiotics.
The data in Table 2 show some remarkable results, confirming that the 
complexation efficiency is not fully controlled by the effect of the complexing agent 
on the complex stability. As the cavity in the crystal lattice formed by Cephradine 
has a two-fold symmetry, it was expected that the dihydroxynaphthalenes arising 
from applying a two-fold symmetry operation on a- and ff-naphthol would be more 
efficient than their monohydroxy analogues. However, the data in Table 2 show that
1,5-dihydroxynaphthalene performs worse than a-naphthol and 2,6- 
dihydroxynaphthalene performs worse than ff-naphthol, despite that the second 
hydroxyl function could be used for additional stabilization through hydrogen 
bonding. The dihydroxynaphthalenes in general, with 1,6-dihydroxynaphthalene as
71
Chapter 5
an exception, perform worse than a-naphthol indicating that the second hydroxyl 
function has no beneficial effect on the complexation efficiency. Similarly, 8- 
hydroxyquinoline performs worse than quinoline. Whether polar groups do 
contribute in a positive sense to the stabilization energy or that their beneficial effect 
fades out due to their increasing AGsolvation can only be ascertained when this 
solvation energy of the complexing agent in water is known. For the subset of five 
molecules shown in Table 3, AGsolvation in water was deduced from literature data.27 
For these five complexants, the AGstabiiization can be correlated with the molecular 
structure of the guest molecules, thereby revealing the essential interactions 
responsible for complex stabilization. The observation that AGstabilization for quinoline 
is only marginally higher than that for complexation with naphthalene, at first sight 
seems illogical. It was expected that quinoline would contribute much more to the 
stabilization energy than naphthalene by hydrogen bonding with water in the 
cavity, using nitrogen as a hydrogen bond acceptor. The crystal structure of the 
complex of Cephradine and quinoline was determined very accurately, even the 
hydrogen atoms of the water molecules could be located. The structure of this 
complex, which is pictured in Figure 1a, reveals that the nearest water molecule is 
positioned with its oxygen toward the nitrogen atom of quinoline, which represents 
a repulsive interaction energy. In contrast, naphthalene can form a weak hydrogen 
bond (Car.H-Owater) with a neighboring water molecule (Figure 1b), which 
contributes favorably to the stabilization energy. In comparison with naphthalene, 
solvation phenomena in a- and ff-naphthol contribute much more to the stabilization 
energy due to the hydrogen bonding (OH-Owater) with these guest molecules, as is 
evident from the crystal structures shown in Figure 1c and 1d. In addition to its role 
as a hydrogen bond donor, the hydroxyl function in the last mentioned complexants 
can also serve as a hydrogen bond acceptor for a water molecule or as in the case of 
the ff-naphthol complex, the amide proton of Cephradine. The difference in AGstab 
between the complexes derived from naphthalene and a- or ff-naphthol, 
respectively, of ca. 12.5 kJ/mole must be attributed to the presence of the hydroxyl 
function in the naphthols. The difference in AGstab between the complexes of 
quinoline and 8-hydroxyquinoline is significantly smaller (9.1 kJ/mole). From the 
crystal structure of the Cephradine/8-hydroxyquinolin complex shown in Figure 1e 
is evident that the hydroxyl-group of 8-hydroxyquinoline does not serve as a 
hydrogen bond donor toward water, but only plays a role as a hydrogen bond 
acceptor, implying that its contribution to the stabilization of the complex must be 
smaller than that of the hydroxyl function of a- and ff-naphthol in complexes 
derived therefrom. In summary, this study of the correlation between the 
stabilization energy and the structural features of these five complexes, reveals that
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the complex stability can be enhanced by hydroxyl groups present in the guest 
molecule via hydrogen bonding. However, stabilization of the complex does not 
necessarily result in more efficient complexation, due to the profound influence of 
the solvation energy of the complexant in some cases. The term AGsolvation may 
become of comparable importance as the AGcomplexation in the equation AGstabilization =
0.5xAGsolvation + AGcomplexation. Thus, a structural variation of the complexant designed 
to stabilize the clathrate complex may be accompanied by an uncorrelated 
contribution to the energy of solvation of the complexant, which may be even larger 
and thus contraproductive to the complexation efficiency. An anticipated beneficial 
effect of polar groups in the complexant may be entirely counterbalanced by an 
increased energy of solvation. Such phenomena are of general importance in host- 
guest chemistry.
Figure 1a The complex of Cephradine and quinoline.
Figure 1b The complex of Cephradine and naphthalene.
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Figure 1c The complex of Cephradine and a-naphthol.
Figure 1d The complex of Cephradine and ff-naphthol.
Figure 1e The complex of Cephradine and 8-hydroxyquinoline
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5.4 Experimental section
The monitoring of the complexation experiments was performed on a 
Pharmacia LKB.LCC 2252 HPLC using a reversed phase column (Merck 50983 
LiChrospher 100RP18, 5 ^m, 250x4 mm). A UV detector (A=254 nm) of Farmacia 
LKB.UV-MII was used for detection. An appropriate eluent for the analysis was a 
mixture of acetonitrile (HPLC grade) and a 50 mM phosphoric acid buffer with 
pH=2.7. The complexing agents a-naphthol, ff-naphthol, 1,4-dihydroxynapthalene,
1,5-dihydroxynaphthalene, 2,7-dihydroxynaphthalene, quinoline, 8- 
hydroxyquinoline and naphthalene were purchased from ACROS, 1,2- 
dihydroxynaphthalene, 1,3-dihydroxynaphthalene, and 2,6-dihydroxynaphthalene 
and 1,6-dihydroxynapthalene were purchased from Aldrich. The Cephalosporins 1-4 
were a generous gift from DSM (Geleen, The Netherlands).
The crystal data of the complexes of Cephradine and naphthalene a-naphthol, ff- 
naphthol and quinoline have been published previously. 10,11
Complexation experiments
Cephalosporin (500 mg) was dissolved in demineralized water (50 ml). The pH was 
adjusted to 6.3 with 5% ammonia (in several applications of selective complexation a 
pH of 6.3 is used). The concentration was determined by HPLC analysis using 
standard solutions of the Cephalosporin. To the stirred Cephalosporin solution, 
complexing agent (1.5 mmole) was added in a pure form and immediately the t=0 
samples were taken. Approximately 200 mg solution was injected through a filter in 
a small flask and the weight of the filtrate was determined accurately. To the filtrate
7.5 ml of acetonitrile was added and the volume was subsequently increased to 50 
ml with 50 mM phosphoric acid buffer with pH=2.7. After homogenization, the 
solution was analyzed by HPLC. In the same way samples were taken and analyzed 
after 30 min, 90 min and 24 h.
X-ray structure analysis of the Cephradine/8-hydroxyquinoline complex.
Crystals of the Cephradine/8-hydroxyquinoline complex, suitable for X-ray 
diffraction studies, were obtained from a water/m ethanol mixture by slow cooling. 
A single crystal was mounted in air on a glass fibre. Intensity data were collected at 
room temperature. An Enraf-Nonius CAD4 single-crystal diffractometer was used, 
Mo-Ka radiation, 6-26 scan mode. Unit cell dimensions were determined from the 
angular setting of 16 reflections. Intensity data were corrected for Lorentz and 
polarization effects. Semi-empirical absorption correction (^-scans)23 was applied. 
The structure was solved by the program system DIRDIF24 using the program
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ORIENT and TRACOR25 to orient and position a ff-lactam fragment in the Patterson 
map and was refined anisotropically, by full-matrix least squares on F2 (program 
SHELXL26) using anisotropic parameters for the non-hydrogen atoms. The 
hydrogens of the ammonium group, the methyl group and the hydroxy group of the 
8-hydroxyquinoline molecule were refined as rigid rotors to match maximum 
electron density in a difference Fourier map. The hydrogens of the water molecules 
could not be localized and are therefore not included in the model. All other 
hydrogens were placed at calculated positions and were refined riding on the parent 
atoms.
Crystal data of the Cephradine/8-hydroxyquinoline complex.
C41H58N7O15.5S2, Mw = 961.06, T = 293(2) K, Monoclinic, C2, a = 23.443 Â, b = 7.0872
o o ^  o
Â, c = 14.896 Â, ff = 108.61, U = 2345.5 Â3, Z = 2, Dc = 1.361 Mgm-3, ref. col./uni. 
2983/2911 Rint = 0.0212, R (all data) R1 = 0.0768, wR2 = 0.1511.
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Chapter 6
C l a t h r a t i o n  M e d i a t e d  E n z y m a t i c  S y n t h e s i s  
o f  C e p h a l o s p o r i n  a n t i b i o t i c s
Abstract: Enzymatic synthesis of cephalosporins is hampered by secondary hydrolysis and 
by complicated down-stream processing. Instantaneous removal of cephalosporin product 
by clathration, using an efficient and selective complexing agent, offers an attractive 
opportunity to tackle these problems. The beneficial effect of in situ clathration during 
enzymatic synthesis, on the Cephalexin concentration is evaluated in a quantitative manner. 
A series of six naphthalene derivatives has been investigated during the enzymatic synthesis 
of Cephalexin. In this series the most promising result was observed for ff-naphthol in case 
immobilized enzyme was used as the biocatalyst, while 1,5-dihydroxynaphthalene gave the 
best results in combination with free enzyme. Also a series of benzene derivatives that form 
clathrates with the cephalosporin antibiotics were subjected to efficiency measurements and 
enzyme inhibition studies. The best results were obtained with methyl 2-aminobenzoate, 2- 
hydroxybiphenyl and methyl 4-hydroxybenzoate. An important advantage of these three 
compounds is that they are environmentally and toxicologically much more acceptable than 
naphthalene derivatives for application in a 'green' process.
6.1 Introduction
The enzymatic synthesis of cephalosporins forms a challenging new 
development for the manufacture of these antibiotics from a ff-lactam nucleus and a 
D-amino acid side chain.1 The enzymatic synthesis offers interesting possibilities for 
improvement of the processes used for the preparation of the cephalosporins. 
Another, attractive aspect of the enzymatic synthesis is the possibility to reduce the
Part of this chapter is submitted for publication: G.J. Kemperman, R. de Gelder, F.J. Dommerholt, 
C.G.P.H. Schroën, R. Bosma, A.J.H. Klunder, B. Zwanenburg, Clathration mediated synthesis of 
Cephradine.
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environmental impact of the processes for the manufacture of these antibiotics.2 
Introduction of biocatalysis will contribute enormously to the greening of the 
chemistry needed for the production of these important antibiotics. This 
development is fully in line with the global trend in the fine-chemical industry.3
A suitable biocatalyst for the coupling of nucleus and side chain is penicillin 
G acylase. Since the equilibrium constant of this thermodynamic coupling is 
extremely low,4 the coupling has to be performed in a kinetic fashion using an 
activated precursor of the side chain in order to obtain a reasonable conversion to 
the product. A severe problem of this kinetic enzymatic synthesis of cephalosporins 
from the ff-lactam nucleus and the ester or amide derivative of the side chain is 
hydrolysis of side chain and product, as is depicted in scheme 1.5'6 In the first step 
phenylglycine amide is converted into its complex with the enzyme (ki), which is 
accompanied by liberation of ammonia. The enzyme-phenylglycyl complex can 
undergo either hydrolysis with water (k2) resulting in the formation of 
phenylglycine or reaction with the ff-lactam nucleus 7-ADCA (k3) to give 
Cephalexin. The cleavage of Cephalexin (k-3) reverts to the enzyme-phenylglycyl 
complex and 7-ADCA. The competing reaction of the thus obtained enzyme- 
phenylglycyl complex with water leads to a loss of product and is often referred to 
as secondary hydrolysis.
nh3 h2o
r- ■ ■ y  k1 k2\Enzyme + Phenylglycine amide ------ ► Enzyme-Phenylglycyl ----- Enzyme + PhenylglyCine
complex
7-ADCA
k 3 k -3
7-ADCA
Enzyme + Cephalexin
scheme 1 Enzymatic synthesis of Cephalexin.
Due to the hydrolysis reactions the yield of the kinetic enzymatic coupling of 
nucleus and side chain is very low.7 The unwanted hydrolysis can in principle be 
suppressed using a solvent other than water, which is, however, neither possible in 
real practice, nor desirable from an environmental point of view. In an alternative 
manner to avoid secondary hydrolysis the cephalosporin product can be removed 
from the aqueous reaction mixture. Two techniques for the removal of Cephalexin 
from aqueous solutions are reported, viz. adsorption using amberlite XAD8 and
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extraction using an aqueous two-phase system.9 However, neither of these 
techniques is selective and consequently the starting materials are also withdrawn 
from the reaction mixture. In contrast to the aforementioned techniques, clathration 
of cephalosporins with a complexing agent such as ff-naphthol is highly selective. 
Hence, clathration of cephalosporins during the enzymatic synthesis may be suitable 
to tackle the problem of secondary hydrolysis. In addition, clathration of 
cephalosporins may be an elegant method to facilitate down-stream processing as 
the precipitated clathrate can be readily filtered off from the rather complex reaction 
mixture. The application of in situ clathration during the enzymatic synthesis of 
cephalosporins has been reported previously.10 Several requirements have to be 
fulfilled by a complexing agent before application during the enzymatic synthesis of 
cephalosporins becomes feasible. First, the clathration process must be sufficiently 
effective under the conditions used for the enzymatic coupling. Second, the 
complexing agent used must not (irreversibly) inactivate the enzyme. And third, 
preferably the complexing agent must be non-toxic. Despite the fact that during the 
decomplexation the complexing agent can be completely removed from the final 
product, the use of a toxic compound, e.g. ff-naphthol, in a 'green' enzymatic process 
is not desirable. This chapter describes the effect of a series of complexing agents on 
the enzymatic synthesis of Cephalexin in a quantitative manner. Furthermore, 
several non-toxic complexants were investigated with regard to complexation with 
Cephradine and enzyme inhibition.
6.2 Enzymatic synthesis of Cephalexin using in situ clathration with 
naphthalene derivatives as complexants.*
The use of in situ clathration of product has been studied during the 
enzymatic synthesis of Cephalexin.10'11 For industrial application of the enzymatic 
synthesis, immobilization of the enzyme has several advantages, as it can be readily 
separated from the reaction mixture and it can be reused for successive batches. The 
enzymatic synthesis of Cephalexin has been investigated using penicillin G acylase 
isolated from E.coli in both the free and the immobilized form, which is referred to as 
Assemblase.12,13 The complexing agents that perform most efficiently in the 
complexation with Cephalexin were used for the in situ clathration during the 
enzymatic synthesis of Cephalexin.14 The results of the enzymatic synthesis of
* Information concerning this paragraph is derived from reference 11.
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Cephalexin at pH=7.5 and T=293 K are collected in Table 1. It appeared that all 
complexants except 1,5-dihydroxynaphthalene caused inhibition of Assemblase. 
Some complexants had a disastrous effect on the enzyme activity which began with 
a decreased residual activity that deteriorated to complete loss of activity within 
several hours of incubation in the case of a-naphthol and 1,6-dihydroxynaphthalene. 
It was found that ff-naphthol caused reversible inhibition only, as after thorough 
washing the activity of Assemblase in the absence of complexing agent was 
comparable with that of fresh Assemblase. As Assemblase accounts for a substantial 
part of the cost price of enzymatically prepared Cephalexin, it is of prime 
importance that the enzyme can be reused for next batches and hence the 
complexing agent should not cause irreversible inhibition of the biocatalyst.
The data in Table 1 reveal that the total yield of Cephalexin is higher in all cases that 
in situ clathration was used when compared with the experiment where the 
complexant is absent. This clearly demonstrates the effect of withdrawal of 
Cephalexin from the reaction mixture on the secondary hydrolysis reaction. It is also 
evident that, for the naphthalene derivatives in Table 1, the most promising result is 
obtained with ff-naphthol as the complexing agent. Despite the fact that 1,5- 
dihydroxynaphthalene is more efficient than ff-naphthol in the withdrawal of 
Cephalexin from aqueous solutions, the amount of Cephalexin obtained during the 
enzymatic synthesis with Assemblase as the biocatalyst is lower when 1,5- 
dihydroxynaphthalene is used.
Table 1 Enzymatic synthesis of Cephalexin using in situ clathration with six naphthalene 
derived complexants (pH=7.5 and T=293 K).
complexing agent [CEX]a total [CEX]b residual
mM mM activity (%)c
none 42 42 100
a-naphthol d d 13
ff-naphthol 10 66 28
1,5-dihydroxynaphthalene 4 54 100
1,6- dihydroxynaphthalene d d 0
2,3- dihydroxynaphthalene 6 54 6
2,7- dihydroxynaphthalene 10 48 29
a The residual concentration of Cephalexin in solution during the enzymatic synthesis. 
b The total amount of Cephalexin formed during the enzymatic synthesis. 
c The residual activity of Assemblase immediately after the addition of the complexing 
agent.
d Not tried because of the severe irreversible inhibition of Assemblase by this complexant.
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As the most promising result with respect to the yield of Cephalexin was 
obtained with ff-naphthol, this complexing agent was used to investigate the 
influence of in situ clathration during the enzymatic synthesis of Cephalexin in more 
detail. An important finding is that the course of the enzymatic synthesis of 
Cephalexin with Assemblase using in situ clathration with ff-naphthol could not be 
predicted correctly by a model that was derived for this purpose (Fig. 1a).6,15 
However, the course of a similar experiment using free enzyme instead of 
Assemblase was predicted very well by a model derived for the enzymatic synthesis 
with free enzyme.11 This implies that ff-naphthol has no effect on the kinetics of the 
enzymatic reaction other than partial inactivation (the residual activity is 28%).16 
Hence, another effect must be responsible for the disagreements between the 
predicted and the experimental course of the enzymatic synthesis using Assemblase. 
An adverse effect that is caused by immobilization of penicillin G acylase is diffusion 
limitation, which affects the kinetics of the enzyme and is therefore included in the 
model for Assemblase.6 Although partial inactivation of the enzyme by ff-naphthol 
as such is not desirable, it may have an interesting side effect. A consequence of a 
lower enzyme activity may be that the diffusion rate of 7-ADCA can keep up with 
the reaction rate, thus counterbalancing the diffusion limitations of Assemblase. This 
was verified by comparison of the experimental course of the reaction using 
Assemblase and in situ clathration with ff-naphthol, with that predicted by the model 
derived for the free enzyme (Fig. 1b). These appeared to be in full agreement 
indicating that indeed the problem of diffusion limitation of Assemblase is 
compensated by partial inactivation of the enzyme.
Interestingly, the course of Cephalexin synthesis using Assemblase in combination 
with 1,5-dihydroxynaphthalene as the complexant can be predicted correctly by the 
Assemblase model. This can be reconciled with the data in Table 1, which show that
1,5-dihydroxynaphthalene does not reduce the activity of Assemblase. Hence, this 
complexant lacks the additional beneficial effect observed for ff-naphthol, viz. lifting 
the diffusion limitation of Assemblase, which explains the lower yield of Cephalexin 
obtained with 1,5-dihydroxynaphthalene despite the more effective complexation of 
this complexant (lower residual concentration of Cephalexin). This implies, however, 
that when free enzyme is used instead of Assemblase in order to rule out the effect 
of diffusion limitation, in situ complexation with 1,5-dihydroxynaphthalene should 
give a higher Cephalexin yield as this complexant is more effective in the 
withdrawal of Cephalexin from solution than ff-naphthol. A synthesis experiment 
using free enzyme and in situ complexation confirmed this hypothesis giving 
Cephalexin yields of 74% and 66% based on 7-ADCA for 1,5-dihydroxynaphthalene
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and ff-naphthol, respectively. However, in contrast to Assemblase, free enzyme is 
inhibited by 1,5-dihydroxynaphthalene resulting in a residual activity of 50%.
Tim e (min) Time (min)
a. Assemblase model b. Free enzyme model
Figure 1 Predicted and experimental course of the enzymatic synthesis of Cephalexin 
using in situ clathration with ff-naphthol. The marks represent the 
experimentally observed concentrations of 7-ADCA (■), phenylglycine amide 
(•), Cephalexin (□) and phenylglycine (o) in the enzymatic synthesis using 
Assemblase as the biocatalyst. The lines represent the corresponding change of 
concentrations with time predicted by the models for Assemblase (a) and free 
enzyme (b).
The models for Assemblase and for free enzyme were used to study the 
influence of the residual concentration of Cephalexin in solution on the maximum 
Cephalexin yield that can be reached during the enzymatic synthesis. The more 
efficient the complexing agent used, the lower the residual concentration. Figure 2 
shows the predicted yield of Cephalexin expressed in mM that can be obtained using 
Assemblase and free enzyme, respectively, as a function of the residual 
concentration of Cephalexin in solution. Clearly, the yield of Cephalexin and 
minimum yield of the unwanted hydrolysis product phenylglycine are obtained 
when the residual concentration approaches zero, i.e. all Cephalexin is removed from 
solution by clathration. Evidently, when a residual concentration below 10 mM can 
be reached by clathration with an appropriate complexant, this results in a 
significant increase of the maximum concentration of Cephalexin. The effect is more 
pronounced for free enzyme than for Assemblase. The calculated effects of in situ 
clathration during the enzymatic synthesis of Cephalexin on the maximum 
Cephalexin concentration and on the synthesis/hydrolysis ratio, are shown in Table
2. The synthesis/hydrolysis ratio indicates how much side-product phenylglycine is
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formed relative to Cephalexin. For free enzyme, the maximum concentration of 
Cephalexin increases from 48 mM to 85 mM, and for Assemblase from 42 mM to 66 
mM. Thus, in situ clathration forms an attractive method to increase the yield of 
Cephalexin during the enzymatic synthesis. In addition, this method facilitates 
down-stream processing of the product.
residual concentration Cephalexin (mM)
a. Assemblase model
100 H 
80 
60 - 
40 - 
20 
0
Cephalexin
phenylglycine
0 10 20 30 40 50 60 70 
residual concentration Cephalexin (mM)
b. Free enzyme model
Figure 2 The predicted dependence of the yield of Cephalexin and phenylglycine on the 
residual concentration of Cephalexin using in situ clathration for Assemblase (a) 
and for free enzyme (b).
Table 2 The predicted effect of in situ clathration during the enzymatic synthesis of 
Cephalexin on the maximum concentration of Cephalexin and on the 
synthesis/hydrolysis (S/H) ratio for Assemblase and free enzyme.
enzyme residual maximum S/H ratio
[CEX] mM [CEX] mM
Free (ideal complexing agent) 0 85 6.5
Free (no complexing agent) 48 48 1.8
Assemblase (ideal complexing agent) 0 66 1.9
Assemblase (no complexing agent) 42 42 1.1
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6.3 Enzymatic synthesis of Cephradine using in situ clathration with  
benzene derived complexing agents.
The beneficial effect of in situ clathration has been clearly demonstrated for 
the enzymatic synthesis of Cephalexin. However, the toxicity of the complexing 
agent has not been taken into account yet. Although the complexing agent can be 
completely removed from the final product it is desirable to use a non-toxic 
complexing agent in a 'green' enzymatic process. The naphthalene derived 
complexants do not meet this requirement. The benzene derivatives that were 
previously identified as complexing agents for Cephradine,17 offer interesting 
prospects as several of them are used as preservatives in various food products. 
Such complexants are environmentally and toxicologically fully acceptable and 
according to their R classification, i.e. the risk of a substance in case of a particular 
exposure such as via skin, eyes, inhalation or swallowing, they have a toxicity index 
similar to other commonly used preservatives. Taking into account the complexing 
capacity and the favorable toxicity index the series of benzene derivatives listed in 
Table 3 were selected for the efficiency study in the enzymatic synthesis of 
Cephradine. These compounds were subjected to efficiency measurements under 
conditions that resemble those of the enzymatic synthesis of Cephradine (pH= 7.2, 
T=5°C). The residual concentration of Cephradine was measured 90 minutes after 
the addition of the complexing agent. The results obtained for the most effective 
complexants under the justmentioned conditions are collected in T able 4. The other 
compounds of Table 3 were not effective at all under the desired conditions and are 
therefore of no interest for the removal of the antibiotic from aqueous reaction 
mixtures. For an acceptable complexant the residual concentration of antibiotic 
should be below 10 mM. Five compounds listed in table 4 met this criterion, viz. 
entries 1, 2, 6, 7, and 8. These five compounds were investigated in enzyme 
inhibition experiments using Assemblase as the biocatalyst.18
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Table 3 The compounds tested in efficiency measurements with Cephradine.
o-toluic acid 3,5-dihydroxybenzoic acid 4-aminoacetophenone
methyl m-toluate methyl 2,4-dihydroxybenzoate catechol
methyl p-toluate methyl 3,5-dihydroxybenzoate recorcinol
2-aminobenzoic acid 3,4,5-trihydroxybenzoic acid hydroquinone
2-aminobenzamide methyl 3,4,5-trihydroxybenzoate pyrogallol
methyl 2-aminobenzoate acetophenone phloroglucinol
methyl 3- aminobenzoate 2-hydroxyacetophenone 4-methoxyphenol
methyl 4-aminobenzoate 2-methoxyacetophenone 2-hydroxybiphenyl
2,4-dihydroxybenzoic acid 2-methylacetophenone benzoic acid
3,4-dihydroxybenzoic acid 4-methylacetophenone vanillin
Table 4 The residual concentration of Cephradine (pH = 7.2 and T = 5 °C) using benzene 
derivatives as complexants.
Entry Complexant [Cephradine] (mM)
1 2-aminobenzoic acid 6.6
2 methyl 2-aminobenzoate 3.7
3 2-aminobenzamide 16
4 2-methoxyacetophenone 15
5 4-aminoacetophenone 16
6 2-hydroxybiphenyl 1.3
7 methyl 4-hydroxybenzoate 5.5
8 methyl 3-hydroxybenzoate 6.9
9 methyl 3,5-dihydroxybenzoate 14
In these studies the activity of the enzyme in the presence of a complexing 
agent was compared with that in the absence of complexing agent. The rate of 
hydrolysis of D-phenylglycine amide (the side chain precursor of Cephalexin) was 
taken as a measure for the enzyme activity. Three types of experiments were 
performed in order to obtain information about both reversible inhibition and 
inactivation (irreversible inhibition) of a complexing agent.
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i. activity measurement in the presence of complexing agent.
ii. incubation of the enzyme with a complexing agent for 16.5 h, then the 
Assemblase was thoroughly washed with water and the activity was 
measured in the absence of complexing agent.
iii. incubation of enzyme with complexing agent for 16.5 h, after washing of the 
Assemblase with water the activity was measured in the presence of 
complexing agent.
The activity measured in experiment i was in all cases lower than the activity 
of Assemblase in the absence of complexant. However, from experiment i it cannot 
be ascertained whether the lower activity is due to reversible inhibition or 
inactivation (irreversible inhibition) by the complexant. Experiment ii indicates 
whether a complexant inactivates Assemblase. When after thorough washing the 
activity of Assemblase in the absence of the complexant is not equal to the activity of 
fresh Assemblase this points to irreversible inhibition by the complexant. If this is 
the case then the complexing agent is not suitable for use during the enzymatic 
synthesis. In case no irreversible inhibition takes place, the activity of Assemblase 
after long-lasting (16.5 h) exposure to a complexant should not further diminish but 
remain constant at the value measured in experiment i. This is verified by 
experiment iii, which in case of reversible inhibition only, should show the same 
activity in the presence of a complexing agent as was found in experiment i. The 
latter was observed for compounds 1-3 shown in Table 5. These three compounds 
only show reversible inhibition and do not permanently inactivate the enzyme. This 
implies that the enzyme can be reused for next batches when exposed to either of 
these three compounds. This is an important observation as the enzyme accounts for 
a substantial part of the total cost of enzymatically prepared cephalosporins. It 
should be noted that compounds 1 and 3 are also effective in the complexation with 
Cephalexin and accordingly also suitable for the clathration mediated enzymatic 
synthesis of this antibiotic. In Table 5 the residual activity of Assemblase when 
exposed to either of the three complexing agents as a percentage of the enzyme 
activity in the absence of complexing agent is listed. These residual activities are 
similar to those measured after exposure to ff-naphthol (see Table 1). As was stated 
before, a decrease of the enzyme activity as such is not desirable but it may have a 
positive effect on the diffusion limitations normally present when Assemblase is 
used as the biocatalyst.
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Table 5 The residual activity of Assemblase in the presence of the complexants.
c omplexing agent residual ac tivity ( % )
2-hydroxybiphenyl 1 30
methyl 4-hydroxybenzoate19 2 30
methyl 2-aminobenzoate 3 40
6.4 Concluding remarks
A positive effect of in situ clathration during the enzymatic synthesis of 
Cephalexin has been demonstrated. During this enzymatic process Cephalexin is 
removed from the solution by clathration with a suitable complexing agent, thereby 
effectively reducing the problem of the secondary hydrolysis of the antibiotic 
product to the cephalosporin nucleus and the side chain as an amino acid. The 
performance of two series of complexants has been evaluated. The major problem is 
the inactivation of the enzyme Assemblase by these complexants. In a series of 
naphthalene compounds 1,5-dihydroxynaphthalene did not affect the Assemblase 
activity, whereas ff-naphthol, 2,3-dihydroxynaphthalene and 2,7-dihydroxy- 
naphthalene caused a decrease of the enzyme activity. The overall performance of ff- 
naphthol was the best of the naphthalene series when Assemblase was used as the 
biocatalyst, this in spite of the fact that 1,5-dihydroxynaphthalene is more efficient in 
the withdrawal of Cephalexin from solution. It should be noted that ff-naphthol 
apparently has an additional positive effect by reducing the diffusion limitation, 
which is normally observed for Assemblase. On the contrary, when free enzyme is 
used the highest yield of Cephalexin is obtained with 1,5-dihydroxynaphthalene as 
the complexant. Kinetic models which predict the course of the enzymatic synthesis 
using either free enzyme or Assemblase show that a significant increase of the 
Cephalexin yield can be achieved when the residual concentration of the complexing 
agent is lower than 10 mM. A drawback of ff-naphthol and 1,5- 
dihydroxynaphthalene from practical point of view is their toxicity and its poor 
environmental image.
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From a series of benzene derived complexants, three are effective in the clathration 
mediated synthesis of Cephradine, v i z .  methyl 2-aminobenzoate, 2-hydroxybiphenyl, 
and methyl 4-hydroxybenzoate.19 These agents showed a reversible inhibitive effect 
on Assemblase resulting in a residual activity of approximately 30% when exposed 
to these compounds. Methyl 2-aminobenzoate and 2-hydroxybiphenyl are also 
effective in the clathration of Cephalexin. It is highly relevant to note that these three 
compounds have a low toxicity, and that two thereof are commonly used as 
preservatives of food products. Application of these toxicologically and 
environmentally acceptable complexing agents in the clathration mediated synthesis 
of cephalosporin antibiotics has interesting prospects, which deserve further 
elaboration.
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6.5 Experimental section
For the analysis of the complexation experiments a Pharmacia LKB.LCC 2252 
HPLC was used, with a reversed phase column (Merck 50983 LiChrospher 100RP18, 
5 ^m, 250x4 mm) and a UV detector (A=254 nm) of Farmacia LKB.UV-MII. An 
appropriate eluent for the analysis was a mixture of acetonitrile (HPLC grade) and a 
50 mM phosphoric acid buffer with pH=2.7. The pH stat apparatus used was a Schot 
Geräte Titrator TR154. Cephradine was a generous gift from DSM Research, Geleen, 
The Netherlands.
Efficiency measurements.
Cephradine (524 mg) was dissolved in water (50 ml). The pH was adjusted to 7.2 and 
the solution was cooled to 5°C. Complexing agent (1.5 mmole) was added as such to 
the stirred solution. The pH was maintained constant during the experiment by 
adding 5% HCl using a pH stat apparatus. After 90 minutes a sample was taken in 
duplo. The samples were filtered in order to remove the precipitated complex and 
subsequently analyzed by HPLC. The residual Cephradine concentration was 
determined using standard solutions.
The compounds that have been tested in efficiency measurements are collected in 
Table 5. In the case of 2-phenylphenol, 4-methylacetophenone and methyl 4- 
hydroxybenzoate, 2 equivalents of complexant (3 mmole) were added as these 
compounds form 1:1 complexes with Cephradine, whereas the other compounds 
form 2:1 complexes.
Assemblase inhibition experiments.18
The rate of phenylglycine amide hydrolysis is taken as a measure for the activity of 
Assemblase. Each experiment was performed under the following conditions:
0.2 %(w/w) of Assemblase relative to phenylglycine amide, starting concentration of 
phenylglycine amide 80 mM, pH = 8, and T = 20°C.
The activity measured during a blanc experiment (in the absence of complexant) was 
taken as a reference, which was put on 100% activity. The residual activity of 
Assemblase in the presence of a complexing agent was expressed as a percentage of 
the activity measured during the blanc experiment. The rate of the phenylglycine 
amide hydrolysis was followed by titration with 80 mM hydrochloric acid.
For the inhibition studies the complexant was added in an amount equimolar to 
phenylglycine amide. For each complexant three activity measurements where 
performed. First the activity of fresh Assemblase was determined in the presence of 
the complexing agent. In a second experiment fresh Assemblase was incubated for
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16.5 hours in the presence of the complexing agent. Next, the Assemblase was 
thoroughly washed with water and its activity was measured in the absence of 
complexing agent. For the third experiment fresh Assemblase was incubated during
16.5 hours in the presence of complexing agent. After washing with water the 
activity of the biocatalyst was measured in the presence of the complexing agent.
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P r e d i c t i o n  o f  C l a t h r a t e  Fo r m a t i o n  b y  
M o l e c u l a r  M o d e l i n g  a n d  Q u a n t i t a t i v e  
S t r u c t u r e  A c t iv it y  R e l a t i o n s h i p s
Abstract: It is desirable to replace the empirical method of choosing new complexing agents 
for cephalosporin antibiotics which is merely based on chemical intuition, by a more 
rational, preferably unbiased, design. Therefore, the possibility of computer assisted 
prediction of complexation has been investigated. Two methodologies have been employed, 
namely a docking approach and a QSAR approach. Prediction of complexation by docking 
molecules into the hosting cavities did not lead to satisfactory results. However, the docking 
results provide an approximate indication of which type of molecules are suitable 
complexing agents. Another approach to tackle the problem of predicting complex 
formation was based on the concept of molecular similarity. By applying QSAR in 
combination with advanced chemometrics, a model with a predictive value above 85% 
could be derived. The ultimate outcome is that the complexation can be predicted using a 
simple equation containing the similarity indices with three guiding compounds only. 
Furthermore, valuable insights in how to deal with molecular similarity problems were 
obtained.
7.1 Introduction
During the last decade the importance of computational chemistry and 
chemometrics has increased significantly. These techniques have had considerable
Part of this chapter has been published: R. W ehrens, R. de Gelder, G.J. Kemperman, B. Zw anenburg 
and L.C.M. Buydens, Analytica Chimica Acta, 1999, 400, 413-424 ; G.J. Kemperman, R. de Gelder, R. 
W ehrens, F.J. Dommerholt, A.J.H. Klunder, L.C.M. Buydens, B. Zwanenburg, J. Chem. Soc., Perkin 
Trans. 2, in  press.
* The author is indebted to Dr. R. W ehrens for his contribution to the research described in  this 
chapter.
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impact on the developments in several fields of chemistry. Especially the field of 
medicinal chemistry has immense benefit of the predictive power of techniques such 
as docking and Quantitative Structure Activity Relationships (QSAR). Hence, many 
pharmaceutical companies have computer aided drug design as a large activity 
within their research programs.
Docking is especially useful for fitting molecules into cavities, such as active 
sites of biological targets. A set of trial molecules can be fitted into an active site of a 
receptor protein and the most suitable ligands can be selected based on the 
interaction energy of the molecules with the receptor site. In this manner, docking 
improves the success rate of combinatorial screening of ligands significantly. An 
essential requirement to perform a docking search is that the molecular structure of 
the receptor site should be known. Docking has been employed for the computation 
of the interaction energies in protein-ligand complexes.1 The technique plays also an 
important a role in de novo drug design. 1 The docking technique has not been 
applied for clathrate type host-guest complexes previously.
Whereas docking makes use of the molecular structure of the receptor, QSAR 
ignores the receptor and focuses entirely on the molecular structure of the ligands. In 
contrast to docking, for which the molecular structure of the receptor is essential, 
QSAR only requires a set of known active ligands for a given receptor but no 
structural information of the receptor site is needed. Starting with a set of known 
ligands QSAR utilizes various statistical methods to derive relationships between the 
molecular structure of the ligands and their affinity for the receptor. Based on the 
thus derived relationships, the affinity of a new molecule can be deduced. As such, it 
can serve as a tool to find the bioactiphore of the ligands as well. QSAR is based on 
the assumption that similar molecules posses similar properties. However, the basic 
question is how to define and quantify the molecular similarity of molecules.
Based on the crystal structures of the clathrate type complexes of 
cephalosporins and ff-naphthol, a large set of novel complexing agents for the 
cephalosporin antibiotics has been found. However, selecting a new molecule for a 
complexation experiment remains a matter of trial and error, positively biased by 
chemical intuition. It is desirable to leave this empirical stage and reach the stage of 
design of new complexing agents on more rational preferably unbiased grounds. 
Both docking and QSAR have been evaluated as computational techniques for the 
prediction of clathrate type complexation of the cephalosporins. This chapter deals
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with the development and evaluation of predictive models derived by the 
abovementioned techniques.
7.2 Theoretical background
Docking.
By docking, molecules can be fitted into a cavity while the interaction energy 
is computed. The interaction energy at optimal fit is a measure for the binding 
affinity of the ligand for that receptor. The interaction energy is represented by the 
sum of intermolecular interactions, which are electrostatic, hydrogen bonding and 
van der Waals interactions. The van der Waals interactions can be described by the 
Lennard-Jones potential, which is shown in equation I. Although hydrogen bonds 
are mainly of electrostatic nature, their beneficial effects can be incorporated 
explicitly as well, by using the so called 10-12 Lennard Jones (A/ r12 -  B /r10) potential 
instead of the 6-12 Lennard Jones potential shown in equation I.
E = A /r12 -  B /r6 (I)
It should be noted that the interaction energy is a measure for the enthalpy of 
binding only, whereas the binding affinity is determined by the Gibbs free energy of 
binding. However, entropy effects can not be taken into account and are thus 
neglected in this approach. Also flexibility in the receptor system can not be dealt 
with correctly in most cases, due to the limits of computational power.
Quantitative Structure Activity Relationships.
Quantitative Structure Activity Relationships (QSAR) are based on the 
assumption that similar molecules exhibit similar properties. The molecular 
properties of interest may vary from the acidity of a carboxylic acid or the reactivity 
of a molecule in a certain reaction to the affinity for a biological target. This chapter 
deals with the property referring to the ability of a molecule to form a complex with 
a cephalosporin antibiotic. More difficult than defining the molecular property is to 
define and quantify molecular similarity. Basically, the question is how to represent 
molecules. Molecular descriptors can be divided in two classes, the local descriptors 
and the global descriptors. Global descriptors describe a molecule as a whole. 
Examples of these are: dipole moment, shape and charge distribution. Local
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descriptors describe a molecule at different locations within the molecule. The 
charge at a certain atom or the presence of a functional group somewhere in the 
molecule are examples of local descriptors. Hence, local descriptors provide a 
possibility to study only the bioactiphore of a molecule. In order to get insight into 
the relationship between the molecular structure of a molecule and its complexation 
behavior, the global descriptors shape and charge distribution have been used to 
calculate molecular similarity parameters, as these seem appropriate for the problem 
of fitting a molecule in a cavity. In addition, 19 physical properties have been used as 
global descriptors for the complexing agents.
The molecular similarities and the physical properties of the guest molecules 
were calculated using the program Tsar.3 The set of molecules selected consists of 
two groups, viz. known complexing agents and compounds that do not form 
complexes with Cephradine. The molecular similarities were calculated based on the 
shape and the charge distribution of the molecules. Since two molecules are most 
similar when the shape similarity and the charge similarity are simultaneously high, 
the following procedure was followed. Two molecules were first aligned with 
respect to their shapes. In their optimal shape alignment the similarities with respect 
to both shape and charge distribution were calculated. In this way two similarity 
matrices were obtained, one containing the shape similarities (Xshape) and the other 
containing the charge similarities at optimal shape overlap (Xcharge).4 This strategy 
was preferred over calculating shape similarity at optimal shape overlap and charge 
similarity at optimal charge overlap, which could result in misleading data as is 
explained in Figure 1. Although molecules a and b are very different, calculation of 
their shape and charge distribution similarities in the way depicted in Figure 1 
would result in high similarity indices. However, when the charge distribution 
similarity is calculated at optimal shape alignment (Figure 1a) the similarity index 
will be much lower. The charge similarity matrix Xcharge serves as a penalty 
function, in case the shape similarity and charge similarity are not simultaneously 
high. The matrix with the 19 physical properties of the molecules is abbreviated as 
Xparam. These 19 physical properties are summarized in Appendix B. The molecular 
similarity is expressed by similarity indices, which are figures between 0 and 1, 
where 0 means no similarity at all and 1 means that the molecules are identical. The 
similarity indices were calculated by Tsar using Hodgkin's method, which is shown 
in equation II. In this equation P can be any property of molecules a and b that can be 
described as a spatial function.
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2- f Pa^  Pb dv
a. Optimal shape alignment b. Optimal charge distribution alignment
Figure 1 Shape versus charge distribution similarity. The contours represent the shapes of 
molecules a and b, and the gray surfaces illustrate their charge distributions.
The statistical methods that have been used are either unsupervised (i. and ii.) 
or supervised (iii.) methods. These will be explained below:
i. Principal Component Analysis (PCA)
The general concept of Principal Component Analysis (PCA) is to search for a 
coordinate transformation in such a way that the new coordinate axes explain in 
descending order of magnitude the variance present in a data matrix.5'6 The original 
variables are weighted in some way and linearly combined to form new variables in 
a new coordinate system. The axes in the new coordinate system are called the 
principal components (PC's). This is graphically explained in Figure 2 for a two 
dimensional problem, which means that each object is characterized by only two 
variables. As is evident from Figure 2, the largest amount of variance parallels (is
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explained) by PC1 and a much smaller amount of variance is explained by PC2. The 
advantage of PCA is that in the new coordinate system the same objects can be 
described with less variables. In fact PCA is a data reduction method.
Figure 2 The principle of PCA for a two dimensional data space.
ii. Cluster Analysis
Although a large variety of clustering algorithms are available, only one will 
be explained to demonstrate the principle of clustering. In this chapter hierarchical 
clustering methods are used. Hierarchical clustering opposes non-hierarchical 
clustering in that when data points are assigned to a particular cluster, they will stay 
in this cluster during the remaining of the clustering process.6 Prior to starting the 
cluster analysis a distance matrix has to be derived from the data matrix. Since the 
present problem is dealing with similarity matrices, these can be converted to 
dissimilarities by the following equation: Dij = Xii + Xjj -  X±¡ -  Xji = 2 - X±¡ -  Xji. This is 
explained in scheme 1, which shows an example of a similarity matrix of the 
molecules a, b, c and d. The distance matrix of Xparam can be derived by using the 
Euclidean distances between each combination of two objects. Mathematically this is 
done by taking the square root of the enumeration of (ai -  bi)2 for all 19 properties, 
where i indicates the i-th property of molecules a and b.
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Scheme 1 Calculation of distance matrices from similarity matrices.
From the distance D1 matrix in scheme 1 it can be seen that molecules a and d 
have the smallest distance. These objects are then combined to form a cluster. The 
distance matrix has to be calculated again thereby regarding the cluster as a new 
object. For the definition of the new object three strategies can be followed, which 
take the average, the largest or the smallest value of the clustered objects. In the 
average linker method, the average similarities of a and d with the other objects are 
used the calculate the new similarity matrix. Then a new distance matrix D2 is 
calculated from the new similarity matrix X2, which is also shown in scheme 1. From 
D2 it is evident that the smallest distance is that between molecule b and cluster ad. 
These are subsequently combined to a new cluster and the whole sequence is 
repeated again. The result of the cluster analysis is shown in Figure 3. The length of 
the branches of the cluster tree correspond to the distance of the clustered objects in 
the distance matrix. In this chapter, a cluster analysis is performed on the similarity 
data of a set of molecules consisting of complexing agents and non complexing 
molecules. This should result in clusters with complexing and non complexing 
molecules, respectively, in different branches of the cluster tree.
a d b c 
Figure 3 The result of the cluster analysis of molecules a, b, c and d.
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iii. Linear Discriminant Analysis (LDA).
Linear Discriminant Analysis is an example of a supervised clustering 
method.7 It is a widely applied classification technique. LDA has been employed 
successfully for a variety of problems, such as the classification of wood, plastics and 
stone in waste, based on infrared reflection measurements.6 Another example comes 
from a medical application, in which LDA is used to classify a pixel measured by 
MRI of a certain tissue, e.g. fat, skull bone, white matter.9 Applying LDA requires 
that the class type or property of each object (molecule) is known. Classification by 
LDA works especially well, when the relationship between the variables of the 
objects and the corresponding class type is of linear nature. For optimal results, the 
data subjected to LDA have to fulfill two important requirements. They should be 
characterized by a Normal distribution with each cluster having a different mean 
value and equal variance. Whether the second requirement is fulfilled by a data set 
consisting of a cluster of complexing molecules and a cluster of non-complexing 
molecules may be argued, since the latter can contain molecules which are much 
more diverse. However, the molecules selected for the data set seem all very similar 
from a chemical intuition point of view.
During an LDA' calculation, the algorithm is forced to search for those variables that 
are able to discriminate between the objects in such a way that the desired clustering 
can be obtained. LDA searches for a line (the discriminant line) in the multivariate 
space on which the objects are projected. During this search process, the variation 
within each cluster is minimized. Simultaneously, the variation between the clusters 
is maximized.6 As a result an optimal classification of the individual objects within 
the clusters is obtained. When there are two clusters, only one discriminant function 
is required. The principle is illustrated in Figure 4, where the two classes A and B 
have been projected on the discriminant line. When a new object is projected on the 
discriminant line, it is classified in cluster B if the discriminant function is positive, 
whereas it is classified in cluster A if the discriminant function is negative. In Figure 
4 it is shown that the test object T is classified in cluster B when projected on the 
discriminant line. Hence, the discriminant function can be utilized as a model for the 
prediction of a property of new object.
A B
T
------- X XXXXX|X x ---- 1— O D Q O O O O iO------
-2 -1 0 1 2
Figure 4 Projection of objects on the discriminant line.
104
Prediction o f clathrate formation by molecular modeling and QSAR.
7.3 Results of the Docking study
Docking in the Cefadroxil cavity.
For the clathrate structures of Cephalexin, Cephradine, Cefaclor and 
Cefadroxil, the "receptor" site for the guest molecules is the cavity formed by both 
the antibiotic molecules and the water molecules. As the structures of these 
"receptor" sites are known from several X-ray analyses, docking seems a suitable 
technique to tackle the problem of predicting complexation. It was found that the 
hosting frameworks of Cephradine, Cephalexin and Cefaclor possess a reasonable 
amount of flexibility both within the type A structure and by crystallizing in a 
different structure.10'11 Therefore, it was expected that these antibiotics would be less 
appropriate to be subjected to docking than Cefadroxil, which forms only complexes 
with the rigid type B structure.10 In addition, the complex of Cefadroxil and 4- 
hydroxybenzoic acid is the most accurately determined structure, in which even the 
hydrogen atoms of the water molecules could be located. After removal of the guest 
molecule 4-hydroxybenzoic acid from the structure, the remaining cavity could serve 
as a "receptor" site for docking studies. Whereas in most applications of docking the 
receptor site consists of only one molecule, e.g. a protein or a molecular host such as 
cyclodextrin, in case of the clathrate cavities the "receptor" site is constructed by 
several cephalosporin and water molecules.
Docking.
The docking study was initiated by placing molecules into the cavity, using 
the Sybyl docking option.12 Several molecules were fitted into the cavity and from 
this preliminary study it was clear that only flat molecules, such as benzene and 
naphthalene derivatives gave a negative (binding) interaction energy. Seemingly, 
the problem is a two dimensional problem resulting from the flat shape of the cavity. 
This flat shape of the cavity is visualized in Figure 5. It also became clear that 
molecules larger than naphthalene derivatives do not fit into the cavity. These 
observed restrictions more or less determine the scope of suitable complexing agents 
for Cefadroxil.
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Figure 5 The Cefadroxil cavity viewed along the c-axis.
Automated docking.
To investigate the predictive power of docking for the problem of clathrate 
type complexation, an automated docking search was performed.13 To perform an 
automated docking search it is necessary to couple a data base of molecules, for 
instance the Available Chemical Directory (ACD) to the docking program. Since the 
ACD is a 2-dimensional data base, the connectivity table of each molecule needs to 
be transformed to 3-dimensional coordinates prior to docking. This can be 
accomplished by a converter program such as Corina.13 After transformation to a 3­
dimensional structure the molecule is docked into the receptor site and by 
minimization of the interaction energy, the optimal orientation of the molecule is 
searched. The interaction energy at optimal fit is used as a scoring function for the 
ultimate selection of the best ligands. The whole procedure is schematically 
presented in scheme 2.
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Scheme 2 The procedure of an automated docking search.
About 25000 molecules from the ACD have been fitted into the Cefadroxil 
cavity. These were ranked according to their binding energy and the 1000 highest 
ranked molecules were considered as possible ligands for the Cefadroxil cavity. By 
careful examination of these 1000 molecules the following observations were made:
i. all molecules are flat, e.g. benzene and naphthalene derivatives.
ii. all molecules are polar, they contain one or more polar groups
iii. the original guest 4-hydroxybenzoic acid is among the 1000 molecules
iv. ff-naphthol and its suitable derivatives10 are not among the 1000 molecules
v. 75% of the first 99 compounds are two-ring systems, e.g. quinoline, indole, 
etc.
vi. 42% of the first 1000 compound are two-ring systems.
Observation i. is in agreement with the manual docking experiments and 
confirms the expectation based on the flat shape of the cavity, which is visualized in 
Figure 5. Virtually all molecules are very polar containing amino- and hydroxyl- 
functions as well as one ore more nitrogen atoms in their ring systems. This is 
probably due to the fact that the electrostatic energy contributes much more to the 
total binding energy than the steric energy, thus favoring polar molecules. 
Fortunately, the original guest 4-hydroxybenzoic acid was also found among the 
1000 best fitting molecules as it should be, since this is the original guest of the cavity 
used for the docking search. However, other known guest molecules were not 
among this set despite the fact that the available space for inclusion should be 
sufficient regarding the number of water molecules incorporated in the cavity.10
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There are two explanations for this. First, there is a possibility that these molecules 
were not among the 25000 molecules, which were subjected for the screening. 
Secondly, the binding energies may be lower than that of the first 1000 molecules. 
This has been verified for a- and ff-naphthol. Molecule number 1000 has a binding 
energy of -23.51 (kcal/mole), whereas a- and ff-naphthol have a binding energy of -  
21.29 and -21.65 (kcal/mole), respectively. This explains the fact that a- and ff- 
naphthol are not on the list of best 1000 ligands. From observations v. and vi. it may 
be concluded, albeit it with care, that two ring systems such as naphthalene, 
quinoline and indole derivatives fit better into the Cefadroxil cavity than one ring 
systems.
Evaluation of the results by complexation experiments.
As the differences in interaction energy between the 1000 molecules are small 
with respect to the errors in the calculated energies, hits should be found randomly 
distributed among them. In order to evaluate the predictive power of the docking 
search, 41 molecules were selected randomly from the 1000 candidate ligands. These 
41 molecules, which are listed in Appendix A, were subjected to complexation with 
Cefadroxil. The results were disappointing since only the original guest 4- 
hydroxybenzoic acid, which was among the test set of 41 compounds, 
experimentally formed a complex with Cefadroxil.
Despite the fact that the Cefadroxil/4-hydroxybenzoic acid complex is the 
most accurately determined structure and as such serves as the basis for the shape of 
the hosting cavity, the result of the automated docking search is very unsatisfactory. 
The disappointing result may be due to the flexibility of the receptor site, formed by 
the framework of Cefadroxil and water molecules. From the crystal structures of the 
Cefadroxil complexes, it is known that the flexibility in the hosting framework is 
limited.10 However, important differences between the hosting cavities of these 
complexes are caused by the water molecules. The number of water molecules in the 
complex is dependent on which guest is included. In addition, the positions of the 
water molecules can be adjusted by the guest.10 These induced fit phenomena were 
not taken into account during the docking search. Furthermore, the force field used 
may not be appropriate for the problem of clathrate type inclusion. The electrostatic 
energy has an overwhelming effect on the total interaction energy. As a consequence 
polar molecules are ranked higher than non-polar molecules due to their hydrogen 
bonding capacities. However, it has been shown that, although the presence of polar 
groups results in a higher interaction energy between host and guest, it is not always
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beneficial for efficient complex formation.15 In conclusion, there are several reasons 
for the poor result of the automated docking search. Alternative methods must 
therefore be explored for predicting suitable complexing agents for cephalosporins.
7.4 Results of the QSAR study
QSAR study on complexing agents for Cephradine.
As mentioned before, docking uses the structure of the receptor site, which 
consists in the present case of both the hosting framework and the water molecules. 
During the docking calculation, flexibility in the receptor site must be taken into 
account explicitly. However, in most cases, flexibility in the receptor site has to be 
neglected because of limitations of computational power. In the case of Cefadroxil, 
the disappointing results were most probably due to the flexibility of the cavity 
caused by the water molecules. The complexes of Cephalexin, Cephradine and 
Cefaclor, however, show flexibility with regard to the water molecules and are also 
able to adjust their hosting frameworks.10'11 In fact, this complexation resembles the 
induced fit in receptor sites often encountered for enzymatic reactions. 
Consequently, not much can be expected from docking into the hosting cavities of 
the complexes formed by these antibiotics. Therefore, the problem of prediction of 
complexation has to be approached in a different manner for these cephalosporins, 
e.g. by using Quantitative Structure Activity Relationships (QSAR). As QSAR focuses 
on the ligands, it takes into account flexibility of both the water molecules and the 
framework of the antibiotic molecules implicitly. Since QSAR requires a reasonable 
number of known ligands (complexing agents), Cephradine was used for this study.
The QSAR study was performed on 99 molecules comprising 56 complexing 
agents and 43 non-complexing molecules. These 99 molecules, the first 99 shown in 
Appendix C, were subjected to calculations of their molecular similarity matrices 
and 19 physical properties using the program Tsar.3 The output consisted of the 
similarity matrices Xshape and Xcharge and the physical property table Xparam. As 
was mentioned above Xshape contains the shape similarities at optimal shape 
overlap and Xcharge contains the molecular similarities with respect to charge 
distribution at optimal shape overlap. The combined matrix of Xshape and Xcharge 
is named Xshch.
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Data validation.
An important step in the analysis of molecular data is the validation. Data, 
whether obtained experimentally, from a data-base or by calculation are never 
completely error-free. It is important to identify molecules that do not conform to the 
general trend in the data set, since they may have a disturbing influence in the 
modeling phase. Outlier identification has been performed by using Rousseew's 
method16 and by using two methods proposed by Egan and Morgan.17 Several 
outliers were detected by these methods, most of them having an energy minimized 
conformation that is not flat. This is a direct result of the composition of the data set, 
where attention was focused on compounds that fit into the cavity. In all cases, the 
outlying observations did not form complexes with Cephradine. Since the 
similarities with the other compounds in the set were not different from the ones of 
the outlying observations, which was measured by row or column means in Xshape 
and Xcharge, it was decided to retain all observations in the data set.
-0 .4  0.0 0.4 0.8 
Lower triangle
Figure 6 Asymmetry in the similarity matrix Xcharge.
As Xshape an Xcharge are similarity matrices they should be symmetrical around 
the diagonal. Comparison of the matrix elements Xab and Xba for the data set 
revealed, however, notable differences. This indicates that aligning molecule a with 
b does not always give the same result as aligning molecule b with a. This is 
visualized in Figure 6, in which the similarities of the lower triangle of Xcharge are 
plotted against the similarities of the upper triangle of Xcharge. The largest 
deviations are found in regions of low similarity. This could indicate that two non­
resembling molecules can be aligned in several ways with similar overlap with 
respect to shape, but with different overlap in charge distribution. This hypothesis is 
supported by the fact that Xshape is much more symmetric. Moreover, calculating
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the shape similarity after aligning on optimal charge similarity also shows 
significant differences between the upper and lower triangle of the shape similarity 
matrix.4 The question arose whether the results obtained by using only the highest 
index of Hab and Hba were different from the results obtained with the asymmetrical 
matrix. No influence, however, was observed. Hence, the asymmetry was ignored 
during this study.
Validation of the data using chemical intuition showed that molecules that seem 
similar regarding their molecular formula indeed have high similarity indices.
Unsupervised methods.
First, the unsupervised method PCA was applied to the similarity matrices 
Xshape and Xcharge. Prior to PCA, the matrices were scaled to zero mean and unit 
variance. Because the results of the PCA on Xshape and Xcharge are similar, only the 
plot of the first two PC's of Xcharge is depicted in Figure 7. No separation of the 
complexing and non-complexing compounds along the first two PC's is observed. 
Clearly, the complexing and non-complexing compounds can not be distinguished 
in this way.
Principal Comp.
Figure 7 The scores of the 99 molecules on the first two PC's of Xcharge. Complexing 
molecules are labeled by y, non-complexing molecules by n.
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Secondly, the data matrices were subjected to a cluster analysis. The cluster 
tree from Xparam, shown in Figure 8, was obtained by using Ward's method.6 The 
two main branches of the cluster tree both contain complexing and non-complexing 
molecules. Despite the fact that Ward's clustering was found to perform quite well in 
other structure-activity applications,18 in this case the results are much less 
satisfactory. The similarity matrices Xshape and Xcharge were transformed to 
dissimilarities as described in the theory section. Clustering of these matrices 
confirmed that no easy discrimination between complexing and non-complexing 
molecules was possible. Since both Xshape and Xcharge gave a similar result only 
Xparam is shown in Figure 8.
Figure 8 The results of cluster analysis on Xparam. Complexing molecules are labeled 1, 
whereas non-complexing are not labeled.
Supervised methods.
Supervised methods like k-nearest neighbors (KNN) and linear discriminant 
analysis (LDA) were applied to investigate whether the complexation behavior of 
molecules could be predicted. As both techniques yielded similar results, only the 
results of the LDA studies are discussed in this chapter.19 The LDA models derived 
from the data set were validated by three methods. The leave-one-out method 
(LOOM) removes one compound from the data set, a new model is calculated based 
on the remaining compounds and the removed molecule is predicted. This method 
yields an estimate of the prediction error of the derived model. However, as the 
column with the similarities of the removed molecule remain in the matrices, this 
method may give a slightly positive biased result.
A second validation method is the permutation test (p-test). Also in this test one 
molecule is removed from the data set and a new model is derived based on the 
remaining molecules. However, now the desired clustering of molecules is chosen 
randomly, instead of demanding the complexing and non-complexing molecules to 
be clustered. The resulting model gives a fully arbitrary prediction of the removed
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molecule, which has a 50% chance to be correct. If in this case the prediction is much 
better, then the corresponding model predicts nonsense. Hence, a predictive error of 
40% may be very significant, whereas a predictive error of 10% may be completely 
useless. In practice, a model of which the outcome of the p-test gives p < 0.05 is 
regarded as significant and p < 0.01 as very significant.
For the third validation the data are divided into a training set and a test set. The 
training set is used to derive a model. The predictive error of the resulting model on 
the independent test set is a measure for the predictive value of this model.
The results are split up in two parts, whereby one deals with modeling on the 
complete dataset and the other only refers to the benzene derivatives. Since, the 
latter constitutes a more homogeneous group of molecules it was argued that these 
might be easier to model. The results of the first approach are shown in Table 1.
Table 1 The results of LDA modeling on the similarity matrices.
Complete data set Benzene derivatives
LOOM (%) p-test (p) LOOM (%) p-test (p)
Xshape 53.5 0.160 55.7 0.116
Xcharge 55.5 0.056 51.9 0.360
Xshch 55.5 0.136 49.4 0.572
The results in Table 1 show that the percentage correctly predicted by LOOM 
are only slightly higher than 50%. Moreover, from the p-tests it must be concluded 
that the models are not significant as in all cases p > 0.05. There are two possible 
explanations for these results. Either the relationship that is searched for (the 
relationship between the complexing behavior and the structure of the molecules) is 
not present or the number of degrees of freedom is too large. The second explanation 
means that too many data are used for the modeling procedure. As a consequence, 
the LDA model is under-determined. If under-determination is the problem, this can 
be circumvented by using less columns to describe the data. The first approach to 
solve this problem was to reduce the amount of data by PCA. The models derived in 
this approach were based on 15 to 30 PC's, which explained 91.9% and 96.1 % of the 
data, respectively. However, the results were disappointing. Hence, another 
approach was considered.
In a second attempt to solve the problem of under-determination, a set of 20 
guiding compounds was chosen on chemical intuition. Subsequently, the LDA
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model was derived based on the similarities of all the molecules with these guiding 
compounds. This means that the sizes of Xshape and Xcharge are reduced from 
99x99 to 99x20 matrices. The results of this approach are shown in Table 2. From 
Table 2 it can be concluded that the predictions based on Xcharge are very 
significant and reasonably well with 67.3 % correct on the complete data set and 74.9 
% correct on the benzene derivatives. The matrix Xshape contains seemingly no 
relevant information and confuses the information of Xcharge in the combined 
matrix Xshch.
Table 2 The results of LDA modeling based on the similarities with 20 guiding 
compounds which are chosen on chemical intuition.
Complete data set Benzene derivatives
LOOM (%) p-test (p) LOOM (%) p-test (p)
Xshape 55.5 0.176 52.5 0.376
Xcharge 67.3 0.004 74.9 0.000
Xshch 62.4 0.008 62.7 0.020
In order to demonstrate that the presence of the guiding compounds does not 
positively influence the results, the same procedure was applied on a data set from 
which the guiding molecules were removed. This means that the guiding 
compounds are no longer present among the model compounds and as a result the 
size of Xshape and Xcharge is now 79x20. As can be deduced from Table 3, the 
resulting models are comparable with those in Table 2 and the presence of the 
guiding compounds among the model compounds does not give a positive bias.
Table 3 The results of LDA modeling based on the similarities with 20 guiding 
compounds, which are chosen on chemical intuition. The guiding compounds 
are not among the model compounds in the dataset.
Complete data set Benzene derivatives
LOOM (%) p-test (p) LOOM (%) p-test (p)
Xshape 54.3 0.204 57.0 0.166
Xcharge 69.1 0.000 72.2 0.000
Xshch 65.4 0.000 63.3 0.012
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Since a reasonably successful method for the development of a model was 
found, the next step was to determine the predictive value of the model on a test set 
of independent molecules. From the experiments described above, it was concluded 
that the matrix Xcharge contains the most relevant information. Therefore Xshape 
and Xshch were ignored in the next experiments. The 79 modeling compounds were 
divided into training set of 40 compounds and a test set of 39 compounds. The same 
was done for the benzene derivatives only, which resulted in a training set 
consisting of 30 molecules and a test set of 29 molecules. In this way 100 arbitrarily 
chosen distributions over training- and test sets were made. For all 100 training sets 
a model was derived by LDA, which was subsequently used to predict the test set. 
The results are shown in Table 4. The predictive ability of the model has slightly 
decreased compared with the LOOM results in Table 3. This may be due to the fact 
that the model is built using a much smaller training set than was used for the model 
in Table 3. Nevertheless, the predictions are still well above 50%, with the best 
predictions reaching a score of 77.5 % on the complete set and 86.2% on the benzene 
derivatives.
Table 4 Prediction of independent test sets used a model based on Xcharge.
The results in Table 4 are promising, especially when taking into account that 
the set of guiding compounds used was not optimized but chosen on chemical 
intuition. Perhaps even better results can be obtained with another set of guiding 
compounds. This possibility was investigated by a random search of 500 attempts 
using subsets of 10 and 20 guiding compounds, respectively. In this way both the 
size and the composition of the set of guiding compounds is examined. In every 
experiment the guiding compounds are not among the model compounds and again 
only Xcharge is used. The two guiding sets consisting of 10 and 20 compounds that 
gave the best LOOM results, were subsequently evaluated using a series of training- 
and test sets in a similar manner as before. The results are shown in Table 5. All 
predictions are very significant with p = 0.000. The LOOM results are approximately 
10% better than those obtained with the guiding molecules chosen based on 
chemical intuition. The LOOM results obtained with 20 guiding compounds are
highest (%)a average (%)b
Complete set 
Benzene derivatives
77.5 62.5
86.2 65.5
a Highest percentage of correct predictions. 
b Average percentage of correct predictions.
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better than those with 10 guiding compounds. In contrast, the reverse was observed 
for the test set predictions of the benzene derivatives. This can be explained by the 
loss of predictive power, due to a large decrease of the number of modeling 
compounds when 20 guiding molecules are used. Nevertheless, the test set 
predictions are much better, ranging from 70% for the complete set to 74% for the 
benzene derivatives.
Table 5 LOOM and test set evaluation using the best performing sets of respectively 10 
and 20 guiding compounds from 500 randomly selected guiding sets.
LOOM (%) test set (%)a
Complete set (10) 74.7 68.9
Complete set (20) 77.8 70.0
Benzene der. (10) 80.3 74.3
Benzene der. (20) 87.5 71.9
a Average percentage of correct predictions.
The results in Table 5 show that by variation of the set of guiding compounds 
the predictive ability of the model can be improved significantly. However, the 
guiding sets used in Table 5 are not necessarily optimal. They are just the best 
among 500 randomly selected guiding sets. Instead of a random search for the 
optimal set of guiding compounds, a more systematic approach was followed as 
well. In order to optimize the set of guiding compounds a genetic algorithm was 
used.20,21 Genetic algorithms (GA's) have shown their ability to solve complex 
optimization problems in several fields, including chemistry.22 The principle of a 
genetic algorithm is easy to understand. It is based on the evolutionary phenomena 
found in nature, such as 'reproduction', resulting in species with chromosomes 
formed by combination of those from the parents, and selection by the 'survival of 
the fittest' criterion. A GA is initiated by generating a population of trial solutions 
for the subsequent problem. Each individual of the population is characterized by a 
chromosome. In the present case the individual is a set of guiding compounds with a 
"chromosome" consisting of a string of compound ID's corresponding to the column 
numbers of the whole set of molecules. All individuals are subjected to LDA 
modeling and the resulting models are evaluated by LOOM. After evaluation the 
individuals are ranked by their LOOM scores. Then the best individuals are selected 
and subsequently reproduced. Reproduction makes use of chromosomal 
recombination and mutation mechanisms, as is illustrated in Figure 9.
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13 38 43 57 71 78 89 one-point cross over 13 38 43 57 47 62 93
------------------------ ►
5 17 26 31 47 62 93 5 17 26 31 71 78 89
13 38 43 57 71 78 89 two-point cross over 13 38 26 31 71 78 89
------------------------ ►
5 17 26 31 47 62 93 5 17 43 57 47 62 93
point mutation
13 38 43 57 71 78 89 ------------------------ ► 13 38 43 57 15 78 89
Figure 9 Three possibilities for chromosomal recombination and mutation during 
reproduction of the selected individuals.
The new individuals are then subjected to LDA and evaluated by LOOM, 
followed by the above described sequence until the termination criterion is reached. 
The termination criterion can be either a desired LOOM, or that no further 
improvement is observed or the number of generations is limited. The basic cycle for 
a GA is depicted in scheme 3.
Scheme 3 The basic cycle of a genetic algorithm.
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In an attempt to improve the set of guiding compounds even further, a GA 
was applied to select sets of guiding compounds. To assess whether even smaller 
sets of guiding compounds could be used to predict complexation, the GA was 
allowed to select a maximum number of either 10 or 20 guiding compounds. Again, 
only the columns of the data set Xcharge were used, which after the addition of 21 
molecules contained 120 molecules in total resulting in a 120x120 matrix (the extra 21 
compounds were predicted by the first models and then experimentally tested). In 
contrast to the previous experiments only the complete set was modeled so no 
distinction was made between benzene and naphthalene derivatives. The LOOM 
error was used as an evaluation function. The complete data matrix was divided in 
five combinations of training sets with 90 compounds and test sets with 30 
compounds. For each of the five training set/test set combinations, five GA runs 
were performed with each a different initial population. Table 6 shows the variation 
in the size of the guiding sets found by the GA, the variation in the LOOM results 
and the average test set predictions obtained using the GA optimized guiding sets. 
The best LOOM results are approximately 10% higher than those obtained with the 
non-optimized guiding set. In fact, even the lowest LOOM scores in Table 6 are 
much higher than those in Table 5. Furthermore, the models described in Table 6 are 
highly significant according to the permutation tests performed with 250 
permutations. In all but one case the permutation test gave p=0.000 and in one case 
the p-test gave p=0.004, which still points to a very significant model. Remarkably, 
although all guiding sets selected exhibit similar performance, their compositions are 
very different. Apparently, it is not important which individual molecules are in the 
guiding set. This is probably due to the fact that most molecules are highly similar to 
at least one or more other molecules within the complete set of 120 molecules. It is, 
however, of importance which combination of guiding molecules is selected for LDA 
modeling. As can be concluded from Table 6, there are more combinations 
comprising different molecules but exhibiting a comparable performance during 
LDA modeling.
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Table 6 The variation of the number of guiding compounds between the independent 
GA runs, the variation in the observed LOOM results and the average test set 
predictions.
no. selecteda LOOM (%)b test set(%)c
Complete set (max. 10) 
Complete set (max. 20)
4-10
8-15
83.3-92.2
87.8-94.4
71.4
70.3
a The variation in the number of guiding compounds. 
b The variation in the LOOM results.
c The average prediction result of five independent test sets.
The LOOM results in Table 6 are still about 15% higher than the average 
predictions of the test sets, which aroused doubts about the robustness of the model. 
Possibly too many guiding compounds were allowed in the GA optimization. This 
has the consequence that the guiding set is specifically optimized to predict the 
training set correctly, whereas it should be trained for a broad range of molecules. By 
allowing a lower number of guiding molecules the GA has to select those molecules 
that are most important for the prediction of the training set. Hence, a less 
specialized guiding set is obtained and prediction of a broader range of molecules 
can be achieved. Therefore the guiding set optimization by the GA was repeated but 
the number of guiding compounds was limited to maximal four. Again five GA runs 
were performed for each of the five training set/test set divisions. It was found that 
the LOOM predictions were generally worse than those in Table 6 obtained by using 
larger guiding sets, but the test set predictions were generally better and moreover 
much more in agreement with the LOOM predictions. All models were evaluated by 
a permutation test which in all cases gave a p-value of 0.000. A graph of which 
compounds had been selected as guiding compounds showed that compounds 113, 
86 and 83 were prominent, as is depicted in Figure 10.
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83 86 113
Compound index
Figure 10 The frequency by which the molecules were selected as a guiding compound.
It appeared that a prediction based on only these three guiding compounds 
led to prediction results of 80.0, 93.3, 86.7, 86.7, and 83.3 % for the five test sets, 
respectively (86% on average). The permutation test gave a p-value of 0.000 thus 
indicating that the model is very significant. From a chemical point of view, it is 
difficult to see why these three molecules were selected by the GA. A plot of the 
differences in class mean between similarities of the complexing agents and the non- 
complexing agents, respectively, with each of the 120 compounds in the data set 
does provide some insight. This plot is depicted in Figure 11. Evidently, molecules 
86 and 113 belong to the 7 compounds with the largest class mean difference. The 
LDA algorithm selects those compounds that contain complementary information, 
which is apparently the case for compounds 83, 86 and 113.
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Compound index
Figure 11 A plot of the class mean difference for the 120 compounds of Xcharge.
As complexation can be predicted by using the similarities of a molecule with 
only three guiding compounds, the equation for calculating the result from the 
similarity indices is very concise, viz. equation III. After computation of the 
similarity indices of a new molecule with compounds 83, 86 and 113 ( S83, S86 and 
S113 respectively), complexation can be predicted with a certainty of approximately 
86% via equation III. Table 7 illustrates how the model can be used to predict the 
complexing behavior of molecules. From the similarity indices S83, S86 and S113, the 
discriminant function is calculated according to equation III. The outcome of this 
prediction has 86% chance to be in agreement with the experimental outcome, which 
is shown in the last column.
D = -0.35XS83 -  0.44XS86 -  0.83xS113 + 0.36 (III)
D > 0 no complexation 
D < 0 complexation
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Table 7 Prediction of complexation for 15 arbitrarily chosen compounds.
IDa name S83b S86b S113b Dc m odeld exp.e
5 1-naphthol 0,400 -0,132 0,400 -0,054 y y
12 3-aminophenol 0,313 0,041 0,400 -0,099 y y
19 benzoic acid 0,535 0,208 0,2000 -0,085 y y
25 tetrahydo-1-naphthol 0,399 0,019 0,310 -0,046 y y
45 4-aminobenzoic acid 0,413 -0,024 0,205 0,056 n n
57 2-brom onaphthalene 0,138 0,013 0,338 0,025 n n
61 nitrobenzene 0,618 -0,052 -0,232 0,359 n n
71 cyclohexanecarboxylic acid 0,401 0,481 0,187 -0,148 y* n
74 cinnamic acid 0,214 0,057 0,139 0,145 n n
81 2-aminobenzamide 0,587 0,461 0,179 -0,197 y y
88 m ethyl 3,5-dihydroxybenzoate -0,291 0,244 0,143 0,236 n* y
95 1,3-diaminobenzene 0,042 -0,148 0,457 0,031 n n
101 1,6-dihydroxynaphthalene 0,235 -0,098 0,472 -0,071 y y
108 4-hydroxyphenylacetic acid 0,205 -0,238 0,327 0,122 n n
119 1-naphthylam ine 0,257 0,086 0,519 -0,199 y y
a The ID refers to the row ID of the molecule in the matrix, see also appendix C. 
b The similarity indexes are rounded to three decimals. 
c The Discriminant parameter calculated according to equation III. 
d Prediction of the model, y and n mean yes or no clathrate formation. 
e Experimental outcome, y and n mean yes or no clathrate formation.
* means incorrect prediction.
7.5 Concluding remarks
Whereas docking has been widely applied for the design of ligands for 
biological targets and bimolecular inclusion compounds, this method has not been 
applied for clathrate type complexes thus far. In case of the cephalosporin clathrates 
the receptor site to be docked into, consists of a framework of several cephalosporin 
molecules. Clathrate formation requires a complete spatial fit of the guest molecule 
in the hosting cavity, while for the formation of receptor-ligand complexes only 
fitting of several interaction points may be sufficient. Furthermore, each cavity 
contains a number of water molecules, which can be partially removed by certain 
guest molecules. In addition, the water molecules can reorient themselves to direct 
their hydrogen bonding donor- and acceptor-sites. These important effects could not 
be taken into account during the automated docking search. Therefore, the docking 
technique is not sufficiently sophisticated for the problem described in this chapter. 
However, docking can serve as a valuable tool to obtain approximate information
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about the type of molecules that could be suitable guests for the hosting cavities in 
the cephalosporin networks.
For the prediction of suitable complexing agents using the concept of 
molecular similarity, the charge distribution and shape were considered as the most 
important parameters determining the complexing behavior of a guest molecule. In 
addition to the similarity data, also a set of nineteen parameters was used to describe 
the molecules. Principal component analysis immediately indicated the complexity 
of the problem, as no separation of complexing and non-complexing molecules was 
observed for the first two PC's on the basis of the data sets Xshape and Xcharge. This 
was confirmed by cluster analyses, as the two main branches of the cluster tree both 
contained complexing as well as non-complexing molecules in the case of Xshape, 
Xcharge and Xparam. The supervised clustering method linear discriminant analysis 
proved to be more successful, although the initial result was not magnificent, a clear 
distinction could be made between the complexing and non-complexing molecules. 
The predictive value could be improved significantly by optimizing the set of 
guiding molecules, which was done by both a random search and by using a genetic 
algorithm. Based on the guiding sets obtained via the genetic algorithm, LDA 
models with a predictive value of 86% could be derived.
The data set Xcharge contained the most relevant information as was shown 
by LDA. This matrix contains the molecular similarity with respect to charge at 
optimal shape overlap. This implies that in order to reach a high similarity index 
both shape and charge distribution similarity of two molecules must be 
simultaneously high. This method for describing molecular similarity proved to be 
very powerful in comparison with the similarity matrices referring to charge or 
shape only. Whereas the desired classification of non-complexing and complexing 
molecules could not be attained from the information of Xshape, the information 
contained in Xcharge was appropriate. In summary, a valuable predictive 
methodology for identifying suitable complexing agents for clathration with 
cephalosporins has been developed. The ultimate result is a simple equation to 
predict whether a compound will be a complexing agent or not. The procedure 
developed may also be applicable for other molecular clathration problems, or more 
general for other problems in host-guest chemistry. The method described in this 
paper requires that for the host-guest system under investigation a series of suitable 
guest molecules are known. Such a series of suitable guest molecules can be found 
by trial and error experimentation. In case the structure of the host-guest complex is 
known, docking in the hosting cavity can be a useful tool to assist the search for
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suitable guest molecules. When a series of suitable guest molecules has been 
discovered, the following procedure may lead to a predicting model equation:
1. Compose a data set; Select a series of molecules comprising both suitable guests 
and molecules that do not form a complex with the host under investigation. 
For the problem of complexation with Cephradine 120 molecules were 
selected for the data set.
2. Calculation of the similarity matrix; Calculate a molecular similarity matrix 
using an appropriate software package such as Tsar.3 Optimize the shape 
overlap of the molecules, followed by calculation of their charge distribution 
similarity index in the thus found orientation.
3. Guiding set optimization and deduction of a model; Initialize a Genetic Algorithm 
(GA) by making a random selection of "chromosomes"containing compound 
ID's corresponding to the similarity matrix calculated in step 2. Start the GA 
cycle, which consists of the following steps. First, models based on the 
molecular similarities of the molecules in the data set with the molecules of 
the selected guiding sets are derived using Linear Discriminant Analysis 
(LDA) and subsequently evaluated by LOOM. The guiding sets of the best 
performing models are reproduced for the next cycle, which is repeated until 
a desired LOOM result is obtained or after the maximal allowed number of 
cycles has been reached.
4. Evaluation of the model using a test set; Select molecules for an independent test 
set, which is predicted by the model and tested experimentally for 
complexation with the host under investigation. In case the complete data set 
is sufficiently large, it can also be divided in a training set and test set prior to 
the G A optimization (step 3). The model can then be evaluated by the 
corresponding test set.
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7.6 Experimental section
X-ray analysis of the complex of Cefadroxil and 4-hydroxybenzoic acid.
Crystal were grown from a solution of Cefadroxil (500 mg in 50 ml H2O) to which 4- 
hydroxybenzoic acid (210 mg, 1.5 mmole), dissolved in methanol (2 ml), was added. 
After cooling to 4°C, needle shaped crystals were formed overnight. A transparent 
colorless crystal (0.36 x 0.16 x 0.10 mm) was mounted on a glass fiber and intensity 
data were collected on a Nonius CAD4 diffractometer. The radiation used was Cuk«
o
(graphite monochromated) with A,=1.54184A. Intensity data were corrected for 
Lorentz and polarization effects. Semi-empirical absorption corrections (y-scan) 
were applied.23 The structures were solved using the program system DIRDIF.24 
Structure refinement was performed by full-matrix least squares on F2 (program 
SHELXL).25
Crystal data: C39H54N6O20S2, Mw = 991.00, T = 208(2)K, Orthorhombic, P212121, a =
o o o _
6.9992(3) A, b = 20.9913(8) A, c = 30.6901(8)A, a  = 90°, ß = 90°, Y = 90°, U = 4509.1(3) 
A3, Z = 4, Dc = 1.460 Mgm-3, refl. collected/unique 4442/4442, g.o.f. on F2 = 1.061, 
SHELXL-97 weight parameters 0.044800 and 0.757600, R (all data): R1 = 0.0284, wR2 
= 0.0679, Largest diff. peak and hole 0.240 and -0.203 e.A-3
Docking experiments .
Manual docking was performed by using the Sybyl12 docking option. The 
Cefadroxil/4-hydroxybenzoic acid structure was used as the parent clathrate, as this 
was the most accurately solved structure. The guest molecule 4-hydroxybenzoic acid 
was removed from the crystal structure. Subsequently, other molecules were put 
into the remaining cavity. Before docking, Gasteiger-Hückel charges were calculated
o
on host, guest and water molecules. The box width during docking was set on 3.5 A, 
covering all interaction of the guest molecule with the surrounding host and water 
molecules. The guest was manually translated and rotated to search for an 
orientation with a negative interaction energy.
For automated docking 25000 compounds were selected from the Available 
Chemical Directory (ACD). The 2-dimensional structures stored in the ACD were 
converted to three dimensional coordinates. Gasteiger-Hückel charges were 
calculated on host as well as on guest and water molecules. After that, the 3­
dimensional structures were put into the cavity and the interaction energy was 
optimized. The molecules were ranked according to their interaction energy with the 
cavity. The best 2000 molecules were stored and the best 1000 were considered as 
potential complexing agents.
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Experimental complexation for the evaluation of the docking results.
To a solution of Cefadroxil (500 mg in 50 ml H2O) complexing agent (1.5 mmole) 
dissolved in methanol (2 ml) was added. The mixture was stored at 4°C for two 
weeks. If crystals had formed these were collected by filtration. The crystals were 
analyzed by powder diffraction. Based on the X-ray powder pattern and the melting 
point, complex formation with Cefadroxil was ascertained.
The compounds that were investigated in this way, are listed in Appendix A.
Calculation of data matrices for QSAR.
Generation of the 3-dimensional molecular structures for the data set was achieved 
by first drawing them using the program Sybyl and subsequent energy minimization 
of the structure by molecular mechanics using Gasteiger-Hückel charges.12 After 
that, the structures were exported as .mol2 files which can be imported in the 
program Tsar.3 Prior to calculation of the similarity matrices, for each structure a 
second energy minimization was performed using the semi-empirical method 
included in Tsar (the VAMP module). Both the similarity matrices and the physical 
property data were calculated using the program Tsar.3 Similarity indices have been 
calculated as follows. Initial alignment of two molecules was made by overlaying 
their centers of mass. Alignment was then optimized based on shape overlap. The 
optimization consisted of two steps. First a full rigid search was performed using 
angular increments of 18°. Next a simplex optimization was applied to fine-tune the 
optimal alignment. At optimal alignment both the shape similarity index and the 
charge similarity index were calculated. The resulting matrices were Xshape, 
containing the shape similarities at optimal shape overlap, and Xcharge, containing 
the charge similarities at optimal shape overlap. The similarity indices were 
calculated as is shown below.
Also the charge similarity and shape similarity at optimal charge distribution 
overlap have been calculated. The resulting matrices revealed virtually the same 
information as Xshape and Xcharge according to PCA, cluster and LDA analyses. 
Hence, only Xshape and Xcharge were discussed in this chapter to avoid confusion.4 
Xparam consisted of 19 physical properties, which are summarized in Appendix B. 
The data set for the QSAR studies was calculated using 99 molecules, which are 
listed in Appendix C.
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QSAR modeling.
Statistical calculations were performed using R26 version 0.63 on a Linux Pentium II 
machine (266 MHz). Genetic algorithms for guiding compound selection were 
performed on SUN workstations using the PGAPack library.27
The PCA on Xshape and Xcharge resulted in the first two PC's which are plotted in 
Figure 7. The amount of variance explained by the first two PC's of Xshape and 
Xcharge was 0.80 (0.57 + 0.23) and 0.49 (0.35 + 0.14), respectively.
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Appendix A
The 41 test set molecules used for the evaluation of the automated docking search in 
the Cefadroxil cavity.
Uric acid 2-aminobenzoic acid 3-aminobenzoic acid
4-aminobenzoic acid 2-hydroxybenzoic acid 3-hydroxybenzoic acid
4-hydroxybenzoic acid 4-hydroxybenzam ide nicotinic acid
8-hydroxyquinoline 8-am inoquinoline 2-hydroxybenzaldehyde
3-hydroxybenzaldehyde 4-hydroxybenzaldehyde 4-am inobenzaldehyde
1-chloro-2,5-dihydroxybenzeen benzam ide benzoic acid
thiobenzam ide nitrosobenzene pyridine-N-oxide
4-nitrophenol phtalim ide phtalic acid anhydride
nicotinamide 4-nitroanilin 3,4-dihydroxybenzoic acid
2,4-dihydroxybenzoic acid 3,5-dihydroxybenzoic acid furan-2-carboxylic acid
4-chlorobenzoic acid 3-chlorobenzoic acid 2-bromobenzoic acid
indole 7-hydroxycoumarine coum arine
naphthalene-1-carboxylic acid 4-methylbenzoic acid aniline
Appendix B
The 19 physical properties of Xparam used for the QSAR studies.
Molecular Surface Area Molecular Volume Ellipsoidal Volume
Total Dipole M oment log P Total Lipole
Inertia M om ent 1 Size Inertia M om ent 2 Size Inertia M om ent 3 Size
Inertia M om ent 1 Length Inertia M om ent 2 Length Inertia M om ent 3 Length
Dipole M om ent X Com ponent Dipole M om ent Y Com ponent Dipole M om ent Z Comp.
Lipole X Com ponent 
Molecular Refractivity
Lipole Y Com ponent Lipole Z Com ponent
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9
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11
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33
34
35
36
37
38
39
40
41
42
43
44
45
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for the QSAR studies.
Name Complex formation
1,2,3-trihydroxybenzene 
1,3,5-trihydroxybenzene
1.2-dihydroxybenzene
1-chloronaphthalene 
a-naphthol
2-aminobenzoic acid 
2-aminophenol 
2-hydroxyacetophenone 
2-hydroxybenzoic acid methyl ester
2-methoxyacetophenone 
^-naphthol
3-aminophenol
3-hydroxybenzoic acid
4-hydroxybenzoic acid
4-methylbenzoic acid methyl ester
5-methoxyindole 
anisole 
benzamide 
benzoic acid 
bipyridine 
indene
indole
quinoline
salicylic acid
tetrahydo-1-naphthol
toluene
vaniline
1.3-dihydroxybenzene
1.4-dihydroxybenzene 
1-indanone
3-hydroxyacetophenone
4-aminoacetophenone 
4-methoxyphenol 
4-methylacetophenone 
acetophenone 
phenol
4-phenylphenol
carbazole
fluorene
4-aminobenzoic acid ethyl ester 
4-aminobenzoic acid methyl ester
3-hydroxybenzoic acid methyl ester
4-hydroxybenzoic acid methyl ester
1-nitronaphthalene 
4-aminobenzoic acid 
4-aminophenol 
4-hydroxybenzaldehyde 
4-hydroxypropiophenone 
4-methylbenzoic acid 
4-nitrophenol 
benzaldehyde
benzoic acid glycol ester 
benzoic acid propaanglycol ester 
benzylalcohol 
N,N-dimethylbenzamide 
propiophenone
2-broomnaphthalene
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
yes
no
no
no
no
no
no
no
no
no
no
no
no
no
no
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58 2-nitronaphthalene no
59 acetylsalicylic acid no
60 naphthalene-1-carboxylic acid no
61 nitrobenzene no
62 1-phenylethanol no
63 2-methylcyclohexanone no
64 3-hydroxybenzylalcohol no
65 4-hydroxyacetophenone no
66 4-hydroxybenzoic acid ethyl ester no
67 4-methoxyacetophenone no
68 anthracene no
69 anthraquinone no
70 benzoine no
71 cyclohexanecarboxylic acid no
72 cyclohexanol no
73 iso-phthalic acid no
74 cinnamic acid no
75 terephthalic acid no
76 1,2,3,4-tetrahydronaphthalene no
77 a-tetralone no
78 trimesic acid no
79 2,4-dihydroxybenzoic acid yes
80 2,4-dihydroxybenzoic acid methyl ester yes
81 2-aminobenzamide yes
82 2-aminobenzoic acid methyl ester yes
83 2-methylbenzoic acid yes
84 3,4,5-trihydroxybenzoic acid methyl ester yes
85 3,4-dihydroxybenzoic acid yes
86 3,4-dihydroxybenzoic acid methyl ester no
87 3,5-dihydroxybenzoic acid yes
88 3,5-dihydroxybenzoic acid methyl ester yes
89 3-aminobenzoic acid no
90 3-aminobenzoic acid methyl ester yes
91 3-methylbenzoic acid yes
92 3-methylbenzoic acid methyl ester yes
93 aniline yes
94 1,2-diaminobenzene no
95 1,3-diaminobenzene no
96 1,4-diaminobenzene no
97 2-aminopyridine no
98 2-hydroxypyridine no
99 4-aminopyridine no
100 1,2,7-trihydroxynaphthalene yes
101 1,6-dihydroxynaphthalene yes
102 1-ace tonaphthon yes
103 2,4-dihydroxy-6-methylpyrimi dine no
104 2-indanol no
105 2-methoxybenzaldehyde yes
106 2-methoxybenzoic acid yes
107 4-chloorbenzoic acid no
108 4-hydroxyphenylacetic acid no
109 6-methoxyindole yes
110 benzy lamine no
111 coumarin yes
112 phtalic acid no
113 m-anisidine yes
114 methyl benzoate yes
115 N,N-dimethyl-4-nitroaniline no
116 4-phluorobenzoic acid no
117 o-vanilin no
118 p-cresol yes
119 1-naphthylamine yes
120 N-methyl methyl antranilate yes
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S y n t h e s i s  o f  C e p h a l e x in ,  C e p h r a d i n e  a n d  
C e f a d r o x il  U s i n g  a  C l a t h r a t i o n  i n d u c e d  
A s y m m e t r ic  T r a n s f o r m a t i o n
Abstract: The cephalosporin antibiotics Cephalexin, Cephradine and Cefadroxil can be 
epimerized at the a-carbon of their amino acid side chains under remarkably mild 
conditions. By clathration with an appropriate complexing agent the cephalosporin epimer 
derived from a D-amino acid can be selectively withdrawn from the equilibrating mixture. 
Accordingly, an asymmetric transformation of the epi-cephalosporin to this desired 
diastereomer can be accomplished. By using this asymmetric transformation, the 
cephalosporins have been prepared starting from racemic amino acid side chains. This 
strategy for the synthesis of cephalosporins using racemic amino acid side chains has 
attractive economical prospects.
8.1 Introduction
Cephalexin 1, Cephradine 2 and Cefadroxil 3 (Chart I) are abundantly used 
antibiotics belonging to the class of the cephalosporins. They are semi-synthetic 
antibiotics consisting of a ff-lactam nucleus and a D-amino acid side chain. The ß- 
lactam nucleus of these cephalosporins can be obtained via chemical modification of 
the penicillin nucleus1 and recently also by direct fermentation.2 The amino acid side 
chains of cephalosporins 1-3 can be prepared from basic organic chemicals.3'4'5'6 The 
final step in the preparation of cephalosporins 1-3 is the coupling of the ß-lactam 
nucleus and the respective side chain. Although the coupling of nucleus and side 
chain can be accomplished enzymatically,7 most manufacturers still use the
This chapter has been published: G.J. Kemperman, J. Zhu, A.J.H. Klunder, B. Zwanenburg, Organic 
Letters, 2000, 2, 2829-2831; G.J. Kemperman, J. Zhu, A.J.H. Klunder, B. Zwanenburg, Eur. J. Org. Chem., 
in  press.
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conventional chemical process for this purpose. Since the yields of the chemical 
coupling reactions are fully optimized, the use of cheaper starting materials becomes 
an interesting option for further cost reduction. In this context, the use of racemic 
amino acids as starting materials for the side chains may offer an attractive cheaper 
alternative for the currently used enantiopure compounds. However, coupling of the 
ß-lactam nucleus with an appropriate racemic amino acid derivative, leads to an 
epimeric mixture of cephalosporins of which only the derivative from the D-amino 
acid exhibits the desired antibiotic activity. Therefore, epimerization of the 
stereogenic center in the amino acid side chain of the epi-cephalosporins is a must to 
make the coupling starting from racemic amino acids an economically feasible one. 
This chapter deals with an asymmetric transformation of epi-cephalosporins to their 
pharmaceutically active diastereomers and the use thereof in the preparation of the 
three target compounds, viz. Cephalexin 1, Cephradine 2 and Cefadroxil 3, from 
racemic amino acid side chains.
Chart I
8.2 Results
Epimerization of the cephalosporins.
Amino acids are usually optically stable and can only be racemized under 
extremely harsh conditions.8 Their rate of racemization can be greatly enhanced by 
prior conversion into their Schiff bases.9,10 The racemization becomes even more 
effective when conducted in the presence of an organic acid.11 In general, any amino 
acid can be racemized by heating in acetic acid, using a catalytic amount of 
aldehyde.11 A generally accepted mechanism for the racemization involves 
isomerization of the Schiff base.10 Rate enhancement of the racemization in acetic 
acid supports this mechanism.11
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Despite the major improvements of the racemization methods of amino acids, 
the conditions described above can not be used for the cephalosporins. Due to the
Exposure to a pH above 8 or to strong acidic conditions causes severe breakdown of 
the cephalosporin. Also the temperatures required for the methods described above 
are too harsh for the ff-lactam antibiotics. Accordingly, the epimerization of the 
cephalosporins was investigated in aqueous solution under mild conditions. It was
promoted epimerization, whereby the latter showed a faster reaction. A catalytic 
amount of aldehyde (10%) appeared to be sufficient. Gratifyingly, the epimerization 
according to scheme 1, can be performed under these very mild conditions. A pH 
between 7 and 7.5 appeared to be appropriate to obtain an acceptable rate of 
epimerization in water at room temperature. The rate of the epimerization was 
monitored by HPLC, the results of which are summarized in Table 1. At equilibrium 
36%, 32% and 37% of the epz-cephalosporins had been formed from Cephalexin, 
Cephradine and Cefadroxil, respectively.
presence of the ff-lactam nuclei they are extremely susceptible to degradation.
found that both salicylic aldehyde and pyridoxal could be used for the Schiff base
h o h 2c
R
c o 2h
c o 2h
c o 2h c o 2h
cephalosporins ep/-cephalosporins
1 R = phenyl, 2 R = 1,4-cyclohexadienyl, 3 R = p-hydroxyphenyl
Scheme 1 The epimerization of Cephalexin, Cephradine and Cefadroxil.
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Table 1 The percentage of epi-cephalosporin formed with time.
Time (h) 0 0.5 1 1.5 2 3 4 6 22
epi-Cephalexin (%) 0 6.5 11 17 19 21 25 24 36
epi-Cephradine (%) 0 5.9 9.9 15 17 19 23 27 32
epi-Cefadroxil (%) 0 20 26 31 32 36 36 36 37
Asymmetric transformation of cephalosporins.
The asymmetric transformation has been studied starting from mixtures of 
cephalosporin diastereomers obtained from the epimerization experiments described 
above. As the solubility difference in water between the cephalosporins and their 
corresponding epimers is rather small, selective crystallization of the desired 
diastereomer cannot be achieved. However, the cephalosporins can be efficiently 
withdrawn from aqueous solutions by clathration with aromatic compounds. For 
Cephalexin and Cephradine a-naphthol is the complexing agent of choice, while for 
Cefadroxil 2,7-dihydroxynaphthalene is preferred.12 It was shown that this 
clathration process is highly selective. Only the cephalosporins derived from D­
amino acids were found in the precipitate, while their epimers remained in solution. 
The precipitation of the complex started within fifteen minutes. During the 
asymmetric transformation the pH was maintained constant by adding acid to the 
reaction mixture. The formation of the cephalosporins from their epimeric mixtures 
was followed with time using HPLC. The results are shown in Table 2.
Table 2 The results of the asymmetric transformation
Time (h) 0 1.5 2.5 4 5 7 24
Cephalexin (%) 64 70 74 76 78 81 90
Cephradine (%) 68 73 77 83 85 87 95
Cefadroxil (%) 63 66 73 82 83 89 94
Synthesis of cephalosporins from 7-ADCA and racemic side chains.
The coupling of the ff-lactam nucleus and the appropriate amino acid side 
chains is conducted via the so-called Dane salt route, as is depicted in Scheme 2.13 
For the preparation of the Dane salt, the racemic amino acid is heated with ethyl 
acetoacetate in the presence of potassium hydroxide. The thus obtained Dane salt is 
then activated by conversion into the mixed anhydride of pivalic acid by reaction 
with pivaloyl chloride. This anhydride is subsequently used in the actual coupling
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reaction with the ff-lactam nucleus, 7-ADCA. In order to make 7-ADCA more soluble 
in dichloromethane its tetramethylguanidine salt is prepared prior to its addition to 
the mixed anhydride. After hydrolytic removal of the Dane protecting group, an 
aqueous solution containing an epimeric mixture of the cephalosporin was obtained 
in yields ranging from 80 to 88%. The lowest conversion was obtained with 
Cefadroxil, while Cephradine gave the highest conversion. It is important to note 
that the Dane salt route is also used in the industrial production of cephalosporins. 
The amino acid side chain of Cephradine, viz. cyclohexadienylglycine, is not 
commercially available in racemic form. The racemate needed for this study was 
prepared by racemization of the enantiopure material by warming an aqueous 
solution of this compound with 1.1 equivalent of sodium hydroxide in the presence 
of a catalytic amount of salicylic aldehyde. Clearly, this racemization proceeds via 
the intermediacy of a Schiff base, which readily racemizes under basic conditions. 
The thus formed racemic cyclohexadienylglycine was converted into its Dane salt 
using sodium hydroxide instead of potassium hydroxide, because the potassium salt 
refused to crystallize. The potassium Dane salts of racemic phenylglycine and p- 
hydroxyphenylglycine were prepared by reported procedures.13
n h 2
x 2
R CO2H
1. KOH
O O
OEt
2 . pivaloyl chloride
O
H N ' ^  OEt 
RA N^ O C O C (M e )3
O
1 .H 2N s
c o 2h
2 . H3O+
R
80-88%
1 R = phenyl, 2 R = 1,4-cyclohexadienyl, 3 R = p-hydroxyphenyl
Scheme 2 The coupling of racemic side chains and the ff-lactam nucleus via the Dane route.
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The epimeric mixture of cephalosporins obtained above contained the epi­
cephalosporin as the major component, implying that the L-amino acid derivative 
had reacted considerably faster in the coupling reaction than the corresponding D- 
form. This remarkable observation has the interesting consequence that in principle 
a higher conversion can be achieved in the coupling of the racemic side chains 
compared with that of the commonly used enantiopure side chains. The required 
epimerization of the epi-cephalosporin (Scheme 3) could be readily accomplished 
under the conditions mentioned above, viz. by treatment of the aqueous solution of 
epimers with 10 mole percent of pyridoxal at a pH of 7.5. The next step is to drive 
the equilibrium of epimeric cephalosporins to the side of the desired epimer having 
the antibiotic activity. Selective clathration with a complexing agent could be 
accomplished for Cephalexin and Cephradine by adding a-naphthol to the mixture 
of equilibrating epimers. For Cefadroxil, 2,7-dihydroxynaphthalene gave the best 
performance in this selective clathration, which still was less effective than in case of 
the other two cephalosporins. After one night, the complexed cephalosporin had 
crystallized and could simply be collected by filtration. Decomplexation was 
achieved by hydrolysis of the complex with aqueous diluted acid and subsequent 
removal of the complexing agent by extraction with ethyl acetate. Neutralization of 
the highly concentrated aqueous solution of cephalosporin resulted in precipitation 
of the ultimate product. The overall yields after decomplexation based on 7-ADCA 
amounted to 68%, 73% and 57%, for Cephalexin, Cephradine and Cefadroxil, 
respectively. The products were analyzed by HPLC to determine the purity and by 
X-ray powder diffraction to ascertain that the desired cephalosporin monohydrate 
had been obtained.
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8.3 Concluding remarks
The cephalosporin antibiotics Cephalexin, Cephradine and Cefadroxil can be 
epimerized at the a-carbon of their amino acid side chains under remarkably mild 
conditions. By selective clathration the cephalosporin with the correct 
stereochemistry in the side chain can be exclusively withdrawn from the 
equilibrating epimeric mixture. In this way an asymmetric transformation of the epi­
cephalosporins into the antibiotics is achieved. By using this asymmetric 
transformation, the objective to prepare the cephalosporin antibiotics Cephalexin, 
Cephradine and Cefadroxil from racemic side chain precursors has successfully been 
accomplished. This new approach to the synthesis of cephalosporins employing 
racemic amino acid as the starting material for the side chains may have attractive 
prospects for cost price reduction in the manufacture of these live saving 
antibiotics.14
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8.4 Experimental section
Cephalexin, epi-Cephalexin, Cephradine and Cefadroxil were obtained from 
the DSM Life Sciences Group (The Netherlands). Pyridoxal was purchased from 
Fluka. a-naphthol and 2,7-dihydroxynaphthalene were purchased from Acros. For 
the HPLC analysis a Pharmacia LKB.LCC 2252 HPLC was used, with a reversed 
phase column (Merck 50983 LiChrospher 100RP18, 5 ^m, 250x4 mm). For detection a 
UV detector (A=254 nm) of Farmacia LKB.UV-MII was used. An appropriate eluent 
for the analysis was a mixture of acetonitrile (HPLC grade) and a 50 mM phosphoric 
acid buffer with a pH of 2.7. The pH stat apparatus used was a Schot Geräte Titrator 
TR154.
Epimerization of Cephalexin, Cephradine and Cefadroxil.
The cephalosporin (1 g, 1.37 mmole) was dissolved in water (20 ml), which was 
adjusted at a pH of 8with diluted NH3 . Pyridoxal hydrochloride (60 mg, 10%) was 
added to the clear solution. Subsequently, the pH was adjusted to 7.5. Samples were 
taken at regular intervals and analyzed by HPLC. After one night at room 
temperature equilibrated solutions were obtained. At equilibrium the amount of 
epimer formed was 36 %, 32% and 37% of epi-Cephalexin, epi-Cephradine and epi- 
Cefadroxil, respectively. These solutions were used to study the asymmetric 
transformation.
Asymmetric transformation of epi-Cephalexin, epi-Cephradine and epi-Cefadroxil.
To the epimerized cephalosporin solution (1.37 mmole in 20 ml water), complexing 
agent (1.5 mmole), i.e a-naphthol for Cephalexin and Cephradine and 2,7- 
dihydroxynaphthalene for Cefadroxil, dissolved in ether (2 ml) was added. The pH 
was maintained constant at 7.5 by adding 5% HCl via a pH stat apparatus. The 
asymmetric transformation was monitored by HPLC. After one night, the 
precipitated complex was filtered from the reaction mixture. The complexes were 
obtained in a yield of 1.11 g (85%) for Cephalexin, 1.18 g (91%) for Cephradine, and
1.2 g (86%) for Cefadroxil.
DL-cyclohexadienylglycine
D-cyclohexadienylglycine (20 g, 0.13 mole) and sodium hydroxide (5.7 g, 0.14 mole) 
were dissolved in water (80 ml). To this stirred solution salicylic aldehyde (1.6 g,
0.013 mole) was added and the solution was heated to 80°C for 2 h. The reaction 
mixture was allowed to cool and then diluted with water (300 ml). Then, the 
reaction mixture was acidified with 95% sulfuric acid to a pH of 2. After 10 min the
141
Chapter 8
reaction mixture was neutralized with ammonia (5%) whereupon the product 
precipitated. The product was thoroughly washed with water and acetone. After 
drying under a flow of nitrogen, racemic cyclohexadienylglycine was obtained in 
nearly quantitative yield (~20 g). Optical rotation: [a]D = 0°. The optically pure D- 
cyclohexadienylglycine has [a]D25 = -89°.4
N-[1-methyl-2-ethoxycarbonyl-vinyl]-a-aminophenylacetic acid potassium salt (Dane-salt of 
racemic phenylglycine)
Racemic phenylglycine (16.1 g, 0.107 mole) and potassium hydroxide (6.2 g, 0.11 
mole) were suspended in methanol (120 ml). The reaction mixture was heated under 
reflux and stirred until the solution was clear. While stirring under reflux, ethyl 
acetoacetate (15 g, 0.115 mole) in methanol (25 ml) was added. The reaction mixture 
was stirred and heated under reflux for 30 min. The reaction mixture was 
concentrated to approximately 60 ml and then allowed to cool. The product 
crystallized as a white solid which was filtered and washed with methanol. After 
drying 27.3 g (85%) of racemic phenylglycine Dane-salt was obtained.
N-[1-methyl-2-ethoxycarbonyl-vinyl]-a-aminocyclohexadienylacetic acid sodium salt 
(Dane-salt of racemic cyclohexadienylglycine)
Racemic cyclohexadienylglycine (19.45 g, 0.127 mole) was suspended in isopropyl 
alcohol (120 ml). To this solution a suspension of sodium hydroxide (5.1 g, 0.128 
mole) in isopropyl alcohol was gradually added. While stirring, the reaction mixture 
was heated under reflux. After both components had dissolved, ethyl acetoacetate 
(17.0 g, 0.131 mole) in isopropyl alcohol (25 ml) was added and the reaction mixture 
was heated under reflux for 3 h. After cooling the product appeared as a white 
crystalline solid. The crystals were collected, washed with isopropyl alcohol and 
subsequently dried under a flow of nitrogen. The desired product was obtained in a 
yield of 34.6 g (95%).
N-[1-methyl-2-ethoxycarbonyl-vinyl]-a-amino-(4-hydroxyphenyl)acetic acid potassium salt 
(Dane-salt of racemic p-hydroxyphenylglycine)
Racemic p-hydroxyphenylglycine (15 g, 89.8 mmole) and potassium hydroxide (5 g, 
90 mmole) were dissolved in methanol (120 ml). The solution was stirred and heated 
under reflux. A solution of ethyl acetoacetate (12.9 g, 99 mmole) in methanol (25 ml) 
was gradually added. The reaction mixture was heated under reflux for 10 min. The 
product crystallized upon cooling. The crystals were collected and washed with 
methanol. After drying the product was obtained in a yield of 21.9 g (77%).
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Synthesis of Cephalexin from 7-ADCA and racemic phenylglycine Dane salt 
The potassium Dane salt of racemic phenylglycine (3 g, 10 mmole) was suspended in 
a mixture of dichloromethane (15 ml) and dimethylformamide (2 ml). To this 
suspension y-picoline (50 mg) was added. The suspension was cooled to -25°C and 
pivaloyl chloride (1.27 g, 10.5 mmole) was added as quick as possible. The reaction 
mixture was stirred for 30 min at a temperature between -20 and -25°C. After that, 
the reaction mixture was diluted with dichloromethane (15 ml) and cooled to -50°C. 
A solution of 7-ADCA (1.9 g, 9 mmole) and tetramethylguanidine (1.1 g, 9.4 mmole) 
in dichloromethane (10 ml), which was cooled at -10°C, was added to the reaction 
mixture in approximately 30 min. The reaction mixture was stirred for 5 h while the 
temperature was allowed to rise slowly to -30°C. When, according to HPLC, the 
conversion of 7-ADCA to Cephalexin had been completed, the reaction mixture was 
allowed to warm to 0°C after which water was added (10 ml). While stirring, the 
reaction mixture was acidified to a pH between 0 and 1 using 37% HCl. The reaction 
mixture was stirred for 10 min while the temperature was maintained at 0°C. The 
dichloromethane layer was separated and washed with 5% HCl (5 ml). To the 
combined aqueous layers pyridoxal hydrochloride (160 mg, 0.8 mmole) was added. 
The pH was adjusted to 7.5 using 5% ammonia and the aqueous reaction mixture 
was allowed to warm to ambient temperature. A solution of a-naphthol (1.3 g, 9 
mmole) in ether (10 ml) was added and the reaction mixture was stirred overnight. 
The precipitated Cephalexin/ a-naphthol complex was filtered off and successively 
washed with ether (5 ml) and water (5 ml). After drying the Cephalexin/ a-naphthol 
complex was obtained in a yield of 3.1 g (73%).
The complex (2 g) was suspended in ethyl acetate (10 ml). While stirring the 
suspension, 5% HCl (~2 ml) was added until both layers had turned completely 
clear. The aqueous layer was separated and washed with ethyl acetate (5 ml). The 
thus obtained aqueous Cephalexin solution was cooled below 5°C. The pH was 
raised to 3 using 25% ammonia and then to a pH of 4 using 5% ammonia, which 
resulted in precipitation of Cephalexin. The mixture was maintained at a 
temperature below 5°C for another 30 min, after which the product was collected by 
filtration. After drying under a flow of nitrogen 1.45 g Cephalexin monohydrate 
(94% on the decomplexation, 68% overall on 7-ADCA) was obtained as a white solid. 
The product had a purity of 97% according to HPLC. X-ray powder diffraction 
confirmed that indeed the desired Cephalexin monohydrate with the correct 
stereochemistry of the biologically active compound had been obtained.
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Synthesis of Cephradine from 7-ADCA and racemic cyclohexadienylglycine Dane salt 
The sodium Dane salt of racemic cyclohexadienylglycine (2.87 g, 10 mmole) was 
suspended in dichloromethane (15 ml). To this suspension y-picoline (50 mg) was 
added. The reaction mixture was then cooled to -25°C and pivaloyl chloride (1.27 g,
10.5 mmole) was quickly added. The reaction mixture was stirred for 30 min at a 
temperature between -20 and -25°C. Then the reaction mixture was diluted with 
dimethylformamide (10 ml) and cooled to -50°C. A solution of 7-ADCA (1.9 g, 9 
mmole) and tetramethylguanidine (1.1 g, 9.4 mmole) in dichloromethane (15 ml), 
which was cooled at -10°C, was added to the reaction mixture in approximately 30 
min. The reaction mixture was stirred for 6 h while the temperature was allowed to 
rise slowly to -30°C. When, according to HPLC, the conversion of 7-ADCA to 
Cephradine was completed, the reaction mixture was allowed to warm to 0°C after 
which water was added (10 ml). While stirring, the reaction mixture was acidified to 
a pH between 0 and 1 using 37% HCl. The reaction mixture was stirred for 10 min 
while the temperature was maintained at 0°C. The dichloromethane layer was 
separated and washed with 5% HCl (5ml). Pyridoxal hydrochloride (160 mg, 0.8 
mmole) was added to the combined aqueous layers. The pH was adjusted to 7.5 
using 5% ammonia and the aqueous reaction mixture was allowed to warm to 
ambient temperature. A solution of a-naphthol (1.3 g, 9 mmole) in ether (10 ml) was 
added and the reaction mixture was stirred overnight. The precipitated 
Cephradine/ a-naphthol complex was filtered off and successively washed with 
ether (5 ml) and water (5 ml). After drying the Cephradine/ a-naphthol complex was 
obtained in a yield of 3.3 g (77%).
The complex (2 g) was suspended in ethyl acetate (10 ml). While stirring the 
suspension 5% HCl (~2 ml) was added until both layers had turned completely clear. 
The aqueous layer was separated and subsequently washed with ethyl acetate (5 ml). 
The resulting aqueous Cephradine solution was cooled below 5°C. The pH was 
raised to 3 using 25% ammonia and then to a pH of 4 using 5% ammonia. This 
operation resulted in the precipitation of Cephradine. The reaction mixture was kept 
at a temperature below 5°C for another 30 min after which the product was collected 
by filtration. After drying under a flow of nitrogen 1.5 g Cephradine monohydrate 
(95% on the decomplexation, 73% overall on 7-ADCA) was obtained as a white solid. 
According to HPLC the purity of the product was 92%. X-ray powder diffraction 
showed that indeed the Cephradine monohydrate having the stereochemistry of the 
biologically relevant product had been obtained.
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Synthesis of Cefadroxil from 7-ADCA and racemic p-hydroxyphenylglycine Dane salt 
The potassium Dane salt of racemic p-hydroxyphenylglycine (3.17 g, 10 mmole) was 
suspended in a mixture of dichloromethane (15 ml) and dimethylformamide (2 ml). 
To this suspension y-picoline (50 mg) was added. The suspension was cooled to - 
25°C and pivaloyl chloride (1.27 g, 10.5 mmole) was added as quick as possible. The 
reaction mixture was stirred for 30 min at a temperature between -20 and -25°C. 
After that the reaction mixture was diluted with dichloromethane (15 ml) and cooled 
to -50°C. A solution of 7-ADCA (1.9 g, 9 mmole) and tetramethylguanidine (1.1 g, 9.4 
mmole) in dichloromethane (15 ml), which was cooled at -10°C, was added to the 
reaction mixture in approximately 30 min. The reaction mixture was stirred for 5 h 
while the temperature was allowed to rise slowly to -30°C. When, according to 
HPLC, the conversion of 7-ADCA to Cefadroxil was completed, the reaction mixture 
was allowed to warm to 0°C and then water was added (10 ml). While stirring, the 
reaction mixture was acidified to a pH between 0 and 1 using 37% HCl. The reaction 
mixture was stirred for 10 min while the temperature was maintained at 0°C. The 
dichloromethane layer was separated and washed with 5% HCl (5 ml). The 
combined aqueous layers were treated with pyridoxal hydrochloride (160 mg, 0.8 
mmole). The pH was adjusted to 7.5 using 5% ammonia and then the reaction 
mixture was allowed to warm to ambient temperature. A solution of 2,7- 
dihydroxynaphthalene (1.4 g, 9 mmole) in ether (10 ml) was added and the reaction 
mixture was stirred overnight. The precipitated Cefadroxil/2,7- 
dihydroxynaphthalene complex was filtered off and successively washed with ether 
(5 ml) and water (5 ml). After drying the Cefadroxil/2,7-dihydroxynaphthalene 
complex was obtained in a yield of 2.7 g (60%).
The complex (2 g) was suspended in ethyl acetate (10 ml). While stirring the 
suspension 5% HCl (~2 ml) was added until both layers had turned completely clear. 
The aqueous layer was separated and subsequently washed with ethyl acetate (5 ml). 
After separation of the layers the aqueous Cefadroxil solution was cooled below 5°C. 
The pH was raised to 3 using 25% ammonia and to a pH of 4 using 5% ammonia, 
leading to precipitation of Cefadroxil. The mixture was stirred for another 30 min at 
a temperature below 5°C, and then the product was collected by filtration. After 
drying under a flow of nitrogen 1.45 g Cefadroxil monohydrate (95% on the 
decomplexation, 57% overall on 7-ADCA), was obtained as a white solid. According 
to HPLC the product was 95% pure. X-ray powder diffraction confirmed that indeed 
the desired Cefadroxil monohydrate with the correct stereochemistry in the side 
chain had been obtained.
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Chapter 9
M o l e c u l a r  Se l e c t iv it y  a n d  C o o p e r a t iv it y  in  
C l a t h r a t e -T y pe  C o m p l e x a t io n  o f  C e p h r a d in e
A  prelim inary  study
Abstract: The separation of ortho- and para-disubstituted benzene derivatives by clathration 
with the antibiotic Cephradine is investigated. For a number of o/p mixtures a high 
preference or even complete selectivity for one of the components in the complexation with 
Cephradine is demonstrated. Although Cephradine is a chiral compound the resolution of 
racemates by clathration with this antibiotic could not be achieved. This is probably due to 
the shape of the hosting cavity formed by the antibiotic in which it is difficult to 
accommodate molecules with sp3 stereogenic centers.
It is shown that exposure of a Cephradine solution to a mixture of complexants may also 
lead to simultaneous inclusion of more than one guest molecule. The observed 
thermodynamic preference for the accommodation of two complexants instead of one 
clearly points to the cooperative effect of two complexants in the thus formed clathrate-type 
complexes. However, the cooperativity of two complexants does not result in a more 
efficient complexation with Cephradine in comparison with complexation using a single 
complexant only.
9.1 Introduction
In chapter 3 it was shown that the accommodation of guest molecules in the 
clathrate-type complexes of Cephradine has a considerable adaptability. 
Nevertheless, this induced-fit phenomenon has its limitations as is demonstrated for
This chapter is subm itted for publication: G.J. Kemperman, R. de Gelder, F.J. Dommerholt, A.J.H. 
Klunder, B. Zwanenburg, M olecular selectivity and cooperativity in  clathrate-type complexation of 
Cephradine, submitted.
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instance by the acceptance of tetrahydronaphthols 1 and 2 as guest molecule while 
decanol 3 does not form a complex. It may further be hypothesized that the 
difference in complexation behavior between molecules of related structures may be 
sufficient to give a selective complexation. Separation of isomeric molecules is then 
an interesting option. When effective, a separation by selective complexation is 
attractive as it is a fast and inexpensive methodology. Toda et al., used inclusion with 
1,1/6/6,-tetraphenylhexa-2/4-diyne-1/6-diol 4 as the host molecule for the separation 
of o- and p-disubstituted benzene derivatives as well as mono- and di-substituted 
naphthalenes.1 In this chapter a preliminary study is described concerning the 
separation of o- and p-disubstituted benzene derivatives using selective 
complexation with Cephradine 5.
As Cephradine is a chiral molecule, optical resolution of racemic mixtures by 
complexation with this antibiotic is, at least in principle, feasible. Accordingly, some 
experiments were conducted to accomplish a resolution of racemates.
OH
OH
Ph
P h-
OH
Ph
Ph
OH
2 31
4 5
In the process of identifying suitable complexing agents for cephalosporin 
type antibiotics individual candidates were subjected to complexation conditions. 
Most efficiently, these experiments were conducted for a series of candidates in a 
parallel fashion. In the preceding chapters the parallel approach was used to identify 
suitable complexants. Sada et al., used the parallel methodology to develop inclusion 
compounds derived from ammonium carboxylates as the hosting system.2 An 
alternative approach would be to expose a hosting compound to a mixture of 
potential complexants, thereby assuming that complexation would preferentially 
occur with the best guest molecule. In fact, this cocktail approach would be very 
attractive in identifying the optimal complexing agent. An additional feature of this 
cocktail approach might be that two or more compounds show a cooperative effect
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in filling up the hosting cavities. The combined properties of two or more 
complexants are then more appropriate for complexation than those of the 
individual compounds. Complexation with more than one guest molecule is often 
referred to as a solid solution. An example of a such process whereby two or more 
molecules are involved, is the resolution of racemates via the Dutch Resolution 
methodology.3 Here potential resolving agents are exposed to a racemate in a 
cocktail fashion. Solid solutions may have a higher density and a lower solubility 
than pure components.4 From this point of view complexation of Cephradine with 
more than one guest molecule could lead to a lower residual concentration of the 
antibiotic than can be reached by using a single complexant. In this chapter some 
preliminary experiments are reported using the cocktail approach.
9.2 Separation of o- and ^-disubstituted benzene derivatives by 
preferential complexation with Cephradine.
A series of o- and p-disubstituted benzene derivatives was subjected to 
complexation with Cephradine. The underlying assumption is that the hosting 
framework of this antibiotic may show preferential or even selective complexation 
with one of the isomers. The o/p mixtures were exposed to the antibiotic using either 
water or ethyl acetate containing 5% of water as the medium. In the latter case the 
cephalosporin forms a suspension. These heterogeneous conditions resemble those 
used by Toda et al. for experiments with host molecules 6, 7 and 8.5 The complexant 
can be readily separated from Cephradine by an acidic or basic hydrolysis of the 
complex followed by extraction with an organic solvent. This separation process 
makes use of the zwitterionic nature of the antibiotic.
There is a considerable solvent effect on the composition of the precipitated 
molecular complexes. In some cases, the selectivity of the complexation is entirely
6 7 8
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opposite for both media, viz. for hydroxyacetophenone and methylbenzoic acid. This 
difference in behavior may be attributed to different Gibbs energies of solvation of 
the guest molecule in the two media. The effect of the Gibbs energy of solvation 
during the complexation has been noted previously.6
Table 1 Cephradine complexation with o/p mixtures of disubstituted benzene 
derivatives.
ortho/para mixture
purity §
ethyl acetate water
hydroxybenzoic acid 84% ortho 52% ortho
aminophenol 81% ortho 100% ortho
dihydroxybenzene 90% para 57% ortho
nitrophenol 67% para *
aminobenzoic acid * 100% ortho
nitrotoluene 72% para *
hydroxyacetophenone 100% para 100% ortho
methoxyacetophenone 62% ortho 100% ortho
methylbenzoic acid 100% para 100% ortho
methyl hydroxybenzoate 73% para 100% para
§ The purity of the major product after decomplexation. 
* No complex formation
9.3 Attempted enantioselective clathration
As indicated in the introduction optical resolution of racemates by 
complexation with these antibiotics is conceivable. It should be noted, however, that 
the cavities in the hosting framework only can accommodate rather flat guest 
molecules. Hence, complexants with sp3 stereogenic centers probably have little 
chance to be accepted in the hosting cavities of cephalosporin antibiotics.7 
Nevertheless, a series of racemic compounds was subjected to complexation 
conditions with Cephradine. The following compounds were investigated: 
phenethylamine, phenethylalcohol, phenylglycine, phenylglycineamide, 
phenylglycine methyl ester, menthol, 1,5-dihydroxy-1,2,3,4-tetrahydronaphthalene, 
benzoine, 2,2'-bisnaphthol, 2-methylcyclohexanone, several racemic natural amino 
acids.
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Neither of these molecules showed enantioselective clathration. In most cases no 
complex formation was observed. Most probably these compounds do not fit in the 
cavities of the Cephradine hosting structure or in case of the more polar amino acids 
they may be too strongly solvated by water which is unfavorable for complex 
formation.6 Even 2,2'-bisnaphthol, which contains two flat naphthol units in a 
twisted position, is not accepted.
9.3 Cooperative effect of complexants in the clathration with  
Cephradine.
The exposure of a solution of Cephradine to a mixture of complexing agents 
may either lead to a preferential (or selective) complexation or to the simultaneous 
inclusion of more than one guest molecule. In the latter case a solid solution will be 
obtained. In order to investigate the possible formation of such a solid solution 
Cephradine was treated with a cocktail of mono-, di-, and tri-hydroxybenzenes. 
Prior to this investigation, these compounds were all subjected individually to 
complexation with Cephradine in order to establish the structure type of the 
resulting complexes by X-ray powder diffraction as well as their complexation 
efficiency by HPLC measurements. The components in this cocktail are all 
reasonably soluble in water. This has the advantage that complexation can start from 
a completely homogeneous solution with equal concentrations of each component. 
This mixture of hydroxybenzenes gave upon treatment with Cephradine needle 
shaped crystals within a couple of hours. An HPLC analysis of the needles revealed 
that all five compounds were incorporated in the obtained crystalline material. The 
ratio of the individual components in the crystals was not the same in successive 
experiments and turned out to be dependent on the precise conditions of the 
complexation experiments. In all cases, however, the needles appeared unstable and 
turned spontaneously into powders upon drying. Therefore single-crystal X-ray 
diffraction was not possible. According to the powder diffraction pattern of the 
resulting powder, the structure does not correspond to any of those found for the 
complexes of Cephradine with either of the individual guest molecules. Another 
interesting observation was that standing in the aqueous mother liquor, the initially 
formed needles recrystallize to form cubes. In contrast to the needles the cubes were 
fully stable and could be analyzed by single-crystal X-ray diffraction. The crystal 
structure, which is depicted in Figure 1, proved that two compounds are included in 
this cube-shaped Cephradine complex, v iz .  1,3-dihydroxybenzene and 1,3,5-
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trihydroxy-benzene. In this structure two types of cavities can be recognized, of 
which one is entirely occupied by 1,3-dihydroxybenzene and the other one for 50% 
by 1,3-dihydroxybenzene and for 50% by 1,3,5-trihydroxybenzene. This results in an 
overall ratio of the respective compounds of 3:1. Powder diffraction showed that this 
crystal structure is isomorphous with that of the powder originating from the 
initially obtained needles. Apparently, the formation of these needles is kinetically 
preferred, but when the needles are kept in the mother liquor they recrystallize to 
the thermodynamically favored cubes containing only 1,3-dihydroxybenzene and 
1,3,5-trihydroxybenzene. It was found that the three component complex of 
Cephradine, 1,3-dihydroxybenzene and 1,3,5-trihydroxybenzene can also be 
prepared directly by treating a Cephradine solution with a mixture of the two 
complexants.
Figure 1 The complex of Cephradine and 1,3-dihydroxybenzene and 1,3,5-trihydroxy- 
benzene as guest molecules.
The formation of a molecular complex of Cephradine with two complexants 
clearly points to a cooperative effect of the two complexants, otherwise there would 
have been the preferential formation of a complex with only one (the most efficient) 
component. The thermodynamic preference of complexation with two guest 
molecules in the hosting framework of Cephradine raised the question whether this
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complex leads to a lower residual concentration of the antibiotic than when the 
complex with only one of the complexing agents is used. Therefore, the residual 
concentration of Cephradine was compared when 1,3-dihydroxybenzene, which is 
the most efficient complexant of the two, was used as a single complexant and when 
a complex with a 3:1 ratio of 1,3-dihydroxybenzene and 1,3,5-trihydroxybenzene was 
applied. It was found that at best a similar efficiency was achieved in both cases. 
There is, therefore, in this case no clear advantage of the use of the complex with two 
components.
Another case of cooperativity of two complexants was encountered when 
Cephradine was treated with a-naphthol and methyl 4-hydroxybenzoate (paraben). 
Similarly ff-naphthol and paraben were jointly accommodated in a complex with 
Cephradine. Both crystalline complexes were analyzed by powder diffraction. The 
powder diagrams clearly revealed that these complexes with two components have a 
C2 cavity structure, which is also obtained with a- or ff-naphthol as the single 
complexant (this complex has a 2:1 ratio of host and guest). Remarkably, the 
complex with paraben as the single complexant has the C2 channel-type structure 
(host:guest is 1:1). Apparently, the inclusion of paraben into the complex together 
with naphthol has a thermodynamic preference for the C2 cavity-type structure. A 
pronounced demonstration of this thermodynamic preference of the C2 cavity 
structure is that the complex of Cephradine and paraben obtained when Cephradine 
is treated with paraben containing a small amount of a- or ff-naphthol as a seed 
molecule, 5% suffices, adopts the C2 cavity structure. The inclusion of even a minor 
amount of naphthol has a profound effect on the structure of the complex.
Also in this case the residual concentration of antibiotic was compared for the case 
with only a-naphthol as the complexant and when a two complexant complex with 
paraben is used. However, the efficiency of the complexation in both cases was 
practically the same. The cooperative effect of two complexants does not lead to a 
more efficient complexation.
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9.4 Concluding remarks
The separation of o/p  mixtures by selective complexation with Cephradine 
has been demonstrated. There is a notable effect of the medium used in the 
complexation experiments. In some cases a complete selectivity was achieved, thus 
allowing the separation of these o- and p- isomers.
An enantioselective complexation in order to accomplish a resolution of a racemate 
was not observed. The reason is that the hosting cavity of Cephradine is not capable 
of accommodating guest molecules with sp3 stereogenic centers.
The cooperativity of two complexants leads to complexes in which two guest 
molecules are incorporated in the hosting framework of Cephradine. Hence, the 
accommodation of two components is thermodynamically preferred over a selective 
complexation with one of the complexing agents. This positive outcome of the 
cooperative effect must be attributed to a strain relieving effect and a subtle pattern 
of molecular interactions throughout the overall structure of the complex, which 
results in an energetic advantage. The two-guest complexes studied do not give a 
lower residual concentration of the antibiotic and accordingly, the use of two 
component complexation has no clear advantage in the enzymatic synthesis of 
cephalosporin-type antibiotics in comparison with the single component 
complexation discussed in preceding chapters. Nevertheless, the cooperative effect 
of two guest molecules in molecular complexation is a remarkable phenomenon that 
is worth further study.
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9.5 Experimental Section
Cephradine monohydrate was a generous gift of DSM Life Sciences Group 
(Geleen, The Netherlands). All complexing agents used are commercially available 
and were purchased from either Acros or Aldrich. X-ray powder patterns were 
recorded on a Philips PW1820 Automatic Powder Diffractometer equipped with a 
Philips PW1830 High Voltage Generator. For the HPLC analysis a Pharmacia 
LKB.LCC 2252 HPLC was used with a reversed phase column (Merck 50983 
LiChrospher 100RP18, 5 ^m, 250x4 mm). For detection a UV detector (A=254 nm) of 
Farmacia LKB.UV-MII was used. An appropriate eluent for the analysis was a 
mixture of acetonitrile (HPLC grade) and a 50 mM phosphoric acid buffer with
pH=2.7.
Cephradine with a mixture of o- and p-disubstituted benzene derivatives.
Cephradine (525 mg, 1.5 mmole) was dissolved in water (40 ml). To this stirred 
solution a mixture of o- and p-disubstituted benzene derivative (0.75 mmole of each) 
dissolved in methanol (2 ml) was added. After one night the resulting crystals were 
collected by filtration. The complex was hydrolyzed in 2M HCl followed by 
extraction of the included compound with ethyl acetate. The ethyl acetate was 
evaporated and the resulting product was analyzed by HPLC.
The experiments were also performed in ethyl acetate. To this end a mixture of o- 
and p-disubstituted benzene derivative (0.75 mmole of each) was dissolved in ethyl 
acetate (10 ml) containing 0.5 ml of water. To this stirred solution Cephradine (525 
mg, 1.5 mmole) was added. After the resulting suspension was stirred overnight, the 
complex was isolated by filtration and analyzed as described above.
Cephradine with phenol, mono-, di- and trihydroxybenzenes.
Cephradine (525 mg, 1.5 mmole) was dissolved in water (50 ml). A mixture of 
phenol, catechol, resorcinol, pyrogallol and phloroglucinol (of each 0.75 mmole) 
dissolved in methanol (4 ml) was added to the Cephradine solution. After the 
crystallization the crystals were collected and analyzed by HPLC and X-ray powder 
diffraction. The cubic-shaped single crystals that resulted from these experiments 
were analyzed by X-ray single crystal diffraction as is described further on in this 
section.
Efficiency measurements were performed similarly as described in chapter 5. To a 
stirred solution of Cephradine (525 mg, 1.5 mmole) in water (50 ml) a solution of 1,3- 
dihydroxybenzene and 1,3,5-trihydroxybenzene (1.5 mmole in total comprising the 
components in various ratio's) in methanol (2 ml) was added. Filtrate samples, taken
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90 min and 24 h after the addition of the complexing agents, were analyzed by HPLC 
to determine the residual concentration of Cephradine.
Cephradine w ith  a - or ff-naphthol and m ethyl 4-hydroxybenzoate (paraben).
Cephradine (525 mg, 1.5 mmole) was dissolved in water (50 ml). To the Cephradine 
solution a mixture of a-(or ff-)naphthol (0.75 mmole) and paraben (0.75 mmole) 
dissolved in methanol (2 ml) was added. After one night crystals were collected by 
filtration and analyzed by HPLC and X-ray powder diffraction.
Efficiency measurements were performed similarly as described in chapter 5. To a 
stirred solution of Cephradine (525 mg, 1.5 mmole) in water (50 ml) a solution of a- 
naphthol (0.75 mmole) and paraben (0.75 mmole) dissolved in methanol (2 ml) was 
added. Filtrate samples, which were taken 90 min and 24 h after the addition of the 
complexing agents, were analyzed by HPLC to determine the residual concentration 
of Cephradine.
C rystal structure  determ ination o f the C ephradine/1,3-dihydroxybenzene/1,3,5- 
trihydroxybenzene complex.
A transparent colorless crystal (0.31 x 0.31 x 0.29 mm ) was mounted on a glass fiber 
and intensity data were collected on a Nonius CAD4 diffractometer. The radiation
o
used was CuKa (graphite monochromated) with a=1.54184A. Intensity data were 
corrected for Lorentz and polarization effects. Semi-empirical absorption corrections 
(y-scan) were applied.8 The structures were solved using the program system 
DIRDIF.9 Structure refinement was performed by full-matrix least squares on F2 
(program SHELXL).10
Crystal data: C42H56N6O14S2, M w = 933.05, T  = 293(2) K, Triclinic, P 1, a = 7.0822(4) A, 
b = 15.5835(11) A, c = 21.6513(14) A, a  = 105.877(14)°, ff = 94.636(11) °, Y  = 91.243(10) °, 
U  = 2288.5(3) A3, Z  = 2, D c = 1.354 Mgm-3, refl. collected/unique 8928 /  8928, g.o.f. 
on F2 = 1.049, SHELXL-97 weight parameters 0.097200 and 0.414400, R (all data): R1 
= 0.0686, wR2 = 0.1559, Largest diff. peak and hole 0.592 and -0.358 e.A'3
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Summary
This thesis deals with selective complexation of the ff-lactam antibiotics 
Cephalexin, Cephradine, Cefaclor and Cefadroxil. These life-saving antibiotics 
belong to the class of the cephalosporins and are already on the market for 
approximately 25 years. Moreover, their markets are forecasted to remain substantial 
for the next two decades. Accordingly, there is both the opportunity and the need for 
innovation of the processes by which these antibiotics are being manufactured. 
Besides improvement of economical benefit, an important driving force behind these 
innovations is reduction of the amount of chemical waste, which is inherently 
formed during the currently used stoichiometric chemical processes. This reduction 
of the environmental impact can be achieved by replacing the conventional chemical 
processes by "green" biocatalytic processes.
NH
2 HN S
c o 2h
I
NH2 H N
CO2H
Cephalexin Cephradine
The cephalosporins are semi-synthetic antibiotics. They consist of a ff-lactam 
nucleus and a D-amino acid side chain. The final step in the preparation of these 
cephalosporins comprises the coupling of the ff-lactam nucleus and the D-amino acid 
side chain. The conventional methodology to achieve this coupling, which is still 
used by most manufacturers, requires stoichiometric chemistry resulting in the 
formation of considerable amounts of chemical waste. A contemporary method 
employs biocatalysis for the coupling of nucleus and side chain. This enzymatic 
coupling does not require activating agents or protective groups and can be
161
conducted in water. An important drawback of the enzymatic coupling is the 
secondary hydrolysis of the cephalosporin product by the enzyme. In addition, 
isolation of the product from the aqueous reaction mixture is hampered as the 
product concentrations obtained by the enzymatic coupling are relatively low and 
because of the presence of starting materials and side-products. Selective 
complexation of the cephalosporins with ff-naphthol, provides an efficient method 
for the isolation of these antibiotics from aqueous solutions. By using complexation 
with ff-naphthol during the enzymatic synthesis, the problem of secondary 
hydrolysis is substantially reduced by instantaneous withdrawal of the product from 
solution, as is depicted in scheme 1 for Cephalexin.
Scheme 1 Complexation w ith  ff-naphthol d u rin g  the enzymatic synthesis o f Cephalexin
Although ff-naphthol is a reasonable complexing agent for the four 
abovementioned cephalosporins, it is marked by some clearly negative features. As 
ff-naphthol is a naphthalene derivative, it has a certain toxicity and associated with 
that an image problem. Hence, ff-naphthol is not particularly suitable for application 
in a "green" enzymatic process. The research described in this thesis was aimed at 
acquiring fundamental knowledge about the selective complexation as well as at the 
improvement of the complexation process with respect to both the efficiency and the 
toxicity of the complexing agent for each of the four antibiotics. Furthermore, the 
question has been addressed whether the acquired insights can be incorporated in a
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computer model, which allows the identification of new complexing agents in a 
rational manner.
In Chapter 2, structure elucidation of the cephalosporin complexes with ff- 
naphthol, using single crystal X-ray diffraction, is described. It was found that the 
complexes are clathrates in which the cephalosporins form the hosting lattice in 
which ff-naphthol is accommodated. The ff-naphthol complexes formed by 
Cephalexin (Figure 1a), Cephradine and Cefaclor are isomorphous, whereas 
Cefadroxil behaves differently in this complexation (Figure 1b), due to the presence 
of the hydroxyl function in the side-chain of this antibiotic.
a
b
Figure 1 The ff-naphtho l (encircled) complexes o f Cephalexin (a) and Cefadroxil (b).
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In Chapter 3, the possibility of replacing ff-naphthol by molecules, which 
exhibit molecular similarity with the original guest, is elaborated. The differences 
found between the ff-naphthol complexes of Cephalexin, Cephradine and Cefaclor 
on one hand and Cefadroxil on the other hand, appeared to have enormous 
consequences for their behavior in the complexation with other molecules than ff- 
naphthol. The hosting structures formed by Cephalexin, Cephradine and Cefaclor 
show a remarkable adaptability and as a result have the ability to adjust the size of 
the hosting cavity to the size of the guest molecule. The hosting framework formed 
by Cefadroxil has only a limited adaptability and lacks the induced fit mechanism 
encountered for the structures of the other three cephalosporins. Consequently, a 
large series of ff-naphthol related guest molecules form complexes with Cephalexin, 
Cephradine and Cefaclor, while Cefadroxil is highly discriminative in 
accommodating conceivable guest molecules.
In Chapter 4 the boundaries of the induced fit mechanism observed for 
Cephalexin, Cephradine and Cefaclor are explored further. For this purpose 
molecules larger than naphthalene, e.g. phluorene, and molecules smaller than 
naphthalene, e.g. benzene derivatives, are investigated in the complexation with 
Cephradine. This is of interest from a fundamental as well as an industrial point of 
view. It was found that a large series of benzene derivatives and several molecules 
larger than naphthalene can form complexes with Cephradine. Several complexing 
agents, lacking the toxicity associated with the naphthalene derivatives, were 
identified among the benzene derivatives. Interestingly, besides the induced fit 
mode observed when naphthalene derivatives were included, also entirely different 
induced fit adaptabilities of the Cephradine lattice were encountered for the 
complexes of Cephradine with benzene derivatives or molecules larger than 
naphthalene. Hence, not only clathrate type complexes can be obtained, but layer 
and channel type structures can be created as well, provided that the appropriate 
complexing agent is selected.
Chapter 5 deals with the efficiency of cephalosporin complexation. It is 
demonstrated that the efficiency of the complexation process can be improved 
significantly when other complexing agents than ff-naphthol are employed. For 
Cephalexin, Cephradine and Cefaclor, which form isomorphous complexes with 
naphthalene derivatives, the complexation process proceeds most efficiently when 
a-naphthol is used as the complexing agent. For Cefadroxil, 2,7- 
dihydroxynaphthalene is the complexing agent of choice. A thermodynamic analysis 
of the complexation reaction, using both efficiency measurements and literature
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data, clearly shows the importance of the Gibbs energy of solvation of a complexing 
agent in water on the efficiency of the complexation reaction. It is concluded that the 
positive effect of polar groups in the guest molecule on the complexation efficiency 
can be diminished or even completely counterbalanced by an increase of the Gibbs 
energy of solvation of the guest molecule.
In Chapter 6 the effect of in s itu  clathration during the enzymatic synthesis of 
Cephalexin is described. The objective to drastically reduce the secondary hydrolysis 
during the enzymatic synthesis of cephalosporins was indeed achieved through 
selective removal of Cephalexin by complexation. As a result a much higher product 
yield can be obtained. This effect becomes really significant when the equilibrium 
concentration of Cephalexin during the complexation process is below 10 mM. 
Furthermore, in this chapter attention is paid to the discovery of complexing agents 
suitable for use during the enzymatic synthesis of Cephradine, having an acceptable 
toxicity. First, compounds were selected from the series of benzene derivatives 
identified as complexing agents for Cephradine (see chapter 4) based on the toxicity 
criterion. These compounds were subjected to efficiency measurements under 
conditions resembling those used for the enzymatic synthesis of Cephradine, viz. 
pH=7.2, T=5°C. Under these conditions, five compounds have a residual 
concentration of Cephradine below 10 mM. The compatibility of these five 
compounds with immobilized Penicillin G acylase was then studied. All five 
compounds inhibit the enzyme, however, three of these, viz. 2-phenylphenol, methyl 
4-hydroxybenzoate and methyl 2-aminobenzoate, exhibit reversible inhibition of the 
enzyme resulting in a lower activity, but not in an inactivation of the enzyme. This 
implies that the enzyme can be reused for successive batches, which is essential as 
the price of the enzyme accounts for a substantial part of the total cost of 
enzymatically prepared cephalosporin.
The study described in Chapter 7 was aimed at the development of a 
computational model for predicting clathration with cephalosporines. It was shown 
that docking of potential complexing agents in the cavity present in the hosting 
lattice formed by Cefadroxil, does not lead to the identification of new complexing 
agents. These poor results obtained by the docking search may be due to the variable 
number of water molecules incorporated in the complexes. The presence of water 
molecules affects the exact size and shape of the cavities present in the hosting lattice 
formed by the cephalosporins. Consequently, the cavity cannot be clearly defined, 
which is essential for a successful docking search. Therefore, another approach, 
which makes use of the molecular similarity principle, for the prediction of
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complexation was investigated. From the calculated molecular similarities of a set of 
120 molecules, comprising both complexing agents and molecules that do not form a 
complex with Cephradine, a predictive model could be derived using Linear 
Discriminant Analysis (LDA). The way in which the molecular similarity was 
calculated appeared to be crucial. Furthermore, in order to derive a useful model, 
LDA has to be applied on the molecular similarities between the molecules in the 
data set and a limited number of guiding compounds rather than on the complete 
similarity matrix. In this way, a model was obtained that predicts whether a 
molecule forms a complex with Cephradine with a predictive score of 86%. This 
model is based on the molecular similarity of a potential complexing agent with only 
three guiding compounds. The procedure used to derive this model may have some 
general relevance for fitting guest molecules in a cavity.
In Chapter 8 the synthesis of Cephalexin, Cephradine and Cefadroxil starting 
from racemic amino acid side chains is described. Since side chains are much 
cheaper in racemic than enantiopure form, this route may be an attractive alternative 
for the current process. However, this route is only economically viable when the 
epi-cephalosporin, formed during the coupling of racemic side chains, can be 
converted into the desired antibiotic having the D-amino acid side chain. For this 
purpose, an asymmetric transformation of the cephalosporins was developed. The 
interesting observation was made that cephalosporins can be epimerized at the a- 
carbon of their side chains under remarkably mild conditions. This epimerization is 
promoted by the formation of a Schiff base of the amino function of the 
cephalosporin with salicylic aldehyde or pyridoxal, which is present in a catalytic 
amount. After the epimerization has reached its equilibrium, the desired 
diastereomer is withdrawn from solution by selective complexation with an 
appropriate complexing agent. In this manner, a complete shift of the equilibrating 
epimeric cephalosporin to the desired diastereomer can be achieved. For the 
coupling of the racemic side chains with the ff-lactam nucleus, the chemical synthesis 
using the Dane salt protected side chain is employed (Scheme 2). Via the asymmetric 
transformation process, the epi-cephalosporin will be epimerized to the desired 
cephalosporin, by selective complexation. After decomplexation, the cephalosporins 
Cephalexin, Cephradine and Cefadroxil are obtained in overall yields of 68%, 73% 
and 57%, respectively.
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Scheme 2 The synthesis o f cephalosporins s tarting from  racemic am ino acid side chains.
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Chapter 9 deals with the complexation of Cephradine with multiple 
complexing agents. The first question that has been addressed is the ability of 
Cephradine to give enantioselective clathration. Resolution of racemic compounds 
by clathration with Cephradine was not successful. However, chemoselective 
clathration using Cephradine as the hosting molecule could be achieved 
successfully. Several ortho/para mixtures of disubstituted benzene derivatives were 
subjected to complexation with Cephradine. In a number of cases complete 
selectivity for either the ortho or para isomer was observed. In addition, it was found 
that the success of chemoselective clathration depends on the solvent used for the 
crystallization. Another intriguing phenomenon is the inclusion of more than one
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type of complexing agent by Cephradine. In several cases complexes of Cephradine 
containing two or more different complexing agents could be prepared. Since during 
the formation of these so-called "solid solutions", crystal packing is optimized 
leading to more efficient crystallization, i.e. a lower solubility of the complex. 
However, a lower solubility of the multi-guest complexes formed by Cephradine 
leading to a lower residual concentration of the antibiotic in water, in comparison 
with the use of a single complexant, could not be demonstrated.
A summary in English and Dutch concludes this thesis.
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Samenvatting
Dit proefschrift handelt over de selectieve complexatie van de ff-lactam 
antibiotica Cefalexine, Cefradine, Cefaclor en Cefadroxil. Deze levensreddende 
antibiotica behoren tot de klasse van de cefalosporines en zijn reeds ongeveer 25 jaar 
op de markt. Volgens voorspellingen zullen de markten voor deze cefalosporines 
ook nog gedurende de volgende twee decennia aanzienlijk zijn. Hierdoor ontstaat 
zowel de mogelijkheid als ook de noodzaak om de processen, waarmee deze 
antibiotica worden gefabriceerd, te innoveren. Naast het opvoeren van het 
economisch rendement, is een andere belangrijke drijfveer voor deze innovaties het 
terugdringen van de hoeveelheid afval die inherent is aan de huidige 
productiemethoden voor de cephalosporines. Dit terugdringen kan worden 
gerealiseerd door de huidige stoichiometrische chemische processen te vervangen 
door "groene" biokatalytische processen.
De cefalosporines zijn semi-synthetische antibiotica. Ze zijn opgebouwd uit 
een ff-lactam kern en een D-aminozuur zijketen. De laatste stap van de bereiding van 
deze cefalosporines omvat de koppeling van de ff-lactam kern en de D-aminozuur 
zijketen. De conventionele wijze waarop deze koppeling tot stand wordt gebracht en 
die nog steeds door de meeste producenten wordt toegepast, vereist 
stoichiometrische chemie, hetgeen de vorming van aanzienlijke hoeveelheden 
chemisch afval met zich meebrengt. Een moderne methode maakt gebruik van
c o 2h c o 2h
Cefalexine Cefradine
c o 2h c o 2h
Cefaclor Cefadroxil
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biokatalyse voor de koppeling van kern en zijketen. Deze enzymatische koppeling 
behoeft geen activerende reagentia en beschermgroepen en kan worden uitgevoerd 
in water. Een belangrijk nadeel van de enzymatische koppeling is de secondaire 
hydrolyse van het cefalosporine product door het enzym. Daarnaast wordt de 
isolatie van het product uit het waterige reactiemengsel bemoeilijkt omdat in het 
geval van de enzymatische koppeling, de verkregen concentraties aan product 
relatief laag zijn, als ook door de aanwezigheid van uitgangsstoffen en bijproducten. 
Selectieve complexatie van de cefalosporines met ff-naftol vormt een efficiënte 
methode voor de isolatie van deze antibiotica uit waterige oplossingen. Door 
gebruik te maken van complexatie met ff-naftol kan het probleem van secundaire 
hydrolyse drastisch worden verminderd, omdat het product direct na de vorming 
aan de oplossing wordt onttrokken. Dit principe is geïllustreerd voor Cefalexine in 
schema 1.
Schema 1 Complexatie met ff-nafto l tijdens de enzymatische synthese van Cefalexine.
Hoewel ff-naftol een redelijk efficiënte complexant is voor de vier 
bovengenoemde cefalosporines, wordt het gekenmerkt door een aantal nadelen. 
Omdat ff-naftol een naftaleenderivaat is, heeft het een zekere toxiciteit en een 
daarmee geassocieerd negatief imago. Derhalve is ff-naftol minder geschikt voor 
toepassing in een "groen"enzymatisch proces. Het onderzoek, dat beschreven wordt 
in dit proefschrift, is gericht op het verwerven van fundamenteel inzicht in de
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werking van de selectieve complexatie, alsmede op het verbeteren van het 
complexatie proces met betrekking tot de efficiëntie en de toxiciteit van de 
complexant voor de vier genoemde antibiotica. Verder werd onderzocht hoe, 
gebruikmakend van de verworven inzichten, een computermodel kan worden 
afgeleid waarmee nieuwe complexanten op een rationele wijze kunnen worden 
voorspeld.
In Hoofdstuk 2 wordt de opheldering van de structuren van de cefalosporine 
complexen met ff-naftol met behulp van éénkristal röntgendiffractie, beschreven. Het 
bleek dat de complexen van het clathraat type zijn, waarbij de cefalosporines het 
gastheer rooster vormen en waarin ff-naftol als gast is opgenomen. Het bleek dat de 
ff-naftol complexen van Cefalexine (Figuur 1a), Cefradine en Cefaclor isomorf zijn. 
Cefadroxil gedraagt zich echter anders in de complexatie met ff-naftol (Figuur 1b), 
hetgeen wordt veroorzaakt door de aanwezigheid van de hydroxyl-functie in de 
zijketen van dit antibioticum.
a
b
Figuur 1 De ff-nafto l (om cirke ld) complexen van Cefalexine (a) en Cefadroxil (b).
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In Hoofstuk 3 wordt de mogelijkheid behandeld om ff-naftol te vervangen 
voor andere moleculen, die moleculaire similariteit met de oorspronkelijke gast 
vertonen. De verschillen die werden gevonden tussen de ff-naftol complexen van 
Cefalexine, Cefradine en Cefaclor enerzijds en Cefadroxil anderzijds, blijken enorme 
consequenties te hebben voor hun gedrag in de complexatie met andere moleculen. 
De gastheerstructuren gevormd door Cefalexine, Cefradine en Cefaclor vertonen een 
verrassend aanpassingsvermogen en zijn als gevolg hiervan in staat om de afmeting 
van de holtes in hun rooster aan te passen aan de afmeting van het gastmolecuul. 
Het gastheerrooster gevormd door Cefadroxil kan zich slechts in beperkte mate 
aanpassen aan de gast en mist het "induced-fit" mechanisme, dat werd 
waargenomen voor de structuren van de andere drie cefalosporines. Dit heeft als 
consequentie, dat een uitgebreide reeks gastmoleculen complexen vormt met 
Cefalexine, Cefradine en Cefaclor, terwijl Cefadroxil erg kieskeurig is met het 
accommoderen van gastmoleculen.
In Hoofdstuk 4 worden de grenzen van het "induced-fit" mechanisme, dat 
werd aangetoond voor Cefalexine, Cefradine en Cefaclor, verder verkend. Hiertoe 
werden moleculen groter dan naftaleen, bv. fluoreen, en moleculen kleiner dan 
naftaleen, bv. benzeenderivaten, onderzocht in de complexatie met Cefradine. Dit is 
zowel vanuit fundamenteel als vanuit industrieel oogpunt interessant. Het bleek, dat 
benzeenderivaten en ook een aantal moleculen groter dan naftaleen, complexen 
kunnen vormen met Cefradine. Een aantal van de nieuw gevonden complex 
vormende benzeenderivaten missen de toxiciteit die karakteristiek is voor de meeste 
naftaleenderivaten. Interessant is de waarneming dat naast het "induced-fit" 
mechanisme in het geval van naftaleenderivaten tevens heel andere "induced-fit" 
mechanismen mogelijk zijn voor de complexen van Cefradine met benzeenderivaten 
of moleculen groter dan naftaleen. Dit betekent, dat, naast clathraat-type complexen, 
ook gelaagde structuren en kanaalstructuren mogelijk zijn, mits hiervoor een 
geschikte complexant wordt geselecteerd.
Hoofdstuk 5 handelt over de efficiëntie van de cefalosporine complexatie. Er 
wordt aangetoond dat de efficiëntie van het complexatie proces significant kan 
worden verbeterd, indien andere complexanten worden gebruikt in plaats van ff- 
naftol. In het geval van Cefalexine, Cefradine en Cefaclor, die isomorfe complexen 
vormen met naftaleenderivaten, verloopt het complexatie proces het meest efficiënt 
met a-naftol als gastmolecuul. Voor Cefadroxil is voor de efficiëntie van het 
complexatie-proces 2,7-dihydroxynaftaleen de beste keuze. Bij een 
thermodynamische beschouwing van de complexatie, gebaseerd op zowel de
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efficiëntiemetingen als op data uit de literatuur, komt duidelijk het effect van de 
Gibbs solvatatie-energie van het gastmolecuul in water, op de efficiëntie van de 
complexatie-reactie tot uiting. Hieruit volgt als belangrijkste conclusie, dat het 
positieve effect van polaire groepen aan het gastmolecuul op de complexatie 
efficiëntie, verkleint of zelfs compleet tegengewerkt kan worden door de toename 
van de Gibbs solvatatie-energie van het gastmolecuul.
Hoofdstuk 6 belicht de effecten van in situ clathraatvorming tijdens de 
enzymatische synthese van Cefalexine. Het bleek dat, door selectieve verwijdering 
van Cefalexine tijdens de enzymatische synthese, de secundaire hydrolyse sterk 
vermindert. Hierdoor kan een veel hogere opbrengst aan product worden 
verkregen. Dit effect wordt significant als de evenwichtsconcentratie van Cefalexine 
tijdens het complexatie-proces lager is dan 10 mM. Verder wordt in dit hoofdstuk 
aandacht besteed aan het vinden van tijdens de enzymatische synthese toepasbare 
complexanten voor Cefradine met een acceptabele toxiciteit. Allereerst werd een 
reeks verbindingen op het toxiciteitcriterium geselecteerd uit de groep 
benzeenderivaten die eerder waren geïdentificeerd als complexant voor Cefradine 
(hoofdstuk 4). Als eerste werd onderzocht welke complexanten voldoende efficiënt 
zijn onder de condities die model staan voor de enzymatische koppeling, namelijk 
pH=7.2 en T=5°C. Bij vijf complexanten is de evenwichtsconcentratie van 
Cephradine onder de bovenstaande condities lager dan 10 mM. Deze vijf 
complexanten zijn onderzocht op hun effect op het enzym. Het bleek, dat deze vijf 
complexanten alle het enzym inhiberen. Echter drie complexanten, namelijk 2- 
fenylfenol, methyl 4-hydroxybenzoaat en methyl 2-aminobenzoaat, inhiberen het 
enzym reversibel, hetgeen resulteert in een lagere activiteit maar niet tot het 
blokkeren van het enzym. Dit impliceert dat het enzym kan worden hergebruikt 
voor volgende batches, hetgeen essentieel is omdat de prijs van het enzym een 
aanzienlijk deel van de totale kostprijs van enzymatisch geproduceerd cefalosporine 
uitmaakt.
Het onderzoek beschreven in Hoofdstuk 7 heeft als doel de ontwikkeling van 
een computermodel, dat gebruikt kan worden voor het voorspellen van 
clathraatvorming met de cefalosporines. Er werd aangetoond, dat "docking" van een 
potentiële complexant in de holte van het gastheerrooster, gevormd door Cefadroxil, 
niet leidt tot de ontdekking van nieuwe complexanten. Mogelijkerwijs is dit 
teleurstellende resultaat van de "docking search" te wijten aan het wisselende aantal 
watermoleculen, dat opgenomen wordt in de holtes in het gastheerrooster. De 
aanwezigheid van watermoleculen in het gastheerrooster, gevormd door de
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cefalosporines, heeft gevolgen voor de exacte afmetingen van de holtes. Het gevolg 
is dat de holte niet precies gedefinieerd kan worden, hetgeen van essentieel belang is 
voor het succes van een "docking search". Daarom werd voor een andere aanpak 
gekozen, namelijk één die gebruik maakt van het moleculaire similariteitsprincipe. 
Uitgaande van de moleculaire similariteiten van een set van 120 moleculen, 
bestaande uit complexanten alsmede moleculen die geen complex vormen met 
Cefradine, kan met behulp van "Linear Discriminant Analysis" (LDA) een 
voorspellend model worden afgeleid. De manier, waarop de moleculaire similariteit 
wordt berekend, bleek uitermate belangrijk te zijn. Verder werd duidelijk, dat, om 
een bruikbaar model af te kunnen leiden, LDA toegepast moet worden op 
moleculaire similariteiten van een reeks moleculen met een beperkt aantal 
gidsstoffen, in plaats van alle 120 moleculen. Op deze manier is een model 
verkregen, dat in staat is om te voorspellen of een molecuul een complex vormt met 
Cefradine met een betrouwbaarheid van 86%. Dit model is gebaseerd op de 
moleculaire similariteit van een molecuul met slechts drie gidsstoffen.
In Hoofdstuk 8 wordt de synthese beschreven van Cefalexine, Cefradine en 
Cefadroxil uitgaande van racemische aminozuur zijketens. Aangezien racemische 
zijketens veel goedkoper zijn dan hun enantiozuivere analoga, zou deze route 
kunnen leiden tot een aantrekkelijk alternatief voor het huidige proces. Om deze 
route economisch levensvatbaar te maken is het echter van wezenlijk belang, dat het 
epi-cefalosporine, dat bij de koppeling van racemische zijketens wordt gevormd, 
omgezet kan worden in het gewenste antibioticum met de betreffende D-aminozuur 
zijketen. Hiertoe werd een asymmetrische transformatie van de cefalosporines 
ontwikkeld. Het bleek, dat de cefalosporines onder opmerkelijk milde condities 
geëpimeriseerd kunnen worden op de a-koolstof van de zijketen. De epimerisatie 
wordt bevorderd door de vorming van een Schiffse base van de amino-functie van 
het cefalosporine met salicylaldehyde of pyridoxal, waarvan een katalytische 
hoeveelheid wordt gebruikt. Nadat het evenwicht van de epimerisatiereactie is 
ingesteld, wordt het gewenste diastereomeer aan het evenwicht onttrokken door 
selectieve clathraatvorming met een geschikte complexant. Voor de koppeling van 
de racemische zijketens met de ff-lactamkern, werd gebruik gemaakt van de 
chemische synthese uitgaande van het Dane-zout van de zijketen, zoals is 
weergegeven in Schema 2. Met behulp van de asymmetrische transformatie kan het 
epi-cefalosporine worden omgezet in het gewenste cefalosporine in de vorm van een 
complex. Na decomplexatie werden de cefalosporines verkregen in opbrengsten van 
respectievelijk 68%, 73% en 57%, voor Cefalexine, Cefradine en Cefadroxil.
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2 . pivaloyl chloride R ^^s^ OCOC(Me)3
O
pyridoxal
complexant
pH=7.5
(cefalosporine)2(ca).xH2O(s)
1. 5% HCl, EtOAc
2 . neutralisatie
R
R complexing agent
Cefalexine fenyl a-naftol
Cefradine fenyl a-naftol
Cefadroxil p-hydroxyfenyl 2,7-dihydroxynaftalene
Schema 2 De synthese van cefalosporines uitgaande van racemische aminozuur zijketens.
Hoofdstuk 9 handelt over de complexatie van Cefradine met meerdere 
complexanten tegelijk. Eerst werd de mogelijkheid onderzocht om Cefradine als 
gastheer te gebruiken voor de chemoselectieve of enantioselectieve 
clathraatvorming. Het onderzoek naar de resolutie van een racemaat van chirale 
verbindingen door middel van clathraatvorming met Cefradine, leidde niet tot 
succes. Chemoselectieve clathraatvorming met Cefradine als gastheermolecuul 
behoort echter wel tot de mogelijkheden. Een reeks mengsels van ortho/para 
digesubstitueerde benzeenderivaten, werd onderworpen aan complexatie met 
Cefradine. In een aantal gevallen vertoont gastheermolecuul Cefradine volledige 
selectiviteit voor de ortho of para gast. Daarnaast bleek, dat welk molecuul wordt
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ingesloten in sommige gevallen afhankelijk is van het gebruikte oplosmiddel. De 
tweede mogelijkheid die werd onderzocht is de simultane insluiting van meerdere 
complexanten in het gastheerrooster gevormd door Cefradine. Aangetoond werd, 
dat complexen van Cefradine met meerdere complexanten kunnen worden gemaakt. 
Aangezien er bij de vorming van deze zogeheten "solid solutions" de mogelijkheid 
is om de kristalpakking te optimaliseren, zou dit kunnen leiden tot efficiëntere 
kristallisatie, gepaard gaande met een lagere oplosbaarheid van het complex. Echter 
een dergelijke lagere oplosbaarheid kon niet worden aangetoond voor de meer-gast 
complexen van Cefradine.
Een samenvatting in het Engels en Nederlands besluit dit proefschrift.
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